The 2nd BSC Based EPHI’s Strategic Management Plan (2015/16 … · 2018-01-17 · The 2nd BSC...

የኢትዮጵያ የሕብረተሰብ ጤና ኢንስቲትዩትEthiopian Public Health Institute

The 2nd BSC Based EPHI’sStrategic Management Plan

(2015/16 to 2019/20)

July 2015

2 The 2nd BSC Based EPHI’s Strategic Management Plan: 2015/16 to 2019/20

MissionThe mission for Ethiopian Public Health Institute is to improve the health of the general public of Ethiopia through undertaking research on priority health and nutrition issues for evidence based information utilization and technology transfer; effective public health emergency management; establishing quality laboratory system; and training public health researchers and practitioners for best public health interventions.

EPHI’s upcoming state of the art laboratory building

Cobas 6000, could analyze 1370 tests per hour.

Vision

To be a center of excellence in public health in Africa.

3The 2nd BSC Based EPHI’s Strategic Management Plan: 2015/16 to 2019/20

ContentI. Acronyms ................................................................................................................................ ......5

II. Forward ........................................................................................................................................7

III. Executive Summary .....................................................................................................................8

Chapter 1: Introduction ...............................................................................................................11

Introduction................................................................................................................................11

Chapter 2: Performance of the first five years BSC Based SPM (2010/11-2014/2015) .........13

2.1 SPM-I: Performance Assessment and Major Achievements in the Past Five Years ...............13

Chapter 3: The 2nd BSC based EPHI’s Strategic Plan .............................................................21

3.1. The Planning Process and Methodology .............................................................................21

3.2. EPHI’s Strategic Assessment ..............................................................................................22

3.3. Strategy (Customer Value Proposition, Strategic Themes and Strategic Results, Perspectives)...29

3.4. Strategic Objectives (SO) ....................................................................................................34

3.5. The Second EPHI’s SPM Strategy Map ...............................................................................45

3.6. Performance Measures and Initiatives for EPHI’s SPM-II ......................................................46

Chapter 4: Costing, Financing and Resource Mapping ...........................................................54

Chapter 5: EPHI SPM Implementation Arrangement ...............................................................57

5.1. Strengthen integration and coordination for successful implementation of the SPM ...........57

5.2. Ensuring the sustainability of the Institute’s achievements ...................................................58

Chapter 6: EPHI SPM Monitoring and Evaluation Framework ................................................61

6.1. The Indicators and Targets for SPM Monitoring and Evaluation ...........................................61

References ...................................................................................................................................72

Annexes ........................................................................................................................................73

Annex-1: Descriptions of strategic initiatives (scopes) and their deliverables ...............................73

Annex -2: Major Activities and specific activities under each initiative and their targets ...............91

Annex -3: Participants of the strategic planning process ..........................................................116


List of TableTable 1: SWOT (Strengths, Weaknesses, Opportunities and Threats) Analysis: ................................23

Table 2: Stakeholders Analysis .........................................................................................................26

Table-3: EPHI’s customer value proposition .....................................................................................29

Table-4: Budget mapping by strategic objectives .............................................................................54

Table -5: Gap analysis of funding (in USD In ‘000’) ...........................................................................55

Table-6: List of performance measures and targets under each objective ........................................63

List of FigureFigure 1: PHE communication and response ..................................................................................15

Figure 2: Weekly surveillance report Completeness &timeliness level in the past 5 years .................15

Figure 3: PHE risk mapping and preparedness ...............................................................................15

Figure 4: Number of trained professionals on PHEM (short term) ....................................................16

Figure 5: PHEM professionals trained in long term scheme (MSc) ...................................................16

Figure 6: SLIPTA Participant Labs. Recognized for star level 1-5 (as of 2015) .................................17

Figure7: Number of EQA evaluated laboratories for one or more tests .....................................17

Figure 8: Number of hospital labs. Equipped with LIS ...............................................................18

Figure 9: Number of laboratory professionals trained in short term trainings ....................................18

Figure 10: Planned, mobilized and utilized budget for the past 5 years ...........................................19

Figure 11: The EPHI’s Performance House (2015/16-2019/2020) ...................................................33

Figure-12: The EPHI Strategy Map (DNA of EPHI)- 2015/16-2019/2020 .........................................45

Figure 13: Monitoring and Evaluation Framework ...........................................................................62


I. AcronymsAMR Antimicrobial Resistance

ANC Antenatal Care

ART Anti-Retroviral Treatment

AWD Acute Watery Diarrhoea

BSC Balanced Scorecard

C Community

CB Capacity Building

CBN Community Based Nutrition

CD Communicable Disease

CMAM Acute Malnutrition Management

CSO Civil Society Organization

DDG Deputy Director General

DG Director General

DoT Directly Observed Therapy Short Course

EDHS Ethiopia Demographic and Health Survey

EDK Emergency Drug Kit

EFY Ethiopian Fiscal Year

EHNRI Ethiopian Health and Nutrition Research Institute

EOC Emergency Operation Center

EPHI Ethiopian Public Health Institute

EPI Expanded Immunization Program

EPRP Emergency Preparedness and Response Plan

F Financial Stewardship

FANC Focus Antenatal Care

FELTP Field Epidemiology and Laboratory Training Program

FMHACA Food, Medicine and Health Care Administration and Control Authority

FMoH Federal Ministry of Health

GTP Growth and Transformation Plan

HAPCO HIV-AIDs Prevention and Control Office

HDA Health Development Army

HIV Human Immuno Deficiency Virus

HSDP Health Sector Development Plan

HSTP Health Sector Transformation Plan

I Indicator

ISO International Organization for Standardization

IYCF Infant and Young Child Feeding

JPCF Joint Partnership Coordination Forum

LIS Laboratory Information System

LLINS Long Lasting Insecticide Nets

LQMS Laboratory Quality Management System

LSA Laboratories Accredited with Limited Scope Accreditation

LSA Limited Scope Accreditation

LTT Long Term Training

MARPS Most at Risk Populations

MDG Millennium Development Goal

MIS Malaria indicator Survey

MNH Maternal and Child Health

MoARD Ministry of Agriculture and Rural Development

MoCS Ministry of Civil Service

MoFED Ministry of Finance and Economic Development

MOST Ministry Of Science and Technology

MTE Mid Term Evaluation

NCD Non Communicable Diseases

NGO Nongovernmental Organization

NNP National Nutrition Program

NPHTC National Public Health Center


NTD Neglected Tropical Diseases

P Internal Process

PFSA Pharmaceuticals Fund and Supply Agency

PHEM Public Health Emergency Management

PMED Planning, Monitoring and Evaluation Directorate

POPs Persistent Organic Pollutants

REQA Regional External Quality Assessment

RRT Rapid Response Team

SARA Service Availability and Readiness Assessment

SI Strategic Initiative

SLIPTA Stepwise Laboratory Improvement Process towards Accreditation

SLMTA Strengthening Laboratory Management Towards Accreditation

SO Strategic Objective

SOP Standard Operation Procedure

SPA Service Provision Assessment

SPM Strategic Management Plan

SWOT Strengths, Weaknesses, Opportunities and Threats

TB Tuberculosis

UNICEF United Nations Child ren’s Fund

VRAM Vulnerability and Risk Assessment and Mapping

WASH Water, Sanitation and Hygiene

WHO World Health Organization


II. ForwardThe Ethiopian Public Health Institute (EPHI) has developed this strategic plan in line with HSTP and GTP-II to address its mission: improve the health of the general public through undertaking research on priority health and nutrition problems for evidence based decision and technology transfer and utilization; effective public health emergency management; establishing quality laboratory system; and training public health researchers and practitioners for better public health interventions.

We have used Balanced Scorecard (BSC) planning and management tool to develop the five years EPHI’s SPM. The BSC is useful for successful implementation of the Institute’s major activities to realize its vision by addressing major public health priority areas in cascaded, sustained and coordinated manner.

We have taken in to account, previous EPHI SPM implementation experience, current situation analysis, HSTP and other national and international relevant documents in the preparation of this public health SPM. The whole process was participatory and consultative of EPHI’s staffs, stakeholders and partners from whom we have incorporated ideas and views.

In order to realize the vision of the Institute, this strategic plan is mainly focused on four thematic areas to excel: research and technology transfer, public health emergency management, quality laboratory system, and leadership and governance towards assuring quality and equity health care services.

I believe that by implementing suchcomprehensive strategic plan, we will be in a good position to address the public health transformation agenda, strong coordination, partnerships and collaborations with all concerned stake holders and partners of the health sector. This will allow us to create conducive environment for shared vision.

Finally, I would like to express my great pleasure and appreciation to the EPHI’s SPM Development Team for their unreserved effort, endurance and commitment in the preparation to deliver such comprehensive five years working document. I would like also to acknowledge the contributions of all partners, stakeholders, and EPHI colleagues for their contribution.

Amha Kebede, Ph D

Director General, EPHI


III. Executive SummaryThe Ethiopian Public Health Institute (EPHI), the former Ethiopian Health and Nutrition Research Institute (EHNRI), is reestablished as an autonomous federal government institute having its own legal personality as the main government body in charge of three main tasks as expressed in the regulation number 301/2013: Research, based on national public health research agenda on priority public health and nutrition issues, generate, translate and disseminate scientific and technological knowledge; surveillance, for the early identification and detection of public health risks and prevent public health emergencies through adequate preparedness, alert, timely information during public health emergency, respond effectively and timely and ensure rapid recovery of the affected population from the impact of public health emergency; Referral diagnostic and Analytical tests and support the capacity building of health and food science laboratories at the national level for quality laboratory services.

In order to better fulfill its mandate and align its engagement with national development priorities, the Institute had developed its first five years strategic plan (2010/11 to 2014/15). Taking into consideration of the achievements, limitations and challenges of the first SPM, the second five years strategic plan (2015/16 to 2020/21) is prepared in accordance with the Balanced Score Card (BSC) principles based on the mission and vision of EPHI, mid-term evaluation results, situations, stakeholders and SWOT analysis, and the customers’/community value propositions. The second five years SPM has four major strategic thematic areas: excellence in research and technology transfer, excellence in public health emergency management, excellence in public health laboratory quality system, and excellence in leadership management and governance, and outlines 15 strategic objectives (4 from community, 7 from internal process, 1financial stewardship and 3 from learning and growth perspectives) which are formulated to realize the strategic results of the strategic themes. Each strategic objective is designed with 67 performance measures, 42 initiatives and 90 major activities according to the prospective of BSC.

The Research and Technology Transfer theme addresses public health research priority areas such as communicable and non-communicable diseases, food science and nutrition issues, traditional and modern medicine, policy, program and strategy evaluation, environmental and occupational health, health systems and reproductive health for policy and programs improvement. The Institute planned to increase local production of vaccines and anti-sera products as well as production packages from traditional medicines and foods with potential for commercialization. Evaluation of diagnostic reagents and kits through technology transfer to ensure availability of sufficient quantities with qualities are focus areas.

The Public Health Emergency Management theme focuses on disease outbreaks and nutritional emergencies. The strategic plan also emphasizes on early and timely detection, risk communication and control of epidemics and other public health threats, reduction in morbidity, mortality as well as case fatality rate of epidemic diseases to cope with existing and emerging and re-emerging epidemics, natural disasters of national and international concerns.

EPHI strives to develop an affordable and sustainable laboratory system whereby quality laboratory services are accessible to all Ethiopians. EPHI tries to fulfill the above achievements by supporting laboratories through capacity building, quality assurance programs, infrastructure development, training and maintenance towards quality assurance and accreditation.

Leadership management and governance strategic theme deals with effective implementation of the SPM to realize the institute vision through engaged leadership. The SPM promotes opportunities that encourage


collaboration and partnership among national and international partners and stakeholders working to address health issues in accordance with Ethiopia’s needs and priorities. Budget breakdown set for different Objectives planned to be addressed during the SPM timeframe period.

EPHI will make sustained efforts to properly document information generated from the respective thematic areas. All evidence-based information are planned to be interpreted, organized and disseminated in a proper manner for appropriate use by policy makers, stakeholders and the community at large. The SPM ensures that appropriate technologies will be transferred, promoted and utilized. The SPM is in line with the priority areas of the Health Sector Transformation Plan (HSTP).


CHAPTER 1


Chapter 1: Introduction

IntroductionThe Ethiopian Public Health Institute (EPHI), which was formerly called as the Ethiopian Health and Nutrition Research Institute (EHNRI), has planned and implemented its first implemented strategic plan (SPM) (2010/11-2014/15) by including research & technology transfer, public health emergency management and quality laboratory system establishment. It has been part of the first Growth and Transformation Plan (GTP), under the final phase of health sector development plan (HSDP-IV) which ended in June 2015. The EPHI has almost finalized its five years (2010/11-2014/2015) strategic plan (SPM).

The Second EPHI SPM is the next five-year strategic plan, which covers from July 2015– June 2020 (2008-2012 EFY). It has been prepared based on the performance evaluation of the first EPHI strategic plan and by in-depth situational assessment of the internal and external conditions of the institute. The Health Sector Transformation Plan goal & need, the country’s global commitment, and the long term Growth and Transformation Plan (GTP) goal have also been considered to design the SPM.

The performance of EPHI in the last five years has been reviewed critically through the Mid-Term Evaluation (MTE), annual and final performance reviews. The second EPHI SPM is prepared as part of the HSTP, which in turn aligned with the second Growth and Transformation Plan (GTP-II) of the country.

This strategic plan has four thematic areas viz: excellence in research and technology transfer, excellence in public health emergency management, excellence in quality laboratory system, and excellence in leadership management and governance. Four perspectives such as Community, Internal Process, Finance, and Learning & Growth have been pointed out and under which 4, 7, 1, and 3 strategic objectives have been designed respectively.

To measure each strategic objective, performance measures (indicators) have been identified and targets are set. Under each strategic objective strategic initiatives have been planned. Major activities and detailed activities also have been planned to address initiative (s).


CHAPTER 2


Chapter 2: Performance of the first five years BSC Based SPM (2010/11-2014/2015)

2.1 SPM-I: Performance Assessment and Major Achievements in the Past Five Years2.1.1. Research and Technology Transfer

Research Dissemination and Translation: To improve the evidence based policy decision making, the institute’s research outputs have been disseminated through various channels. During the last five years, 87 (four years) research technical reports were disseminated to different stakeholders and concerned bodies. Moreover, the Institute managed to disseminate 175 research findings in peer reviewed Journals and many research preliminary and final results have been disseminated through national & international conferences, workshops and newsletters and website. In addition, two policy briefs on human resource capacity to effectively implement malaria elimination in Ethiopia, prevention of postpartum hemorrhage in Ethiopia, improving healthcare financing in Ethiopia, improving the health extension program in Ethiopia and improving skilled birth attendance in Ethiopia were developed and disseminated.

Development of Vaccines and Food Products: To increase production and the availability of vaccines, plant based medicines, Complementary foods and other biological products the Institute has been undertaking various researches. The institute produced and distributed 83,166; 21,838; 22518 and 26,280 doses of Fermi vaccine for human and animal use from 2010/11 to 2014/15, respectively, to treat rabies infected patients. To improve the rabies vaccine technology, the institute has developed a new rabies cell culture vaccine production package for animal use and handed over to National Veterinary Institute for mass production while the vaccine dosage determination study for human use is undergoing. Three standardized food products from ground nut and quality protein maize was developed and one indigenous food processing technology was also documented. Further, food composition table and dietary menu were developed.

Disease Survey and Surveillance: National surveys and surveillances on infectious diseases have been conducted. Among these, the first National TB prevalence survey, EDHS+, ANC Sentinel HIV Surveillance (round 2009 and 2014), HIV prevalence survey among MARPs, HIV Case Based Surveillance Sexually Transmitted Illness surveillance, the annual TB/HIV co-infection surveillance and malaria indicator survey (MIS) were conducted and results were disseminated. Routine annual viral surveillances on polio, measles, rota, rubella, influenza and other respiratory diseases including meningitis and pediatric bacterial meningitis have been conducted. Survey of the neglected tropical diseases including rabies, lymphatic fliariasis, onchocercheasis, schitosmiasis have been conducted. Haemophilus Influenza types B Survey, TB-HIV DOT program evaluation have been also conducted.


Drug and Insecticide Resistance Survey and Surveillance: With regards to anti-microbial and insecticide resistance surveys, the HIV drug resistance early warning indicators assessment, HIV drug resistance threshold survey and HIV drug resistance prevention monitoring surveys, first and second line TB drug resistance surveillance, National malaria drug and insecticide resistance surveys, Gonorrhea drug resistance &serological survey, Coartem efficacy Monitoring study were conducted.

Food &Nutrition and Survey and Research: During the past five years the institute has conducted national surveys on nutrition, food consumption survey, national nutrition program baseline survey, iron-foliate supplementary adherence promotion study, iodine consumption survey. National Nutrition Program (NNP) evaluation and operation researches, Calcium Intake, Chickpea Based Children supplementary food for treatment of moderately acute malnourished children, Shelf-life determination on six foods, Study on the national IYCF policy and program: Achievements and gaps, Fluoride intake and mitigation strategy in the rift valley of Ethiopia, and Study of nutritional profile of Moringa species were conducted.

Evaluation: ART advanced clinical monitoring; Bottled Water Quality Assessment, Evaluating Efficacy of LLINs, Trance metal exposure, GeneXpert and Malaria RTD evaluations were conducted.

Health System Research: with regard to health system research the institute has undertaken nationally relevant surveys to evaluate the health sector programs impacts. These include Service Provision Assessment (SPA+), Expanded Immunization Program (EPI) Survey, Evaluations of Health Sector MDGs, Maternal and Newborn Healthcare Program Evaluation, Post Measles Immunization Coverage survey, Meningitis Immunization Coverage Program; Hospital based Pattern and Trend of non-communicable diseases survey (Population based non-communication diseases survey) and national FANC survey were conducted.

Traditional and Modern Medicine: survey on traditional medicine utilization and practice among health professionals, healers and community was conducted. Plant based medicine development study for diabetics, asthma, diarrhea, hypertensive, antihelmentic, malaria, dermal fungus, water-purification and animal skin has been conducting. Unidentified Liver Disease Investigation Study was also conducted.

2.1.2. Public Health Emergency Management (PHEM)Communication, Response and Recovery: The Institute implementing to strengthening public health emergency communication, response, rehabilitation and recovery for early verification outbreaks and epidemics. During the first three years, the percentage of health events communicated within 1 hour of the occurrence of PHE and alerting stakeholders after 30 minutes of case investigation were increasing reaching up to 86% in 20011/12 (see figure 1). In 2014/15, 83% of identified risks (mainly Acute Watery Diarrhea (AWD), measles, malaria, meningitis, flooding, mal-nutrition and Ebola) were communicated to concerned bodies within the specified period.

Integrated Public Health Surveillance: To improve the early detection and identification of public health emergencies, Integrated Public Health Surveillance System has been established and currently the institute is receiving weekly diseases surveillance reports from more than 22,000 health facilities located in all over the country. The institute is receiving surveillance report that combines communicable disease surveillance, nutrition surveillance and monitoring of


health events apart from many other hazards. The completeness and timeliness of reports are significantly improving and have reached 91% and 90% in May 2015, respectively (see figure 2).

Percent of health events communicated to relevant

bodies with specified period

Percent of risk profiles communicated to relevant

bodies within specified period

Proportion of PHE with prevention and control

measures initiated within 48hrs

2010/11

2011/12

2012/13

2013/14

2014/15

Five Year Target

120

100

80

60

40

20

7786

78

6153

100 100 100

7685 83

100

67.575 75

10088

100

Figure 1: PHE communication and response

Weekly Emergency Survillance Report Completness and Timliness (Percentage)

0

25

50

75

100

2010/11 2011/12 2012/13 2013/14 20114/15

Percentage of completeness Percentage of timeliness

37

6376

92 88 91 90

Figure 2: Weekly surveillance report Completeness & timeliness level in the past 5 years

Public Health Emergency Risk Mapping and Preparedness: Improving risk identification and institutional preparedness for existing and emerging epidemic-prone diseases is one of the prioritized areas. The percentage of threats/ risks identified and communicated to the regions and partners shows significant progress, increasing from 18% in 2010/11 to 100% in 2014/15 (see figure 3). The achievement shows (figure 3) that 100% identified PHE risks had adequate stockpiles of drugs and medical supplies at the center as per the PHEM guideline. Although it is improving, the availability of sufficient stockpiles of drug and medical supplies at lower administration level has to be further strengthened as a short fall is evidenced.

0

20

40

60

80

100

120

2010/11

2011/12

2012/13

2013/14

2014/15

Five Year Target

Percent of threats/ risk mapped and communi-cated to the regions and

partners

Percent of identified risks with EPRP prepared

Proportion of PHE with adequate stockpiles

1830

75

100 100 100

53

100

45

100 100 100 100 100 100 100 100 100

Figure 3: PHE risk mapping and preparedness


0 1000 2000 3000 4000 5000

2014/15

2013/14

2012/13

2011/12

2010/11

2874125

260148

26042

280320

287368

Planned Trained on PHEM skills

Number of PHEM and Other Health Professionals Trained on Short term PHEM Trainings

Figure 4: Number of trained professionals on PHEM (short term)

With short term trainings scheme 4985 health professionals were trained on management of public health emergencies during five years, among which significant number of trained personnel are recorded in the years 2014/15 due to extensive training program on Ebola management. Moreover, the institute, in partnership with universities and other partners, coordinated the provision of Field Epidemiology and Laboratory Training Program (FELTP) at master’s level. Accordingly, about 86 professionals from all regional states as well as PHEM center have graduated from FELTP (Figure 5).

These trainings significantly boost the human resource capacity in managing public health emergencies at regional as well as central level.

Number of Trained PHEM on Field Epidemiology and Laboratory (Masters Program

0

20

40

60

Trained Planned

2010/11 2011/12 2012/13 2013/14 2014/15

1320 21

40

15

40

13

40

24

13

Figure 5: PHEM professionals trained in long term scheme (MSc)

2.1.3. Quality Laboratory SystemLaboratory Accreditation: To improve the quality of laboratories and hence to enable them

for accreditation, the institute implemented Stepwise Laboratory Improvement Process towards

Accreditation (SLIPTA) Program with the collaboration of partners and regional laboratories.

For the last five years, 109 regional and hospital laboratories were involved in SLIPTA initiative.

The enrolment’s goal is to produce measurable improvement and prepare laboratories for

international accreditation to ISO- 15189 standards. Participant laboratories of the SLIPTA

program have brought visible changes and improvement in their laboratory quality and service


provisions. Although the five targets were very ambitious, the current assessment shows that

21, 12, 7 and 2 laboratories got 1, 2, 3 and 4 star level recognition.

SLPTA Participant Laboratories Recognized For Different Star Level (As of 2015)

Star 1 Star 2 Star 3 Star 4 Star 50

20

40

60

80

100

11 7 4 1 0 515

3839

88

Figure 6: SLIPTA Participant Labs. Recognized for star level 1-5 (as of 2015)

External Quality Assessment: An innovative EQA samples and feedback transportation was established through postal services. Currently, 175 laboratories have participated for one or more tests of EQA (Figure 7) samples including Digital-PT, UKNEQAS, DNA-PCR, Viral Load and TB Culture. Further, 93% of health facility laboratories in the country are linked through postal services for DBS, TB and EQA sample transportation that improved the public access to different laboratory services.

0

50

100

150

200

2010/11 2011/12 2012/13 2013/14 2014/15

118100

145120

154120

156 155175 175

Performance Planned

Number of EQA Ecaluated Laboratories (for one or more tests)

Figure7: Number of EQA evaluated laboratories for one or more tests

Laboratory Manuals and Guidelines: To standardize laboratory diagnostic and operational procedures, more than 20 different laboratory guidelines, manuals and formats were developed and disseminated. These include malaria diagnostic manuals, EQA guidelines, quality manual, referral linkage, epidemic prone diseases manual, early infant HIV diagnostic manual, various training manuals, and national bio-safety manual.

Laboratory Information System: The standardization of laboratories further strengthened through installing Laboratory Information System (LIS) for 22 hospital laboratories that improve information sharing and data management among laboratory technicians and clinicians (Figure 8). Moreover, database for EQA, training and maintenance services were developed and

disseminated to regional laboratories.


0

10

20

30

40

10

20

13

20 2225

22 24 22

40

2010/11 2011/12 2012/13 2013/14 2014/15

Performance Planned

Number of Hospital Laboratories Equiped with Laboratory Information System (LIS)

Figure 8: Number of hospital labs. Equipped with LIS

Laboratory Trainings: To strengthen the capacity of regional and hospital laboratories, during

the last five years, the Institute had given trainings to 4198 laboratory professionals that engaged

in different laboratory activities (Figure 9) mainly on SLIPTA, LIS, HIV, TB & malaria diagnostics,

quality management, safety and microbiology, laboratory management and laboratory machine

maintenance.

0

300

600

900

1200

1500

1800

2100

1407 1402

640

1481

752

1655

876

1740

523

1816

2010/11 2011/12 2012/13 2013/14 2014/15Performance Planned

Number of Laboratory Professionals Trained

Figure 9: Number of laboratory professionals trained in short term trainings

Diagnostic Equipments and Laboratory Renovation: To improve and decentralize

laboratories diagnostic capacity of special and referral services, regional and hospital laboratory

establishment and renovation have been undertaken. State of the art laboratories were built in

Adama Regional Laboratory, Bahirdar Regional Laboratory and Hawassa regional laboratory. And

in addition to these Mekele, Dessie and Nekempte regional laboratories are under construction.

Furthermore over 200 laboratories are enabled to provide different special and referral services


2.1.4. Leadership and ManagementFinancial plan, mobilization and utilization in the past five years have been indicated on figure-10.

0

100

200

300

400

500

600

214

109 119

253219

156

202168

101

286

170

128

563

168

104

2010/11 2011/12 2012/13 2013/14 2014/15

Budget Mobilized Expenditure

Annual Financial Budget, Mobilized and Utilization (in 000,000 ETB)

Figure 10: Planned, mobilized and utilized budget for the past 5 years


CHAPTER 3


Chapter 3: The 2nd BSC based EPHI’s Strategic Plan

3.1. The Planning Process and MethodologyIn the five years strategic planning (2015/16-2019/2020) process, the Balanced Score Card (BSC), which is the strategic planning and management system designed to help everyone in an organization understand and work towards a shared vision and strategy, has been used. The Strategic planning process aimed to produce a document that enables EPHI to address public health issues such as research and technology transfer, public health emergency management and establishing quality laboratory system in the country.

The second BSC Based EPHI’s 5 years SPM has been emanated from the Health Sector Transformation Plan (HSTP), started by formulating and incorporating the strategic objectives from EPHI contributions as part of HSTP. The objectives like ‘improve research and evidence for decision making’, ‘improve health related disaster risk management’, ‘enhance use of technology & innovation’, and improve equitable access to quality health services have been incorporated into the HSTP as the technical wing contribution of EPHI in areas of research & technology transfer, public health emergency management, and quality laboratory system establishment in the country. In parallel to working together with the HSTP planning team, EPHI has developed its SPM by assigning a technical working group (Core team), composed of professionals from different disciplines.

The whole SPM planning process has been coordinated and guided by Planning, Monitoring and Evaluation Directorate (PMED) under the supervision of the senior management. Four sub-teams for respective thematic areas (Research & technology transfer, PHEM, Quality laboratory system, and leadership management & governance) have been formed to prepare the strategic plan in linking with the core team by applying ‘top down and bottom up planning principles’. In order to align the five years strategic plan of the Institute with the upcoming HSTP, the group participated in 5-days HSTP preparation workshop, which was organized by FMoH, to engage in detailed discussions with various FMoH’s agencies and partners.

In top down approach the EPHI SPM has been designed and prepared by cascading from the HSTP and then the Institute’s strategic themes, results, objectives and initiatives have been formulated in cascaded manner; while bottom up planning has been implemented by intensive involvement of all sub-teams, directorates, case teams and experts/researchers from all directorates. Bottom up planning has been intensively exercised more on cost, major activities, initiatives planning and strategic objectives refinement.

From the logic of BSC, strategic planning starts at high strategic altitude: mission, vision, and core values which are then translated into desired strategic themes and results. Strategic themes (organization’s pillars of excellence) are selected to focus efforts on the strategies that will lead to success. Then the strategy has been decomposed into strategic objectives that can be monitored using performance measures. Performance measures allow the Institute to track results against targets, and to celebrate success and identify potential problems early for the needed action. The strategic initiatives, which are the ones that translate the strategy into a set of high-priority programs/


mega-projects/major activities to ensure the success of strategy, have been developed. Under each initiative major activities have been also planned.

To substantiate the strategic plan, relevant inputs were taken from documents and experiences of EPHI and HSDPs, FMoH guidelines and other national and international records. Two SPM preparation workshops were conducted (one from December 30 to January 4/2015; and the other from April 5-9/2015) in which EPHI staff members from various fields of all directorates/departments have participated in the sessions to provide the necessary inputs and expertise to enrich the plan.

For the completion the Institute has conducted a three days (June 18-20, 2015 at Adama) stakeholders’ consultative workshop to get additional inputs and incorporated the workshop inputs into the final strategic plan of EPHI.

3.2. EPHI’s Strategic AssessmentMission:

The mission of EPHI is to improve the health of the general public of Ethiopia through undertaking research on priority health and nutrition issues for evidence based information utilization and technology transfer; effective public health emergency management; establishing quality laboratory system; and training public health researchers and practitioners for best public health interventions.

Vision:

To be a center of excellence in public health in Africa.


Table 1: SWOT (Strengths, Weaknesses, Opportunities and Threats) Analysis:

Enablers PainsStrengths: Weaknesses:Research and Technology Transfer

Long years research experience

Human resource availability

Implementation of BSC

Good laboratory infrastructure/setup

Program management is improving:

Availability of strategies and guidelines like MNH road

map, NNP, NTD road map, NCD strategy, Referral

system guideline, health facility standards,etc.

Legal framework for surveillance /surveys/ research

1.Research and Technology Transfer

Shortage of mega project approach

Weak team sprit/focus

High attrition rate of staff and lack of staff retention

mechanism

Weak integration of work.

Weak communication with potential partners.

Weak commitment of the staff.

Lack of accountability at all levels.

Poor logistic system

Organizational structural problem

Skill gap

Poor/ dissatisfaction on results/findings dissemination.

Poor translation, utilization and follow up of research

results

Weak joint planning with stakeholders

Public Health Emergency Management

Institutionalization of PHEM

Presence of FETP training program

Established surveillance system at all levels

Presence of developed guidelines, SOPs and

reporting Formats

Provided Advanced and basic Epidemiology Trainings

Presence of Monitoring and evaluation Mechanisms

Presence of regular assessment system

Presence of established Task Forces and technical

Working groups

Trained RRT in all regions

Presence of rumor registration and verification

mechanism

2.Public Health Emergency Management

Late detection and response of outbreaks

Not fully functional EOC

Weak coordination and collaboration with other sectors

and FMoH directorates

Slow development and implementation of E-PHEM

Weak team sprit/focus

Limited Stockpiling of emergency drugs and medical

supplies for priority diseases

Absence of sustainable laboratory reagent supply system

National Quality Laboratory System

Decentralized laboratory services

Committed and qualified staff

Well established national laboratory network and

referral services

Smooth communication with partners laboratory

quality management system being actively

implemented

3.National Quality Laboratory System

Low adherence to planned activities

Weak Inter-departmental collaboration

Lack of staff motivation mechanism

Inadequate commitment for referral services

Lack of high Bio-safety level laboratory service

Limited laboratory capacity


Enablers PainsStrengths: Weaknesses: Program and Project Management

Good Planning culture in place (BSC based)

Good Monitoring system in place

Strong performance follow up using BSC

Improved Integrated Supportive Supervision practice

A start in SPM midterm evaluation

4.Program and Project Management

Shortage of mega project approach

Shortage of project design and management

Human Resource Development

Good trend in long and short term training experience

to develop human resource

5.Human Resource Development

Gap in human resource development strategy

Shortage of retention mechanism.

Gap in knowledge management

Resource mobilization & utilization

Presence of good relationship with governmental and

non-governmental organization.

Presence of experience for fund mobilization and

utilization

6.Resource mobilization & utilization

Gap in designing mega projects and integrated fund

mobilization approach.

Unorganized resource mobilization.

Inefficient grant management

More than sixty percent of mobilized fund has been spent

for field car rent due to shortage of the institute owned

cars.

Gap in resource mobilization strategy.

Inefficient procurement/logistics system.

Donor dependency/ High donor source for research

& technology transfer, PHEM and laboratory capacity

building


Enablers PainsStrengths: Weaknesses:Leadership, management & governance

Long years public health leading experience and

exposure

Legal support/framework

performance follow up system in place

Institutionalization of service improvement approaches

like BSC

Coordination, collaboration and partnership

experience

International

National

Civil service HDA platform (case team

(1:5),transformation, directorates and management

coordination and leadership)

Establishment of public wing’s forum

Ensured legal framework for implementing the

Institute’s mandate areas

7. Leadership, management & governance

Weak leadership commitment on decision making

Gap in organizational structure

Gap in strategic thinking

Gap in system establishment / operation

Weak coordination.

Opportunities: Threats:High government commitmentPresence of partners and donorsPresence of FETP residentsAvailability of new initiatives (HDA, one health approach, etc)Presence of WHO surveillance officers at lower levelGood will/trust from customer and stakeholdersStrong legal frame workContinuous support from government & development partners. Existence of in country accreditation systemPresence of revised health sector policy

Attractive salary scale of other similar government & non-government institutions as compared to EPHI (Increasing pull factor for the experienced workers)Variable remuneration system Growing of competitive institutionsEmergence and reemergence of disease epidemicsConflicts in neighboring countriesMovement of peopleLow predictability of foreign fundingPorous boarderWeak health system in emerging regionsClimate changeGlobal economic crises limiting partner support (Diminishing trend of foreign support)Inadequate professional competence


Table 2: Stakeholders Analysis

StakeholdersBehaviors we desire

Their needsResistance issues

Their influence

Institutional response

Community Participation, engagement, ownership andhealthy life style

Access to evidence-based health information and service empowerment

Dissatisfactionopting for unsafe alternativesunder utilization

High Advocacy, ensure participation,quality and equitable service and information

FMoH, Parliaments, MoFED, MoCS

Ratification of Policy proclamations, policies, etc.resources allocation

Implementation of proclamations, policy, etc.Equity & quality plans Visionary leadershipCommitted to accomplish mission and visionGood governanceAccountability and timely reporting Deliverables and timely reportingEfficiency and effectiveness Efficient system and competency of compliance management

Administrative measuresOrganizational restructuring influence on budget allocation

High Put in place a strong M&E system & comprehensive capacity building mechanisms

Regional Health Bureaus and health facilities

Commitment, participation and collaboration

Effective Coordination and joint agenda setting Joint Planning, Implementation and joint EvaluationSupportive action and collaborationSystematic capacity building and skill transfer

FragmentationDissatisfaction

High Put in place a strong M&E system & comprehensive capacity building mechanisms




Their influence


Line Agencies (FMHACA, HAPCO, Health Insurance Agency, PFSA)

Inter-agencies collaborationconsider health in all policies and strategies

Evidence-based information; research coordination, Technical support


High CollaborationTransparencyAdvocacy

Health professional training institutes

Knowledgeable, skilled and ethical health professionals produced

Technical support Curriculum revision

Medium Policy and leadership support

Development Partners

Harmonized & alignedParticipation,More financing andTechnical support

Financial system accountable & transparent Involved in planning, implementation, and M&E

FragmentationHigh transaction Inefficiency & ineffective

Medium Government leadershipTransparency Efficient resource use Build financial management capacity

NGOs, CSO, and professinal associations

Harmonisation & alignementParticipation, ressource & TAParticipate in licensing and accreditation Promote professional code of conduct

Involvement in planning, implementation & M&EParticipation

DissatisfactionFragmentationScale downWithdrawal

Medium Transparency, AdvocacyCapacity buildingFinancial support

MoSTLocal Universities

Commitment, participation, collaboration

Coordination and collaboration on research and technology transferInnovative research work and motivational schemesCollaboration on ethical and scientific research management


Medium Put in place a strong collaboration & coordination




Their influence


Public WingCitizens

Commitment,Participation

Good GovernanceTransparencyParticipatory arrangementsEfficient serviceAccountability and effective use of public property

Dissatisfactionopting for unsafe alternativesunder utilization

High Motivation, Involvement

Staffs/Civil servants/

Commitment,Participation

Motivational schemesConducive working environmentUnderstanding and on the same page on policies and procedures of governmentTransparency and clear guidance

DissatisfactionUnproductive Attrition

High Motivation, Involvement, Accountable

Directorates/ Sections

Commitment,Participation, visionary

Shared responsibilitiesDirectional clarityInspirational and competency development systemDynamic and friendly structure

DissatisfactionUnproductive

High Motivation, Involvement, Accountable

MoARD Commitment, participation, collaboration

Coordination and collaboration on PHEMCoordination and collaboration on zoonosis disease management


Medium Put in place a strong collaboration & coordination

Core values:

· Evidence based decision

· Pro-activeness and Responsiveness

· Transparency and Accountability

· Respect to humanity


· Self reliance

· Solidarity

· Ability to exercise professional values, ethics and judgment

· Inclusiveness

3.3. Strategy (Customer Value Proposition, Strategic Themes and Strategic Results, Perspectives)3.3.1. Customer Value Proposition

Table-3: EPHI’s customer value proposition

Product or service attributes Image Relationship

Products & services the EPHI provides have these characteristics:Problem solving

High Efficacy

Accessible (Information and product)Authentic research Timely responseProactivness Quality laboratory service Accessibility–information, physical, financial, etc.Timeliness of servicesAuthentic information Safe and conducive environmentEmpowering community & employeesConducive environment

The image that the EPHI wants to portray has the following characteristics:Problem solver Scientific

Citizens-focusedSupportive Communicative Environment consciousTrustworthyTransparent/AccountableSupportiveProfessionalCustomer-Friendly/OrientedCommitted

The relationship the EPHI wants with its community and stakeholders could be described as:Professional

ResponsiveParticipatory/ Cooperative TrustworthyComplementaryCooperative (participatory)Respectful & ethicalHarmonious (Mutual Understanding)Transparent relationshipDependable (Stewardship)ResponsiveEquitable

3.3.2. Strategic Themes and Strategic ResultsStrategic Theme 1: Excellence in Research and Technology Transfer

This theme aims to undertake research, surveillance and technology transfer activities towards the improvement of evidence based information for decision making through dissemination, translation and utilization of synthesized evidence base information that are systematically reviewed and consolidated from research, evaluation, and surveillance outputs for appropriate use by stakeholders including policy makers such as FMoH, WHO, UNICEF, etc. and the public at large. Production of packages from traditional medicines as-well-as foods that have potential for commercialization and development of vaccines and Anti-Sera products will also be performed. Technology production packages will be disseminated in the form of technology


briefs in an attempt to transfer the outcome for the industries, beneficiaries and the public. The ultimate aim of the theme is provision of timely evidence based information, production packages and technology production to stakeholders including policy makers and the public to strengthen the health system.

Strategic Result: Evidence that will be translated into policies, programs, public education, product packages and products.

Key Concepts: With this thematic area the following major activities and results will be delivered to improve the health of the public:

· Surveillances , research and evaluations will be conducted to generate peer reviewed journals, technical reports and synthesized evidences,

· Synthesized evidences will be disseminated and then translated into programs, interventions, policies and/or used as reference/witness for interventions which are implemented in the right way.

· Ensuring utilization of synthesized evidences that will be disseminated and translated, Technology generation in the form of production packages particularly traditional medicines, vaccines and other Anti-Sera, and complementary/supplementary foods. It includes evaluation of diagnostic technologies, dissemination of production packages, production of vaccines, and distribution of products to users.

· Ensuring utilization of production packages and products.

Strategic Theme 2: Excellence in Public Health Emergency Management

Strategic Result 2: Protected and rehabilitated community from consequences of public health emergency

· Minimized/avoided morbidity, disability and mortality due to epidemics and other public health threats ; Psychosocial support provided and health system rehabilitated

· Timely detected and communicated risk of diseases epidemics and other public health threats

· Adequate resources (drugs, vaccines (buffer stocks), personal protection equipment (PPE), emergency health kits, reagents ,medical supplies) and trained human resource for epidemic preparedness ,response and control measures

Key Concepts: Epidemic Preparedness, surveillance and communication, response and recovery. The success in this strategic theme will be measured by:

· Early detection and control of epidemics and other public health threats,

· Reduction in morbidity and mortality,

· Reduction in case fatality rate of epidemic diseases.

How does the Theme and result move us to a higher level of Performance?

Through ensuring community ownership epidemics and other priority public health emergencies

will have been effectively and efficiently prevented and controlled.


Strategic Theme 3: Excellence in Quality Laboratory System

This theme aims at undertaking programmatic activities towards building a National Laboratory

System that is capable to:

· Contribute to the improvement in quality of health care service delivery through the

provision of accurate, reliable and timely results that are critical for the correct diagnosis

of diseases, treatment monitoring and prognosis of outcomes

· Effectively support Public Health Emergency Management System through the precise

detection and characterization of epidemic prone diseases and hazardous environmental

substances of public health importance

· Generate accurate and reliable data for laboratory based clinical and public health

researches.

· Ensure availability and accessibility of laboratory testing services to all citizens.

Strategic Result: Quality assured laboratories and services

Key Concepts: Guiding principles behind this theme and the anticipated strategic results are

that all medical and public health laboratories in the envisioned system shall:

· Be required to implement laboratory quality management system in order to provide

testing services that fulfill pertinent international quality requirements,

· Strive towards accreditation to ISO 15189 or 17025 standards,

· Have the necessary technological and human resource capacities to provide services

that satisfy their customers’ expectations,

· Have demonstrated capacity to perform all types of tests for clinical and public health

importance,

· Have well established and effectively functioning network structure to ensure accessibility

of laboratory testing services to all citizens.

Strategic Theme 4: Excellence in Leadership, Management and Governance

Strategic Result: Effective and efficient management and governance system

This theme aims at enabling environment for the successful implementation of the three core

thematic areas through availing the state of the art infrastructure, having motivated and skilled

human resource, creating well developed system, efficient coordination and collaboration with

partners. These are:

· The Institute will be equipped with state of the art facilities with competent human

resource to be reference in management and result based structural set up

· Automate all activities and making all program implementations supported by the latest

technology

· Effective coordination, program implementation, monitoring and efficient resource

mobilization and utilization

· Strong communication, collaboration and partnership for joint mission accomplishment


· Ensuring transparency, accountability, ethical and public focused working environment

Key Concepts: The concepts for this strategic theme are to create enabling environment for the

three strategic themes and ultimately achieving the mission and vision of the Institute with:

· Conducive working environment and maintaining motivated competent human resource

· Having robust system to track all programs to ensure compliance

· Working with partnership with national and international collaborators to make the

Institute competent in its mandate

3.3.3. Strategic Perspectives:Perspective Key Concept Key Questions

Community (C)

“Evidence based ““Accessible ““Scientific”

How can we enable the customers/community to receive our services and product?

Internal process (P) “Effective and Quality”“Scientific and systematic” Utilization”

How can we enhance our integration & responsiveness in order to improve quality, timeliness, & functionality?

Financial Stewardship (F) “Efficient mobilization and Utilization” How do we mobilize and utilize more resources effectively and efficiently?

Learning & Growth (CB) “Efficiency” “Capacity”

To excel in our processes, what capacities must our organization have and improve?


3.3.4. The EPHI Performance House

Solidarity

Evidence based decision

Transparency and Accountablity

Proactiveness and Responsive Self relianceInclusivenessRespect toHumanity

EPHI Mission: To improve the health of the general public throught undertaking research on priority

health and nutrition issues so as to develop, disseminating new scientific knowledge and technology transfer; public health emergency

management; establish quality laboratory sustem throughout the country; and training public healthresearchers and practitioners for best public health interventions.

EPHI Vision: To be a centre of excellence in public health in Africa

Strategic ThemesValues Values

Perspectives

CommunityCustomer

InternalProcess

Finance

Learning and growth

Excellence in leadership

management and

governance

Excellence in quality

laboratory system Excellence in

public health emergency

management

Excellence in research and technology

transfer

Engaged Leadership: Interactive Communication

Figure 11: The EPHI’s Performance House (2015/16-2019/2020)


3.4. Strategic Objectives (SO)3.4.1. EPHI’s Strategic Objectives along with the strategic

perspectives and themes

Perspectives Strategic Objectives

Community (C) C1: Improve translation and utilization of evidence based information, production packages and products

C2: Improve public health emergency response and rehabilitation

C3: Increase and maintain quality assured laboratories

C4: Enhance community ownership

Internal process (P) P1: Improve public health surveillance system

P2: Improve research and evaluation on key health & nutrition issuesP3: Improve technology evaluation and transfer

P4: Improve public health emergency preparedness

P5: Enhance laboratory quality management system implementationP6: Strengthening Laboratory Capacity for Referral and Backup Testing Services

P7: Improve programs/projects and Institutional policies Development and Management

Financial Stewardship (F) F1: Improve financial resource mobilization and utilization efficiency

Learning & Growth (CB) CB1: Improve Human Resource Development, management and GovernanceCB2: Enhance Infrastructure and System developmentCB3: Enhance Communication, collaboration and Partnership

3.4.2. EPHI’s Strategic Themes and Strategic Objectives Alignment with HSTP Objectives

HSTP Strategic Objectives (SOs) EPHI SOs, cascaded from HSTP SOs

P8: Improve Research and Evidence for Decision MakingCB1: Enhance use of Technology & Innovation

C1: Improve translation and utilization of evidence based information, production packages and productsP2: Improve research and evaluation on key health & nutrition issuesP3: Improve technology evaluation and transfer

P2:Improve Health Related Disaster Risk MgtC2: Enhance community ownershipP6: Improve community participation and engagement

C2: Improve public health emergency response and rehabilitationP1: Improve public health surveillance system P4: Improve public health emergency preparednessC4 Enhance community ownership


P1: Improve Equitable Access to Quality Health Services

C3: Increase and maintain quality assured laboratories P5: Enhance laboratory quality management system implementationP6: Strengthening Laboratory Capacity for Referral and Backup Testing Services

P3: Enhance Good GovernanceP5:Improve logistic supply and managementP7:Improve resource mobilizationCB2:Improve development and management of human resource for healthCB4:Enhance Policy and Procedures

P7: Improve programs/projects and Institutional policies Development and ManagementF1: Improve financial resource mobilization and utilization efficiencyCB1: Improve Human Resource Development, management and GovernanceCB2: Enhance Infrastructure and System developmentCB3: Enhance Communication, collaboration and Partnership

C1: Improve translation and utilization of evidence based information, production

packages and products

Description:

To improve translation and utilization of evidence based information the following major activities

will be conducted; dissemination of synthesised evidence-based information of research,

surveillance and technology transfer outcomes for appropriate use by stakeholders including

policy makers such as FMoH, WHO, UNICEF, etc. and the public at large. Here, the synthesised

information will consist of information that are systematically reviewed and consolidated on

diseases epidemiology, prevention, control, treatment and diagnosis of key communicable

and non-communicable diseases, nutrition issues, traditional medicine and health system for

appropriate use by the end users.

Production packages developed from traditional medicines as-well-as foods that have potential

for commercialization and products like vaccines and Anti-Sera will be produced in the Institute.

Developed technology production packages disseminated in the form of technology briefs in an

attempt to transfer the outcomes for the industries. Public education through mass media will

be conducted to the public to educate and create awareness about the outcomes. In addition,

disseminated evidence based information; production packages and products will be assessed

and evaluated to ensure their proper utilization by key stake holders including policy makers and

the public.

Outcome:

· Translated and utilized evidences

· Translated and utilized production packages

· Utilized products

Key component:

· Review and synthesis of evidences systematically

· Dissemination and translation of synthesized information for key stakeholders including

policy makers/programmers and the public

· Translation and utilization of synthesized information, production packages and products


C2: Improve health emergency response and rehabilitation

Description:

This strategic objective includes a set of activities which follow the warning or alert communicated

and encompasses action pre, during and post the event. The activities include rapid field

assessment, outbreak investigation, prevention and control activities, monitoring, mobilization

of drugs, vaccines, medical supplies, and nutritional supplements and other relevant materials

as well as funds to Regions and Woredas in case of Public Health Emergency especially in

vulnerable populations with limited access to health services such as displaced or nomadic

groups. Identifying the extent of damage caused by an incident, conducting thorough post-

event assessments and determining and providing the support needed for recovery and

restoration activities to minimize future loss from a similar event is also a major component of

rehabilitation and recovery.

Outcome:

· Damaged health system and affected communities rehabilitated.

· Implemented control and prevention measures

Key component:

· Rapid Assessment/ outbreak investigation,

· Quarantine and isolation,

· Case management,

· Health information and communication,

· Post Emergency assessment and recovery.

C3: Increase and maintain quality assured laboratories

Description:

Laboratory accreditation will be a significant milestone to ensure the provision of quality laboratory

services and serves as an overarching metric for the implementation of quality management

system standards. Laboratories implementing comprehensive quality assurance measures or

have achieved accreditation to international standards are capable of generating accurate and

reliable information that is critical for the diagnosis of diseases, monitoring of treatment and

prognosis as well as prevention at individual and community levels. As such, implementation

of initiatives that enhance the efforts of laboratories in the national system towards sustainable

improvement thus accreditation is the strategic priority of EPHI.

One of such proven initiatives for the systematic and structured implementation of laboratory

quality standards is the Stepwise Laboratory Improvement Process towards Accreditation

(SLIPTA). As a national laboratory improvement strategy, SLIPTA will be implemented at all tiers

of the national laboratory network whereby the National and Regional Reference Laboratories,

all hospital laboratories and those of Health Centers with high test volumes will be given priority.

Ensuring quality-assured laboratory services at all tiers of the national laboratory system will not

only improve the quality of healthcare delivery and case management but will also effectively

support disease prevention and responses to public health emergency situations.


In order to maximize the utilization of quality-assured laboratory services, it is imperative that

functional interfaces exist between the laboratory system and its immediate customers, the

clinical service, the PHEM system and health researchers. Thus, an initiative with various scopes

of activities will be implemented to ascertain the seamless flow of information between the

laboratory system and its customers.

Outcomes:

· Quality diagnostic laboratory services

· Quality public health laboratory services

· Laboratories that generate quality data for health researches

Key components:

· SLMTA implementation

· Laboratory Audits and Continuous Quality Improvement (SLIPTA)

· Laboratory-customer interface ISO Accreditation

C4: Enhance community ownership

Description:

Enhancing community ownership refers to the end result of empowering communities to produce their own health. It addresses the social, cultural, political and economic determinants that underpin health, and seeks to build partnerships with other sectors in finding their own solutions to their own problems. Community ownership is attaining a much higher result by empowering the community to do health and health related activities by itself for its own wellbeing. Hence, community ownership ensures sustainable development in the health of the community. Community ownership guarantees solidarity among neighborhoods as they clearly understand health is a Public good. In community ownership, the community is collectively responsible for individual member’s action and hence works towards assisting each other to shoulder the collective accountability. As the result, individual actions will be healthy developing into healthy family and community. It describes the focus on the community ownership in decision making in all matters of its own health. It is when it exerts necessary effort to make sure its voice is heard in decision making; and influence over or take control of its own health.

The community ownership influences the health system positively to deliver better health services in equitable manner as the community considers it has a role in the health system as its own property. It implies community understand individual health behavior can affect the public and hence each member of the community behaves responsibly to carry out surveillance of reportable diseases and any unusual events at the community level using the existing structures

such as households, 1 to 5 networks and development teams.

Outcome:

· Model family, model development team, model Kebeles and model Woredas

Key Components:

· Community surveillance

· Outbreak response and prevention


P1: Improve public health surveillance system

Description:

This strategic objective includes both indicator-based and event-based components of public

health and nutrition surveillances on communicable and non-communicable diseases (CDs

and NCDs), demographic and behavior, utilization of fortified foods, micronutrient status of

population and salt iodization coverage, drug resistance and drug utilization related resistance

on its irrational utilization. It also includes insecticide resistance activities from selected areas,

reproductive health, environmental tracking, identifying and closely monitoring of public health

threats, predicting the risk it poses on the health of the public and the health system. The

ultimate aim is provision of timely and complete information for proactive prevention of health

threats by decision makers for improving quality of life.

This includes identifying and closely monitoring public health threats, predicting the risk it poses

on the health of the Public and the health system, and the provision of timely and effective

information that allows preparing for effective response or taking action to avoid or reduce risk

throughout the country.

Outcome:

· Generated surveillance outputs in the form of technical reports.

· Generated surveillance outputs in the form of peer reviewed journals

· Complete and timely delivered information from weekly disease monitoring

Key components:

· Surveillances on:

· Diseases and their determinants

· Drug and insecticide resistance

· Food and Nutrition issues

· Reproductive health issues

· Maternal death

· Laboratory

· Environmental Tracking

· Event Monitoring and Communication.

P2: Improve research and evaluation on key Health and Nutrition issues

Description:

This objective’s scope includes research and evaluation of communicable and non-communicable

diseases and their determinants, traditional and modern medicine, food and nutrition, policy,

strategy and programs, health system, environmental and occupational health and their

determinants and reproductive health. Survey activities that generate standardized information

on trends of priority diseases, their epidemiology and behaviour and anthropology/socio-culture

determinants will also be included. Synthesised data will be utilized by policy makers at the


national, regional and Woreda levels, including stakeholders such as WHO, UNICEF, etc., for

implementing tools and mechanisms development to reduce morbidity and mortality. In general,

generation of reliable data as an outcome on health, nutrition and health system programs will

be used for the improvement of public health problems.

Outcome:

· Generated research outputs in the form of technical reports

· Generated research outputs in the form of peer reviewed journals.

Key component:

· Diseases research and their determinants

· Traditional and modern medicine research

· Food and Nutrition research

· Policy and program evaluation

· Health system research

· Environmental, occupational health and their determinants research

· Reproductive health research

P3: Improve technology evaluation and transfer

Description:

This objective is about identification, transfer and adaptation of new health technologies

from abroad and also use of local technologies (indigenous knowledge) for product and

production packages. Activities include health technology evaluation, validation, adaptation and

development of new products and their transfer to users through commercialization and other

beneficiaries, respectively.

Outcome:

· Identified, transferred and adapted technology

· Developed production packages and technology products

Key component:

· Develop technology production packages from indigenous practices and abroad.

· Production of products

· Evaluate diagnostic technology

P4: Improve public health emergency preparedness

Description:

This strategic objective focuses on strengthening capacity in recognizing and responding

to public health emergencies through conducting regular risk identification and analysis,

establishing coordination and collaboration, enhancing community participation and

implementing community-based interventions, putting in place the necessary logistic and fund,

equipping public health personnel and respondents with the necessary knowledge and tools,


and educating the public on related measures to be taken to prevent and control the event

during the pre emergency phase and ensuring their monitoring and evaluation.

Outcome:

· Developed risk profile

· Developed Epidemic Preparedness Response Plan and Humanitarian Requirement

Document

Key component:

· Vulnerability assessment and Risk analysis

· Capacity building (system and human)

· Stockpiling resources (medications, equipment)

· Risk reduction

P5: Enhance laboratory quality management system implementation

Description:

Provision of accurate, reliable and timely laboratory test results is the centerpiece and ultimate

goal of public health laboratories. Implementation of Laboratory Quality Management System

(LQMS) in its entirety across all laboratory processes and disciplines is crucial for the proper

diagnosis of diseases, monitoring of treatments and prognosis of outcomes. Timely detection

and characterization of epidemic prone and other diseases of public health importance

including hazardous environmental substances are dependent on the capacity and quality of

testing practices which in turn are closely related to the level of laboratory quality management

implementation.

Ethiopian laboratories of all tiers have been striving to implement laboratory quality management

system over the past few years. However, many factors have been limiting their pace towards

the ultimate goal thus necessitating further efforts in the years to come to maintain what has

been achieved so far and remaining to be accomplished. As part of this strategic objective, many

initiatives and activities will be undertaken to ensure the holistic implementation of all essentials of

quality. In this regard, initiatives and activities pertaining to ensuring organizational commitment

and support to quality services, personnel and equipment management, purchasing and

inventory, process control and improvement, information management, document and records,

occurrence management, facility and safety, customer satisfaction, assessment and monitoring

and evaluation of implementation including infrastructure upgrading will be undertaken.

Outcome:

· Laboratories implementing all essentials of laboratory Quality Management System

Key components:

· Organization and Management commitment

· External Quality Assessment

· Document and information management


· Equipment and supplies management

· Process control and process improvement

· Facility and safety

· Laboratory

· In-service Trainings

P6: Strengthening Laboratory Capacity for Referral and Backup Testing Services

Description

The health care system in Ethiopia relies upon a tiered network of laboratories that include

national and regional reference laboratories, hospital and health center laboratories with an

increasing degree of specialized testing capacity towards the apex. This variation in testing

capacities between the tiers necessitates the availability of reliable specimen referral linkage

system within the network to ensure the accessibility of laboratory testing services to all citizens.

Existing arrangements for inter-laboratory backup testing support will be strengthened to ensure

uninterrupted services due to equipment failures; human resource constraints supply shortages,

etc. The national and regional reference laboratories will serve as the main centers for referral

and backup testing services. Thus, special attention will be paid to building the capacity of

national and regional clinical and public health reference laboratories through the introduction of

advanced tests and technologies. Capacities will also be built at federal health institutions and

regional specialized hospitals to foster their abilities to provide extended referral testing services.

Utmost efforts will be made to strengthen the capacities of EPHI’s National Reference Labs

which are the backbones of the national laboratory system in the evaluation, introduction and

scaling up of novel laboratory methods and technologies.

Existing vertical and horizontal laboratory networks will be strengthened, robust and functional

national system for integrated specimen management and transportation including result

feedbacks will be developed and implemented.

Over time, EPHI aims at building the necessary capacities at all tiers or facilities to enable

them provide the expected testing services rather than relying on referral and backup support

systems.

Outcomes:

· Functional and optimized tiered laboratory network

· Robust and reliable specimen and results transportation system

· Strong and effective system for inter laboratory backup (vertical /horizontal) and referral

testing services

· New/advanced testing methods and technologies in place

Key components

· Strengthening system for Specimen referral and backup testing services

· Introduction and expansions of specialized/ esoteric tests

· Introduction of advanced methods and technologies


P7: Improve programs/project, Institutional policies Development and Management

Description:

This objective is planned to set institutional policies, procedures and guidelines for all services

provided by the institute and to put in place effective and efficient program/project management

system. This has two major categories; first Institutional policies, procedures and guideline is

to in place complete administrational, financial and technical procedures in order to improve

efficiency and transparency and the second is Program/ project development and management

system includes priority setting, proposal development, efficient implementation, monitoring

and evaluation.

Outcome:

· Increased efficiency and effectiveness of program/ project implementation

· Ensured transparency and good governance

Key component:

· Administrative, Financial, programmatic and technical procedures and guidelines

development

· Priority setting, proposal development, implementation, monitoring, supportive

supervision and evaluation

F1: Improve financial resource mobilization and utilization efficiency

Description:

This objective is planned to avail financial resources needed to execute all the targeted activities

for the whole thematic areas. It has two major categories; financial resource mobilization and

proper utilization of the mobilized financial resources. The base for financial resource mobilization

is the costed strategic plan document. It covers resource mapping, identification of gaps by

each thematic area, development of financial resource mobilization strategy and mobilization

through proposal development, negotiation with funders and contractual agreements. Proper

financial resource utilization covers efficient use of the mobilized finance through procurement

and logistic supplies, tracking, monitoring, evaluation and inspection of program and projects.

Outcome:

· Efficient program/ project implementation

· Proper utilization of the availed resources

Key component:

· Financial resource mapping

· Detailed gap identification by thematic areas

· Development of Financial resource Mobilization strategy

· Proposal development, Negotiation, MoU signing and project commencement

· Execution and implementation in accordance with the plan and project agreement

· Monitoring and evaluation plan development


CB1: Improve Human Resource Development and Governance

Description:

This objective has three major categories. The first category is to develop health development

army through applying all HDA schemes. The second one is to have high quality human

resource for the Institute by availing human resource for the execution of planned activities

through recruitment, promotion and applying different retention schemes; skill development

through short and long term trainings based on identified training needs, establishing public health

training operational system, which consists making the National Public Health Center (NPHTC)

fully operational by creating proper structure, operational set up and curricula development.

The third category is providing long term and short term training to improve overall skill and

knowledge of health workers that contribute for health sector transformation.

Out comes:

· Skilled and high caliber work force

· Efficient health service delivery in the Institute

Key component:

· HDA development scheme through continuous evaluation and upgrading

· Identification of human resource gap and designing strategy to fill it

· Capacity development of the Institute HR through long term and short term training

· Implementing staff retention schemes

· Establishing the public health training center operational system

CB2: Enhance Infrastructure and System development

Description:

The Infrastructure part of the objective is the physical construction of the Institute’s premise and

technical facilities to enhance institutional capacities. System development part of the objective

is the automation, data base and online communication establishment for efficient and effective

execution of EPHI’s mission.

Outcome:

· Efficient performance

· Intensive technical facilities with established technology

· Fully Automated and efficient systems

Key component:

· Survey and design work based on the targeted needs

· Contract out and physical construction


· System design and networking

· Contract out and operationalize the system

CB3: Enhance Communication, Coordination and Partnership

Description:

This objective has two categories; the first is to have effective and efficient communication

to promote and publicize the services and achievements of the Institute to the general public

and other stakeholders. The second is to strengthen coordination and partnership with local,

regional and international partnership towards achieving the mission and vision of the Institute.

Outcome:

· Increased public awareness on the service provision

· Better performance through partnership

Key component:

· Identification of target audiences

· Develop and implement communication strategy

· Identification of local, regional and international partners

· Create forum based on the intended partnership

· Build coordination and partnership


3.5. The Second EPHI’s SPM Strategy Map

Engaged Leadership: Interactive Communication

Com

mun

ityIn

tern

al P

roce

ssLe

arni

ng a

nd G

row

thFi

nanc

ial

Ste

war

dshi

p

C2: Improve publichealth emergency

response andrehabilitation

C1: Improve translationand utilization ofevidence based

information, productionpackages and products

C4: Enhancecommunityownership

P4: Improve publichealth emergency

preparedness

P3: Improve technologyevaluation and

transfer

P2: Improving researchand evaluation on key

health and nutrition issues

CB2: Enhance infrastructureand system development

CB3: Enhance communication,coordination and partnership

F1: Improve efficient mobilization and utilization of financial resources

Vision: To be a centre of excellence in public health in Africa

C3: Increase andmainatain quality

assured laboratories

CB1: Improve humanresource development,

management andgovernance

P1: Improve publichealth surveillance

systemP6: Strengthening

laboratory capacity forreferral and backup

testing sevices

P5: Enhance laboratoryquality management

system implementationP7: Improve programs/ projects

and institutional policiesdevelopment and

management

Figure-12: The EPHI Strategy Map (DNA of EPHI)- 2015/16-2019/2020


3.6. Performance Measures and Initiatives for EPHI’s SPM-II

3.6.1. C1. Improve utilization of evidence based information, production packages and products

Performance measures:

By the end of 2020:

1. Thirty one synthesized evidence-based information generated and disseminated for

decision making in five years

2. 89% of synthesized evidence-based information utilized by decision making,

3. Five types of vaccines and serum products distributed in five years.

4. 99% of doses/vials of vaccines and Anti-Sera products utilized,

5. Ten production packages disseminated in five years

6. 99% of production packages utilized,

7. Sixty one types of diagnostic technologies disseminated in five years

8. 99% of distributed diagnostic technologies utilized

Strategic Initiatives:

1. Disseminate evidence based information, product packages and products

2. Ensure translation and utilization of evidence based information, product packages and

products

3.6.2. C2: Improve public health emergency response and rehabilitation1


By the end of 2020:

1. Increase proportion of affected people provided rehabilitation from 36% to 95%,

2. 85% of epidemics controlled within the standard of mortality,

3. Proportion of health facilities rehabilitation increased to 95%,

4. 95% of public health risks averted.


1. Strengthen Epidemic response and rehabilitation

1 Operational definition for Rehabilitation includes .1 maintaining basic health service by erecting temporary shelters, mobilization of health workers and/or provision of emergency health kits. 2. Giving psychosocial support during a disaster.


3.6.3. C3: Increase and maintain quality assured laboratoriesPerformance measures:

By the end of 2020:

1. Increase proportion of hospital and regional laboratories with SLIPTA Star-levels 3-5,

from 20% to 100%

2. Increase proportion of health center laboratories with SLIPTA Star-levels 1-5, from 1% to

85%

3. 375 laboratories accredited with limited scope accreditation (LSA) ISO 15189 and/or

17025 in five years

4. 97 laboratories accredited with full scope accreditation ISO 15189 and/or 17025 in five

years

5. 100% of laboratories improving their limited scope accreditation (LSA) status

6. 100% of laboratories maintaining their full accreditation status

7. Increase customer satisfaction to ≥95% within five years


1. Implementation of Stepwise Laboratory Quality Improvement Process towards

Accreditation (SLIPTA)

3.6.4. C4: Enhance community ownershipPerformance measures:

By the end of 2020:

1. Increase proportion of Kebeles implementing community based surveillance, from 0 to

80%.


1. Implementation of community based surveillance

3.6.5. P1: Improve Public Health Surveillance System Performance measures:

By the end of 2020:

1. 43 publications produced in peer reviewed journals from surveillance in five years

2. 197 technical reports produced from surveillance in five years

3. 95% of health facilities reporting complete and timely weekly diseases report

4. Increase proportion of health facilities using e-PHEM reporting, from 0 to 80%



1. Surveillance of diseases and their determinants

2. Surveillance of drugs and insecticide resistance

3. Surveillance of food and nutrition issues

4. Surveillance of reproductive health issues

5. Strengthen routine Surveillance (IDS, Nutrition)

6. Establish Emergency Operation Centres (EOCs)

3.6.6. P2: Improve research and evaluation on key health and nutrition issues


By the end of 2020:

1. 153 publications produced in peer reviewed journals from research in five years

2. 683 technical reports produced from research in five years


1. Conduct diseases and their determinants research

2. Perform traditional and modern medicine research

3. Conduct food and nutrition research

4. Carryout policy, strategy and program evaluations

5. Conduct health system research

6. Conduct environmental, occupational health and their determinants research

7. Conduct reproductive health research

3.6.7. P3: Improve technology evaluation and transfer Performance measures:

1. Five vaccines and serum products produced.

2. Ten production packages generated.

3. Sixty one types of diagnostic technologies evaluated and recommended.

4. 45 publications produced in peer reviewed journals

5. 91 technical reports produced from technology evaluation and transfer in five years


1. Develop health technology production packages from abroad and indigenous practices


2. Production of health technology products

3. Evaluation of diagnostic and disease preventive technologies

3.6.8. P4: Improve public health emergency preparedness Performance measures:

By the end of 2020:

1. Increase proportion of identified potential epidemics with adequate Emergency Drug &

Kits (EDKs) and other supplies from 71% to 95%


1. Vulnerability Assessment and Risk mapping (VRAM) and avail emergency supplies

3.6.9. P5: Enhance laboratory quality management system implementation


By the end of 2020:

1. Increase proportion of laboratories implementing all essentials of LQMS from 30% to

100%

2. 430 laboratories equipped with electronic LIS in five years

3. Increase proportion of laboratories participating in EQA from 75% to 100%

4. Thirteen equipment maintenance workshops established and/ or strengthened in five

years

5. 100% of laboratories below 5% service interruption rate due to equipment failures and/or

supply stock outs

6. 100% of EQA rechecking laboratories with database


1. Implementing External Quality Assessment (EQA)

2. Documents and information management

3. Equipment and supplies management

4. Process control and process improvement

5. Facility and safety


3.6.10. P6: Strengthening Laboratory Capacity for Referral and Backup Testing Services Performance measures:

By the end of 2020:

1. Increase proportion of laboratories networked to referral testing services from 60% to

100%

2. 100 % of health facilities have implemented test menu per established standard

3. 35 facilities capacitated (Full packages) for detection and characterization of epidemic

prone disease and other disease of Public Health importance

4. 100% provision for national, regional and international referral network system at all times

for epidemic prone and other disease of public health importance.


1. Strengthening laboratory network and referral testing services

2. Strengthening diagnostic capacity of Laboratories

3.6.11. P7: Improve programs/projects and institutional policies development and management


By the end of 2020:

1. 16 programs/projects monitoring rounds conducted in five years.

2. 7 programs/projects/SPM evaluations conducted in five years.

3. 50 Institutional policies, guidelines and manuals developed and updated in five years.


1. Strengthening program/project monitoring and evaluation system

2. Strengthen administrative and technical policies and guidelines

3.6.12. F1: Improve financial resource mobilization and utilization efficiency


By the end of 2020:

1. Increase proportion of mobilized financial resource from 80% to 100%

2. Increase proportion of utilized resources from 75% to 100%

3. 100% of good performance compliance issues in line with the standards


4. 100% of procured and availed goods & supplies, construction and services

5. Reduce stock wastage rate to 2%.

6. Reduce procurement lead time from 240 days to 120 days


1. Establish efficient financial resource mobilization and utilization system

2. Strengthening logistics management system

3.6.13. CB1: Improve Human Resource Development, Management and Governance


By the end of 2020:

1. Increase proportion of employees achieving best performance with HDA Capacity

Building scheme to 95%

2. Increase proportion of employees trained with Long Term Training (LTT) from 95% to

100%

3. Increase proportion of employees trained with Short Term Training (STT) from 98% to

100%

4. Reduce staff attrition rate to 3%

5. 100% of standards achieving good governance

6. Increase staff satisfaction to 95%


1. Strengthen HDA of the Institute to enhance performance and productivity

2. Strengthen Human Resource Development through trainings

3. Recruit and retain the skilled human resource

4. Enhance good governance

5. Mainstreaming of gender, HIV control and environmental issues

3.6.14. CB2: Enhance Infrastructure and System development


By the end of 2020:

1. Fourteen physical facilities established in five years

2. Seventeen operations automated and put into operation



1. Build and strengthen administrative and technical infrastructures

2. Developing database(one data clearing house) and automate all operations

3.6.15. CB3: Enhance Communication, Coordination and Partnership


By the end of 2020:

1. Three communication systems developed and operationalized

2. Thirty two national/regional/ international collaborations established in five years

3. Nineteen national/regional/ international partnerships established in five years

4. 100% of national/regional/ international collaborations and partnerships maintained


1. Establish information and communication system

2. Strengthening collaboration and partnership at all level


CHAPTER 4

54 The 2nd BSC Based EPHI’s Strategic Management Plan: 2015/16 to 2019/20C

hapt

er 4

: Cos

ting,

Fin

anci

ng a

nd R

esou

rce

Map

pin

g

The

budg

et h

as b

een

estim

ated

bas

ed o

n ac

tivity

cos

ting

and

orga

nize

d by

the

stra

tegi

c ob

ject

ives

. Ta

ble-

4: B

udge

t map

ping

by

stra

tegi

c ob

ject

ives

S. O

bjec

tives

Bud

get (

in U

SD

) by

budg

et y

ears

(‘00

0’)

2015

/16

2016

/17

2017

/18

2018

/19

2019

/202

0

Com

mitt

edG

apTo

tal

Com

mitt

edG

apTo

tal

Com

mitt

edG

apTo

tal

Com

mitt

edG

apTo

tal

Com

mitt

edG

apTo

tal

C1:

Impr

ove

utiliz

atio

n of

evi

denc

e ba

sed

info

rmat

ion,

pro

duct

pa

ckag

es a

nd p

rodu

cts

3337

8274

1034

1192

2866

3860

6229

2700

7860

6187

6062

6527

463

3552

9938

2762

3839

3373

3934

11

C2:

Impr

ove

publ

ic h

ealth

em

erge

ncy

resp

onse

and

re

habi

litat

ion

8000

-80

0071

50-

7150

7865

-78

6586

5186

5195

1795

17

C3:

Incr

ease

and

m

aint

ain

qual

ity a

ssur

ed

labo

rato

ries

10

81-

1081

1040

-10

4010

50-

1050

-10

4010

40-

5261

5261

C4:

Enh

ance

com

mun

ity

owne

rshi

p5,

800

-5,

800

5,80

0-

5,80

05,

800

-5,

800

5,80

0-

5,80

05,

800

-5,

800

P1:

Impr

ove

publ

ic h

ealth

su

rvei

llanc

e sy

stem

16

5190

1363

417

8824

1757

4684

,279

2600

2518

9994

9723

628

7230

2152

619

125

4065

122

874

8563

3143

7

P2:

Impr

ove

rese

arch

and

ev

alua

tion

on k

ey h

ealth

&

nutr

ition

issu

es72

5795

5488

178

0676

1573

159

317

7504

871

5126

703

3385

471

667

2797

299

639

3095

810

979

4193

7

P3:

Impr

ove

tech

nolo

gy

eval

uatio

n an

d tr

ansf

er

3750

1403

717

787

4125

1492

5617

1875

2555

327

428

2064

1542

117

485

2167

1484

117

008

P4:

Impr

ove

publ

ic h

ealth

em

erge

ncy

prep

ared

ness

8377

38-

8377

3889

8832

-89

8832

9680

15-

9680

15-

8371

1683

7116

9208

2892

0828

P5:

Enh

ance

labo

rato

ry

qual

ity m

anag

emen

t sy

stem

impl

emen

tatio

n50

68-

5068

6753

-67

5333

53-

3353

-27

5327

53-

2453

2453

P6:

Stre

ngth

enin

g La

bora

tory

Cap

acity

for

Ref

erra

l and

Bac

kup

Test

ing

Ser

vice

s

2083

-20

8320

50-

2050

2050

-20

50-

2050

2050

-20

5020

50


P7:

Impr

ove

prog

ram

s/pr

ojec

ts a

nd In

stitu

tiona

l po

licie

s D

evel

opm

ent a

nd

Man

agem

ent

3350

-33

5032

10-

3210

3956

3956

3636

3636

5212

-52

12

F1: I

mpr

ove

finan

cial

re

sour

ce m

obiliz

atio

n an

d ut

ilizat

ion

effic

ienc

y84

2067

7315

193

6212

3713

9925

6728

4084

1081

273

6444

9211

856

8035

4941

1297

6

CB

1: Im

prov

e H

uman

R

esou

rce

Dev

elop

men

t, m

anag

emen

t and

G

over

nanc

e

1025

010

250

7425

7425

8168

8168

8984

8984

9883

9883

CB

2: E

nhan

ce

Infra

stru

ctur

e an

d S

yste

m

deve

lopm

ent

2189

0060

0022

4900

1936

0019

3600

2026

7020

2670

2155

021

550

8600

8600

CB

3: E

nhan

ce

Com

mun

icat

ion,

C

oord

inat

ion

and

Par

tner

ship

1350

1350

2700

110

110

220

121

121

242

133

133

266

147

146

293

Tota

l23

3055

710

4085

2434

642

1614

422

1549

7317

6939

514

0887

475

9884

2168

758

1701

8712

7405

214

4423

993

714

1372

952

1466

666

Tabl

e -5

: Gap

ana

lysi

s of

fund

ing

(in U

SD

In ‘0

00’)

Bud

get Y

ear

Tota

l est

imat

ed c

ost

Res

ourc

e C

omm

itted

Res

ourc

e G

apG

over

nmen

tA

idTo

tal

2015

/16

2434

642

7962

6115

3429

623

3055

710

4085

2016

/17

1769

395

7654

7384

8949

1614

422

1549

73

2017

/18

2168

758

1277

4912

8112

514

0887

475

9884

2018

/19

1444

239

1635

9865

8917

0187

1274

052

2019

/202

014

6666

667

195

2651

993

714

1372

952

Tota

l92

8370

019

2027

636

9747

856

1775

436

6594

6


CHAPTER 5


Chapter 5: EPHI SPM Implementation Arrangement

5.1. Strengthen integration and coordination for successful implementation of the SPM The full implementation of the five years strategic plan requires active involvement and participation

of all the stakeholders and partners from community level to central level in accordance with the

roles and responsibilities given to them. The management of SPM comprises structured consultation

forums and a joint decision-making framework. The plan will be implemented in a coordinated manner,

with the collaboration of all the stakeholders and partners by implementing regulations and strategies

such as International Health Regulation, the one health approach, and Global Health Security Agenda.

Additional technical knowhow and resources will be mobilized using all the opportunities that arise in

the process. To coordinate and manage the implementation of the EPHI’s SPM, the Institute will have

the consultative and review institutional frameworks as described below so as to have the integrated

and well-coordinated institutional frameworks.

5.1.1. Joint Partnership and Coordination Forum (JPCF)This coordination forum comprises DG, DDGs, representative from FMOH, key partners

representatives from the three thematic area who give guidance on the implementations of

strategic activities and overview the performances of the three joint partnership coordination

forums of the thematic areas. DG and PMED will serve as the chairman and secretary of this

forum, respectively, and the forum will meet biannually (every 6 months).

The main roles of the forum are:

· Follow up and gives advice on the major strategic activities

· Advise on the resource mobilization and support alternatives

· Review reports and give feedback on key programmes/projects performances

· Overview the supportive supervision findings and give feedback for improvement

5.1.2. Joint Partnership Coordination Forum of Research and Technology Transfer (JPCF-RTT)

This coordination forum comprises DDG of RTT, key Public Health Research University

institutions representatives, One Research Responsible Head from each RHB. This committee

is chaired by DDG- RTT and have regular meeting once in two months. The Secretary for this

forum is SERO.

The main roles of the forum are:

· Agenda setting and discuss on key focus area of research priorities, and guide on the

research resource mobilization and support alternatives

CHAPTER 5


· Review reports and give feedback on key research programs performances and

documentation

· Overview the research and technology transfer development policy briefings.

5.1.3. Joint Partnership Coordination Forum of PHEM (JPCF-PHEM)

This coordination forum comprises DDG of PHEM, key partners’ representatives working on

PHE, PHEM Heads from each RHB, relevant experts and PR from EPHI. The forum is chaired

by DDG of PHEM and the regular meeting will be held once in two months. The Secretary for

this forum is the EPHI’s public relation.

The main duties are:

· Follow up and give guidance on the PHEM, and work in collaboration with the other

sectors

· Guide on the resource mobilization and support alternatives

· Mobilize all necessary resources at times of emergency

· Review reports and give feedback on key program performances

· Overview the supportive supervision findings and give feedback for improvement

5.1.4. Joint Partnership Coordination Forum for Laboratory Quality Management (JPCF-LQM)

This coordination forum comprises LCB, Technical experts from key partners, regional laboratory

heads from RHBs and representatives working in laboratory quality assurance. The forum is

chaired by LCB and Secretary is up on assignment by the forum. The forum regular meeting

will be once in two months.

The main duties and responsibilities of the forum are:

· Follow up and give guidance on the major laboratory quality management and

maintenance management

· Work on the resource mobilization and support alternatives

· Review reports and give feedback on key program performances

5.2. Ensuring the sustainability of the Institute’s achievementsThe Institute has planned the SPM to implement it in coordination and collaboration with stakeholders

and partners by decentralizing and cascading the SPM into regions. The stakeholders and partners

will use this strategic plan to guide them for the development of locally appropriate strategic plans

and action plans and design its implementation arrangements. Improvement of national and regional

public health research institutes, universities and others engaged in public health research and

capacitate them in terms of trainings, research methodologies and infrastructure. Coordination of

national public health research, policy/program/strategy evaluation and surveillance in collaboration


with similar institutions based on the country priority health agenda. Strengthening collaboration and

partnership of public health research by developing, institutionalizing and implementing one health

research framework that evolve potential partners such as local and international Research institutes,

Universities, and others engaged in public health and related research. Intramural and extramural

research approach will be applied for successful implementation of the SPM.

5.2.1. Improve human resource through trainingThe human resource capacity of the PHEM, laboratory quality system and research structures

will be strengthened. The research and laboratory quality system structures will be strengthened

at national and regional level. Long term and short term trainings will be given to enhance

the capacity of EPHI staffs as well as the regions. Short term trainings will be given for health

professionals (regions, health facilities) to strengthen research, laboratory quality, and PHEM. The

PHEM structures at national, regional, zonal, woreda levels as well as the critical Directorates

in MoH, EPHI and other Institutions such as Ministry of Agriculture will be staffed with highly

trained health workers (Field Epidemiologists). Basic level trainings on PHEM will also be given

to all Woreda level PHEM staffs.

5.2.2. Strengthen Capacity in Infrastructure and Logistic Enhancing the capacity of laboratory physical infrastructures and resource availability is paramount

for the Institute’s success. The Institute has planned to establish high level laboratories and

emergency operation centers. The Institute has consumed large amount of budget for vehicle

rent every year; so that it is critical to purchase and make avail the required amount of vehicles for

sustainable implementation of its SPM throughout the five years and beyond.

The surveillance of diseases, early detection of outbreaks and responding to any of the outbreaks

in fastest possible ways will be achieved through transformation of the reporting system by

full implementation of electronic reporting system (e-PHEM). Laboratory capacity at national

and regional levels will be upgraded so that prompt laboratory diagnosis of pathogens will be

achieved.

5.2.3. Project design and implementationThe Institute will focus on appropriate project cycle management to develop mega projects

in coordination and collaboration with stakeholders and partners for sustainable resource

mobilization and SPM implementation. Partners will also use the plan for identifying and

developing strategic roles to fill gaps in technical and resources inputs critical for the attainment

of the strategic objectives.

5.2.4. Planning and BudgetingBy cascading the SPM into annual plans of action, joint planning and reviews with stakeholders

and partners will be conducted every year throughout the SPM implementation period.

Collaboration, partnership, and agreements with all stakeholders and partners/funders are

expected to focus on priorities and targets of the strategic and annual plans. Budgeting will be

done every year based on priorities, targets, and availability of resources from goverment and

partners.


CHAPTER 6


Chapter 6:EPHI SPM Monitoring and Evaluation Framework

6.1. The Indicators and Targets for SPM Monitoring and EvaluationPlanning, Monitoring and Evaluation Framework

The Institute upgraded the Planning Monitoring and Evaluation structure to directorate level to scale up its monitoring and evaluation efforts. The BSC based planning and progress monitoring will be followed. The Institute’s annual planning emanates from and based on the strategic plan prioritized areas. The plan will coordinate and guide the development of mega projects in close collaboration with concerned directorates and stakeholders. Annual joint plan will be conducted with the public wing including regional health bureaus and selected stakeholders.

The Institute’s monitoring and evaluation framework would be based on the identified performance measures. Continues monitoring of progress will be conducted using the HDA forums and bottom up approach at all level starting from case team, transformation, directorate and the council forums. The consolidated report will be prepared on quarterly bases and discussed with the Institute’s general staff forum and submitted periodically to concerned stakeholders for effective and efficient evidence based decision making. Bi-annual joint progress review with prioritized stakeholders and joint supportive supervision to the regional states would be implemented. The strategic plan midterm and final evaluation will be conducted to assess the progress and impact of the Institute’s activities towards universal health care coverage. Separate evaluations will be conducted for selected mega projects and programs implemented by the Institute.

The input, output, outcome and impact indicators are listed in the M&E matrix including baseline data and targets for the next five years (Figure 13 and Table 6). The input and process indicators will be monitored routinely at every stature of the Institute to ensure efficient availability and utilization of resources and activities are getting done while the output indicators would be assessed to cheek the delivery of outputs to the final users. The outcome and impact indicators will be validated with the midterm and final evaluation of the strategic plan to assess the Institute’s contribution towards the

HSTP’s universal health coverage and beyond.


Indicator Level Inputs Process Output Outcomes Impact

Indicator Domain

Good governance and availability of sufficient human, financial and physical resources.

Surveillance, research and evaluation, technology transferEmergency preparednessLaboratory quality & capacity

Availability of evidence based information, vaccines, supplementary foods and anti-sera productsDelivery of PHE response and rehabilitation services Enhanced laboratory quality Management System and Capacity

Uptake of availed evidence based information, vaccines, supplementary foods and other anti-sera productsAccess to PHE response and rehabilitation services Access to of quality assured laboratories

Health policies and programs Improvement Access to quality health primary services Morbidity and mortality due to public health emergency

Data Collection and Analysis

Administrative Records and Sources Synthesized Review

Financial Reports

Joint Supportive Supervision reports

Strategic Plan Midterm and Final Evaluations Projects and programs evaluations Quarter and annual reports

Communication and use

Periodic Reports, Joint Reviews, Global Reports, Conference Proceedings, Journals, books and book chapters

Figure 13: Monitoring and Evaluation Framework

Further, the Institute’s scientific conference will be conducted every year to validate and disseminate

the Institute research outputs. Project validation workshops will also be organized in collective

manner based on the research sub thematic areas. Documentation of lessons learned and organized

experience sharing with national and international peer organization especially from sub-Saharan

African countries will be conducted. Approved research project would be reviewed periodically to

check weather projects are conducting according to the scientific and ethical protocols.


Tabl

e-6:

Lis

t of p

erfo

rman

ce m

easu

res

and

targ

ets

unde

r eac

h ob

ject

ive

Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

C1.

Impr

ove

utiliz

atio

n of

evi

denc

e ba

sed

info

rmat

ion,

pro

duct

ion

pack

ages

and

pro

duct

s

C1.

I1P

ropo

rtio

n of

syn

thes

ized

ev

iden

ce-b

ased

info

rmat

ion

utiliz

ed b

y de

cisi

on m

akin

g.O

utco

me

Num

ber o

f s

ynth

esiz

ed &

ut

ilized

evi

denc

es /

num

ber o

f sy

nthe

size

d ev

iden

ce-b

ased

in

form

atio

n di

ssem

inat

ed

Ass

essm

ent

repo

rt%

Not

A

vaila

ble

6078

8389

C1.

I2

Num

ber o

f syn

thes

ized

ev

iden

ce-b

ased

info

rmat

ion

gene

rate

d an

d di

ssem

inat

ed

for d

ecis

ion

mak

ing

Out

put

-P

rogr

ess

Rep

ort

Num

ber

110

510

6

C1.

I3Ty

pes

of v

acci

nes

and

seru

m

prod

ucts

dis

trib

uted

.O

utpu

t-

Pro

gres

s R

epor

tN

umbe

r1*

1*1*

3**

4**

5**

C1.

I4P

ropo

rtio

n of

dos

es/v

ials

of

vac

cine

s an

d A

nti-S

era

prod

ucts

util

ized

.O

utpu

t

Num

ber o

f dos

es/v

ials

of

prod

ucts

util

ized

/ N

umbe

r of

dos

es/v

ials

of p

rodu

cts

dist

ribut

ed

Pro

gres

s R

epor

t%

Not

A

vaila

ble

8085

9095

99

C1.

I5P

rodu

ctio

n pa

ckag

es

diss

emin

ated

.O

utpu

t-

Pro

gres

s R

epor

tN

umbe

rN

ot

appl

icab

le1

31

23

C1.

I6P

ropo

rtio

n of

pro

duct

ion

pack

ages

util

ized

.O

utco

me

Num

ber o

f pro

duct

ion

pack

ages

ut

ilized

/ N

umbe

r of p

rodu

ctio

n pa

ckag

es d

isse

min

ated

.

Pro

gres

s R

epor

t%

Not

ap

plic

able

100

8675

8999

C1.

I7Ty

pes

of d

iagn

ostic

te

chno

logi

es d

isse

min

ated

Out

put

-P

rogr

ess

repo

rtN

umbe

r2

1013

1212

14

C1.

I8P

ropo

rtio

n of

type

s of

di

agno

stic

tech

nolo

gies

ut

ilized

Out

com

eTy

pes

of d

iagn

ostic

tech

nolo

gies

ut

ilized

/ T

ypes

of d

iagn

ostic

te

chno

logi

es d

isse

min

ated

Ass

essm

ent/

Pro

gres

s re

port

%10

070

7792

9299


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

C2:

Impr

ove

publ

ic h

ealth

em

erge

ncy

resp

onse

and

reha

bilit

atio

n

C2.

I1P

ropo

rtio

n of

affe

cted

peo

ple

prov

ided

reha

bilit

atio

nO

utpu

tN

o. o

f Peo

ple

prov

ided

re

habi

litat

ion/

No.

of P

eopl

e af

fect

ed b

y m

ajor

PH

Es

Pro

gres

s R

epor

t%

3680

8585

8595

C2.

I2P

ropo

rtio

n of

hea

lth fa

cilit

ies

reha

bilit

ated

Out

put

No.

of H

ealth

Fac

ilitie

s R

ehab

ilitat

ed/N

o. o

f Hea

lth

Faci

litie

s D

amag

ed

Pro

gres

s R

epor

t%

Not

av

aila

ble

8590

9595

95

C2.

I3P

ropo

rtio

n of

pub

lic h

ealth

ris

ks a

vert

edP

roce

ssN

o. o

f Pub

lic H

ealth

Ris

ks

aver

ted/

No.

of H

ealth

risk

s id

entifi

ed

Pro

gres

s R

epor

t%

Not

av

aila

ble

5075

8590

95

C2.

I4P

ropo

rtio

n of

epi

dem

ics

cont

rolle

d w

ithin

the

stan

dard

of

mor

talit

y O

utco

me

No.

of E

pide

mic

s co

ntro

lled

with

in th

e st

anda

rd o

f mor

talit

y /

No.

of E

pide

mic

s oc

curr

ed

Pro

gres

s re

port

&

surv

eilla

nce

repo

rt

%N

ot

avai

labl

e50

6075

8585

C3:

Inc

reas

e an

d m

aint

ain

qual

ity a

ssur

ed la

bora

torie

s

C3.

I1P

ropo

rtio

n of

hos

pita

l and

re

gion

al la

bora

torie

s w

ith

SLI

PTA

Sta

r-le

vels

3-5

Pro

cess

N

o. o

f hos

pita

l and

regi

onal

labs

w

ith S

LIP

TA le

vel 3

-5/T

otal

No.

of

hosp

ital &

regi

onal

labs

Aud

it/as

sess

men

t re

port

%

2040

6080

9010

0

C3.

I12

Pro

port

ion

of h

ealth

cen

ter

labo

rato

ries

with

SLI

PTA

S

tar-

leve

ls 1

-5P

roce

ss

No.

of h

ealth

cen

ter l

abs

with

S

LIP

TA s

tar l

evel

1-5

/Tot

al N

o. o

f he

alth

cen

ters

labs

Aud

it/as

sess

men

t re

port

%

110

2040

6085

C3.

I13

Num

ber o

f lim

ited

scop

e ac

cred

ited

(LS

A) l

abor

ator

ies

to IS

O 1

5189

and

/or 1

7025

O

utpu

t Li

mite

d sc

ope

accr

edita

tion

(for

one

or m

ore

test

s)P

rogr

ess

repo

rtN

umbe

r 2

4560

7590

105

C3.

I14

Num

ber o

f ful

l sco

pe

accr

edite

d la

bora

torie

s to

IS

O 1

5189

and

/or 1

7025

Out

put

Full

scop

e ac

cred

itatio

n (

for a

ll te

sts)

Pro

gres

s re

port

Num

ber

06

618

2938


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

C3.

I15

Pro

port

ion

of la

bs im

prov

ing

th

eir L

SA

sta

tus

Out

put

Num

ber o

f lab

s th

at e

xpan

d th

eir

LSA

by

at le

ast o

ne te

st ty

pe /

All

num

ber o

f lab

s w

ith L

SA

Pro

gres

s re

port

%

010

0 10

010

010

010

0

C3.

I16

Pro

port

ion

of la

bs

mai

ntai

ning

the

ir ac

cred

itatio

n st

atus

Out

put

Num

ber o

f lab

s m

aint

aini

ng th

eir

accr

edita

tion

stat

us/A

ll nu

mbe

r of

acc

redi

ted

labs

to I

SO

151

89

and/

or 1

7025

Pro

gres

s re

port

%0

100

100

100

100

100

C3.

I7P

erce

nt o

f cus

tom

er

satis

fact

ion

Out

com

e

Num

ber o

f cus

tom

ers

satis

fied

(with

≥80

per

cent

) /to

tal n

umbe

r of

cus

tom

ers

incl

uded

in th

e su

rvey

Sur

vey

repo

rt%

Not

av

aila

ble

5060

7585

≥95

C4:

Enh

ance

com

mun

ity o

wne

rshi

p

C4.

I1P

ropo

rtio

n of

keb

eles

that

im

plem

ent c

omm

unity

bas

ed

surv

eilla

nce

Pro

cess

N

o. o

f ke

bele

s im

plem

entin

g co

mm

unity

sur

veilla

nce

/Tot

al N

o.

of k

ebel

es in

Eth

.

Pro

gres

s R

epor

t %

00

1040

6080

P1:

Impr

ove

Pub

lic H

ealth

sur

veilla

nce

Sys

tem

P1.

I1N

umbe

r of p

ublic

atio

ns

prod

uced

on

peer

revi

ewed

jo

urna

ls f

rom

sur

veilla

nce

Out

put

-P

rogr

ess

Rep

ort

Num

ber

717

1014

1728

P1.

I2N

umbe

r of t

echn

ical

repo

rts

prod

uced

from

sur

veilla

nce.

Out

put

-P

rogr

ess

Rep

ort

Num

ber

2421

5344

4841

P1.

I3P

ropo

rtio

n of

hea

lth fa

cilit

ies

repo

rtin

g co

mpl

ete

and

timel

y w

eekl

y di

seas

es re

port

Out

put

Num

ber o

f Hea

lth F

acilit

ies

send

w

eekl

y re

port

on

Thur

sday

/N

o of

Hea

lth F

acilit

ies

Expe

cted

to

repo

rt

Sur

veilla

nce

Rep

ort

%77

8590

9595

95

P1.

I4P

ropo

rtio

n of

hea

lth fa

cilit

ies

usin

g e-

PH

EM re

port

ing

Out

put

No.

of H

ealth

Fac

ilitie

s us

ing

e-P

HEM

/# o

f Hea

lth F

acilit

ies

Expe

cted

to re

port

Sur

veilla

nce

repo

rt%

Not

A

vaila

ble

3045

5075

80


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

P1.

I5P

ropo

rtio

n of

PH

EM w

eekl

y di

seas

es re

port

s(bu

lletin

s)

dist

ribut

ed

Num

ber o

f PH

EM w

eekl

y di

seas

es b

ulle

tins

dist

ribut

ed/

Tota

l No.

of W

eeks

Pro

gres

s R

epor

t%

7785

8895

9598

P1.

I6P

ropo

rtio

n of

pos

t epi

dem

ic

asse

ssm

ent c

ondu

cted

Out

put

No.

of P

ost E

pide

mic

s as

sess

men

t con

duct

ed/N

o. o

f m

ajor

pub

lic h

ealth

em

erge

ncie

s oc

curr

ed

Pro

gres

s R

epor

t%

5070

7585

8590

P2:

Impr

ove

rese

arch

and

eva

luat

ion

on k

ey h

ealth

and

nut

ritio

n is

sues

P2.

I1N

umbe

r of p

ublic

atio

ns

prod

uced

in p

eer r

evie

wed

jo

urna

lsO

utpu

t-

Pro

gres

s R

epor

tN

umbe

r93

2939

4960

78

P2.

I2N

umbe

r of t

echn

ical

repo

rts

prod

uced

from

rese

arch

and

ev

alua

tion

Out

put

-P

rogr

ess

Rep

ort

Num

ber

3385

116

130

145

167

P3:

Impr

ove

tech

nolo

gy e

valu

atio

n an

d tr

ansf

er

P3.

I1Ty

pes

of v

acci

nes

and

seru

m

prod

ucts

pro

duce

dO

utpu

tP

rogr

ess

Rep

ort

Num

ber

1*1*

1*3*

*4*

*5*

*

P3.

I2N

umbe

r of p

rodu

ctio

n pa

ckag

es g

ener

ated

Out

put

-P

rogr

ess

Rep

ort

Num

ber

01

31

23

P3.

I3Ty

pes

of d

iagn

ostic

te

chno

logi

es e

valu

ated

and

re

com

men

ded

for u

seO

utpu

t-

Pro

gres

s R

epor

tN

umbe

r2

1013

1212

14

P3.

I4N

umbe

r of p

ublic

atio

ns

prod

uced

in p

eer r

evie

wed

jo

urna

lsou

tput

-P

rogr

ess

Rep

ort

Num

ber

85

69

1213

P3.

I5N

umbe

r of t

echn

ical

repo

rts

prod

uced

ou

tput

-P

rogr

ess

Rep

ort

Num

ber

012

1718

1826

NB

:

* Th

e sa

me

prod

uctio

n of

the

prod

uct w

ill co

ntin

ue o

nly

for 2

yea

rs.

** N

ewly

dev

elop

ed p

rodu

cts

prod

uctio

n w

ill co

ntin

ue.


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

P4:

Impr

ove

publ

ic h

ealth

em

erge

ncy

prep

ared

ness

P4.

I1

Pro

port

ion

of id

entifi

ed

pote

ntia

l epi

dem

ics

with

ad

equa

te E

DK

s an

d ot

her

supp

lies

Out

put

No.

of P

oten

tial e

pide

mic

s w

ith

adeq

uate

ED

Ks

and

supp

lies/

No.

of

iden

tified

Pot

entia

l epi

dem

ics

Pro

gres

s re

port

%71

7580

8590

95

P5:

Enh

ance

labo

rato

ry q

ualit

y m

anag

emen

t sys

tem

impl

emen

tatio

n

P5.

I1P

ropo

rtio

n of

labo

rato

ries

impl

emen

ting

all e

ssen

tials

of

LQM

S

Out

put

Num

ber o

f lab

orat

orie

s im

plem

entin

g LQ

MS

/To

tal

num

ber o

f lab

orat

orie

s in

the

coun

try

Pro

gres

s re

port

%30

5065

8095

100

P5.

I2N

umbe

r of l

abor

ator

ies

with

ele

ctro

nic

labo

rato

ry

Info

rmat

ion

Sys

tem

O

utpu

t -

Pro

gres

s re

port

Num

ber

2240

6080

100

150

P5.

I3

Pro

port

ion

of la

bora

torie

s pa

rtic

ipat

ing

in E

xter

nal

qual

ity a

sses

smen

t pro

gram

s (E

QA

)

Out

put

No.

of l

abor

ator

ies

part

icip

ated

in

EQA

/To

tal n

umbe

r of l

abor

ator

ies

in th

e co

untr

y

Pro

gres

s re

port

%

7580

8590

9510

0

P5.

I4

Num

ber o

f equ

ipm

ent

mai

nten

ance

wor

ksho

ps

esta

blis

hed

and/

or

stre

ngth

ened

Out

put

-P

rogr

ess

repo

rtN

umbe

r 4

913

1313

13

P5.

I5

Pro

port

ion

of la

bora

torie

s be

low

5%

ser

vice

in

terr

uptio

n ra

te d

ue to

eq

uipm

ent f

ailu

res

and/

or

supp

ly s

tock

out

s

Out

put

No.

of l

abs

belo

w 5

% s

ervi

ce

inte

rrup

tion

rate

/Tot

al N

o. o

f gov

. la

bs in

the

coun

try

Pro

gres

s re

port

%N

ot

Ava

ilabl

e40

6075

8510

0

P5.

I6P

ropo

rtio

n of

EQ

A

rech

ecki

ng la

bora

torie

s w

ith

data

base

Out

put

Num

ber o

f lab

orat

orie

s w

ith

data

base

/ to

tal n

umbe

r of E

QA

re

chec

king

labo

rato

ries

in th

e co

untr

y

Pro

gres

s re

port

%5

2550

7585

100


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

P6:

Stre

ngth

enin

g La

bora

tory

Cap

acity

for R

efer

ral a

nd B

acku

p Te

stin

g S

ervi

ces

P6.

I1P

ropo

rtio

n of

labo

rato

ries

netw

orke

d to

re

ferr

al te

stin

g se

rvic

esO

utpu

t N

umbe

r of l

abs

havi

ng a

cces

s to

refe

rral

test

ing

serv

ices

/ to

tal

num

ber o

f ref

errin

g la

bora

torie

s

Ass

essm

ent

repo

rt

%60

7580

8590

100

P6.

I2P

ropo

rtio

n of

hea

lth fa

cilit

ies

have

impl

emen

ted

test

men

u pe

r est

ablis

hed

stan

dard

Out

put

Num

ber o

f lab

s im

plem

ente

d tie

r lev

el s

tand

ard

men

u /

tota

l nu

mbe

r of l

abor

ator

ies

in th

e co

untr

y

Ass

essm

ent

repo

rt%

Not

av

aila

ble

4060

8090

100

P6.

I3

Num

ber o

f fa

cilit

ies

capa

cita

ted

for d

etec

tion

and

char

acte

rizat

ion

of e

pide

mic

pr

one

dise

ase

and

othe

r di

seas

e of

Pub

lic H

ealth

im

port

ance

Out

put

-P

rogr

ess

repo

rtN

umbe

r5

510

105

5

P6.

I4

Pro

port

ion

of te

st s

ervi

ce

prov

isio

n fo

r nat

iona

l, re

gion

al a

nd in

tern

atio

nal

refe

rral

net

wor

k sy

stem

at a

ll tim

es fo

r epi

dem

ic p

rone

and

ot

her d

isea

se o

f pub

lic h

ealth

im

port

ance

Out

put

Num

ber o

f tes

t ser

vice

s pr

ovid

ed

/Tot

al n

umbe

r of t

est s

ervi

ce

requ

este

d in

the

refe

rral

net

wor

k sy

stem

Ass

essm

ent

repo

rt a

nd /

or p

rogr

ess

repo

rt

%N

ot

avai

labl

e10

010

010

010

010

0

P7:

Impr

ove

prog

ram

s/pr

ojec

ts a

nd in

stitu

tiona

l pol

icie

s de

velo

pmen

t and

man

agem

ent

P7.

I1N

umbe

r of p

rogr

ams/

proj

ects

mon

itorin

g ro

unds

co

nduc

ted

Out

put

-pr

ogre

ss

repo

rtN

umbe

r20

44

44

4

P7.

I2N

umbe

r of e

valu

atio

ns

cond

ucte

d O

utpu

t-

prog

ress

re

port

Num

ber

11

22

2


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

P7.

I3N

umbe

r of

Inst

itutio

nal

polic

ies/

guid

elin

es/m

anua

ls

deve

lope

d an

d up

date

dO

utpu

t-

prog

ress

re

port

Num

ber

1012

1214

66

F1: I

mpr

ove

finan

cial

reso

urce

mob

ilizat

ion

and

utiliz

atio

n ef

ficie

ncy

F1.I1

Pro

port

ion

of m

obiliz

ed

finan

cial

reso

urce

O

utpu

tM

obiliz

ed fi

nanc

ial r

esou

rce

in

Birr

/ To

tal fi

nanc

ial g

ap id

entifi

ed

in B

irr

Pro

gres

s re

port

%65

7075

8085

90

F1.I2

Pro

port

ion

of u

tiliz

ed

reso

urce

s O

utpu

tU

tiliz

ed re

sour

ces/

Pla

nned

re

sour

ces

to u

tiliz

eP

rogr

ess

repo

rt%

7585

9597

100

100

F1.I3

Pro

port

ion

of g

ood

perfo

rman

ce c

ompl

ianc

e is

sues

in li

ne w

ith th

e st

anda

rds

Out

put

Num

ber o

f goo

d pe

rform

ance

co

mpl

ianc

e is

sues

han

dled

w

ith ≥

90%

per

fect

ion

as p

er

set s

tand

ards

/ To

tal n

umbe

r of

com

plia

nce

issu

es h

avin

g st

anda

rds

Pro

gres

s re

port

and

A

udit

repo

rt%

100

100

100

100

100

100

F1.I4

Pro

port

ion

of p

rocu

red

and

avai

led

good

s &

sup

plie

s,

cons

truc

tion

and

serv

ices

Inpu

t

On

time

proc

ured

and

ava

iled

good

s &

sup

plie

s, c

onst

ruct

ion

and

serv

ices

as

per n

eed/

Tota

l nee

d of

goo

ds &

supp

lies,

co

nstr

uctio

n an

d se

rvic

es to

be

avai

led

Pro

gres

s re

port

and

A

udit

repo

rt%

50

9095

100

100

100

F1.I5

Pro

port

ion

of s

tock

was

ted

due

to e

xpiry

Out

put

Am

ount

of c

hem

ical

s an

d re

agen

ts e

xpire

d /T

otal

am

ount

of

chem

ical

s an

d re

agen

ts a

vaile

d

Pro

gres

s re

port

an

d A

udit

repo

rt%

Not

av

aila

ble

98

76

5

F1.I6

Pro

cure

men

t lea

d tim

e (d

ays)

Inpu

t-

Pro

gres

s re

port

an

d A

udit

repo

rtN

umbe

r24

021

021

018

015

012

0


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

CB

1: Im

prov

e H

uman

Res

ourc

e D

evel

opm

ent ,

Man

agem

ent a

nd G

over

nanc

e

CB

1.I1

Pro

port

ion

of e

mpl

oyee

s ac

hiev

ing

best

per

form

ance

w

ith H

DA

Cap

acity

Bui

ldin

g sc

hem

e

Out

put

Num

ber o

f em

ploy

ees

achi

evin

g av

erag

e ‘A

’ lev

el p

erfo

rman

ce/

Tota

l num

ber o

f em

ploy

ees

Pro

gres

s re

port

%65

7080

9095

≥95

CB

1.I2

Pro

port

ion

of e

mpl

oyee

s tr

aine

d w

ith lo

ng t

erm

tr

aini

ng (L

TT)

Out

put

No.

of e

mpl

oyee

s tr

aine

d w

ith

LTT/

Tota

l num

ber o

f em

ploy

ees

to b

e tr

aine

d w

ith L

TT

Pro

gres

s re

port

%95

100

100

100

100

100

CB

1.I3

Pro

port

ion

of e

mpl

oyee

s tr

aine

d w

ith s

hort

term

tr

aini

ng (S

TT)

Out

put

No.

of e

mpl

oyee

s tr

aine

d w

ith

STT

/ To

tal n

umbe

r of e

mpl

oyee

s to

be

trai

ned

with

STT

Pro

gres

s re

port

%98

100

100

100

100

100

CB

1.I4

Pro

port

ion

of s

taff

attr

ition

ra

te re

duct

ion

Out

put

Num

ber o

f pot

entia

l sta

ffs

rele

ased

/Tot

al n

umbe

r of s

taffs

av

aile

d in

a y

ear

Pro

gres

s re

port

%N

ot

avai

labl

e6

54

33

CB

1.I5

Pro

port

ion

of s

tand

ards

ac

hiev

ing

good

gov

erna

nce

Out

put

Num

ber o

f st

anda

rds

with

goo

d go

vern

ance

pra

ctic

es(≥

90%

)/ To

tal n

umbe

r of

stan

dard

s fo

r as

surin

g go

od g

over

nanc

e

Pro

gres

s re

port

%N

ot

avai

labl

e85

9095

9810

0

CB

1.I6

Pro

port

ion

of s

taffs

sat

isfie

dN

umbe

r of

staf

fs s

atis

fied/

Tot

al

num

ber o

f st

affs

Pro

gres

s re

port

%N

ot

avai

labl

e65

7585

9095

CB

2: E

nhan

ce In

frast

ruct

ure

and

Sys

tem

dev

elop

men

t

CB

2.I1

Num

ber o

f ph

ysic

al fa

cilit

ies

es

tabl

ishe

dO

utpu

t-

Pro

gres

s re

port

Num

ber

11

62

5


Sr.

No

Indi

cato

rTy

pe o

f M

easu

reFo

rmul

aD

ata

Sou

rce

Uni

t of

Mea

sure

Bas

elin

e

Targ

ets

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

2019

/ 20

CB

2.I2

Num

ber o

f au

tom

atio

ns

esta

blis

hed

and

Ope

ratio

naliz

edO

utpu

t -

Pro

gres

s re

port

Num

ber

Not

av

aila

ble

103

4

CB

3: E

nhan

ce c

omm

unic

atio

n, c

oord

inat

ion

and

part

ners

hip

CB

3.I1

Com

mun

icat

ion

syst

ems

deve

lope

d an

d op

erat

iona

lized

-

Pro

gres

s re

port

Num

ber

13

33

33

CB

3.I2

Nat

iona

l/reg

iona

l/in

tern

atio

nal c

olla

bora

tions

es

tabl

ishe

d

-P

rogr

ess

repo

rtN

umbe

r20

1010

55

2

CB

3.I3

Reg

iona

l/int

erna

tiona

l pa

rtne

rshi

ps e

stab

lishe

d

-P

rogr

ess

repo

rtN

umbe

r2

44

44

3

CB

3.I4

Pro

port

ion

of n

atio

nal/

regi

onal

/ in

tern

atio

nal

colla

bora

tions

and

pa

rtne

rshi

ps m

aint

aine

d

No.

of

colla

bora

tors

an

d pa

rtne

rs

wor

king

w

ith E

PH

I/To

tal N

o. o

f co

llabo

rato

rs

and

part

ners

co

mm

itted

co

llabo

ratio

n &

par

tner

ship

Pro

gres

s re

port

%70

7580

8590

95


ReferencesCenter for Disease Control and Prevention. 2009. CFS Public Health Research Program 5-year Strategic

Plan.

Ethiopian Health and Nutrition Research Institute. (2009). Master Plan for the Public Health Laboratory System in Ethiopia, 2nd edition, 2009-2013, Addis Ababa.

Ethiopian Health and Nutrition Research Institute. (2011, 2013). Annual Plans (2010/11-2012/13). Addis Ababa.

Ethiopian Health and Nutrition Research Institute. (2011, 2012, 2013). Annual Performance Report (2010/11, 2011/12 and 2012/13. Addis Ababa

Ethiopian Health and Nutrition Research Institute. (2010). A Five Year Balanced Score Card Based Strategic Plan (2010/11-2014/5), Addis Ababa.

Ethiopian Health and Nutrition Research Institute. (2012). Public Health Emergency Management: Guideline for Ethiopia, Addis Ababa.

Ethiopian Public Health Institute. Annual Plans (2013/14-2014/15). Addis Ababa.

Ethiopian Public Health Institute. (2014). Annual Performance Report (2013/14), Addis Ababa.

Ethiopian Public Health Institute, (2013). Midterm Evaluation of the Implementation of Strategic Plan (2010-2015).

Ethiopian Public Health Institute. (2015). Annual Performance Report (2014/15). Addis Ababa.

Federal Democratic Republic of Ethiopia. Ministry of Health. (2008) Program Implementation Manual of National Nutrition Programme (NNP)-I, Addis Ababa.

Federal Democratic Republic of Ethiopia. MoFED. (2010). FDRE Growth and Transformation Plan (GTP-Volume I), Addis Ababa.

Federal Democratic Republic of Ethiopia. MoFED. (2015). FDRE Growth and Transformation Plan (GTP-Volume II), Addis Ababa.

Federal Democratic Republic of Ethiopia, Ministry of Health. (2010). Health Sector Development Plan IV, Addis Ababa

Federal Democratic Republic of Ethiopia, Ministry of Health. (2015). Health Sector Transformation Plan, Addis Ababa

Maarten O Kok and Albertine J Schuit, Contribution mapping: a method for mapping the contribution of research to enhance, its impact, Health Research Policy and Systems 2012, 10:21, page 1-16.


Ann

exes

Anne

x-1:

Des

crip

tions

of s

trat

egic

initi

ativ

es (s

cope

s) a

nd th

eir

deliv

erab

les

SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

C1: Im

prov

e ut

ilizat

ion

of e

vide

nce

base

d in

form

atio

n, p

rodu

ctio

n pa

ckag

es a

nd p

rodu

cts

C1.S

I1

Diss

emin

ate

evid

ence

bas

ed

info

rmat

ion,

pr

oduc

t pac

kage

s an

d pr

oduc

ts

This

mea

ns d

isse

min

atio

n of

syn

thes

ised

evi

denc

e-ba

sed

info

rmat

ion

of r

esea

rch,

sur

veilla

nce

and

tech

nolo

gy tr

ansf

er o

ut c

omes

for a

ppro

pria

te u

se b

y st

akeh

olde

rs in

cludi

ng p

olic

y m

aker

s an

d th

e pu

blic.

Evi

denc

e ba

sed

info

rmat

ion

abou

t pro

duct

ion

pack

ages

dev

elop

ed fr

om tr

aditi

onal

m

edici

nes

and

food

s th

at h

ave

pote

ntia

l for

com

mer

cializ

atio

n, fo

ur v

accin

e ty

pes

(rabi

es, (r

abie

s an

d m

enin

goco

ccal

) and

bio

logi

cal w

ill b

e pr

oduc

ed t

o pr

even

t in

fect

ious

dis

ease

s. In

form

atio

n of

tec

hnol

ogy

prod

uctio

n pa

ckag

es w

ill b

e di

ssem

inat

ed in

the

form

of t

echn

olog

y br

iefs

in a

n at

tem

pt to

tran

sfer

the

evid

ence

s fo

r the

indu

strie

s, m

anuf

actu

rers

. Out

puts

of p

rodu

ct p

acka

ges

and

prod

uctio

ns w

ill a

lso

be d

isse

min

ated

usi

ng a

ppro

pria

te le

gal f

ram

ewor

k an

d ch

anne

ls to

end

us

ers.

Diss

emin

ated

evi

denc

e ba

sed

info

rmat

ion,

pr

oduc

tion

pack

ages

and

pr

oduc

ts.

C1.S

I2

Ensu

re

tran

slat

ion

and

utiliz

atio

n of

ev

iden

ce b

ased

in

form

atio

n,

prod

uct p

acka

ges

and

prod

ucts

This

initi

ativ

e is

abo

ut en

surin

g ut

ilizat

ion

of d

isse

min

ated

evi

denc

e ba

sed

info

rmat

ion,

pro

duct

ion

pack

ages

and

pro

duct

s. A

ctiv

ities

inclu

de a

sses

smen

t an

d co

ntrib

utio

n m

appi

ng (e

valu

atio

n)

of s

ynth

esis

ed e

vide

nce-

base

d in

form

atio

n of

res

earc

h, s

urve

illanc

e an

d te

chno

logy

tra

nsfe

r ou

tcom

e ut

ilizat

ion

by s

take

hold

ers

inclu

ding

pol

icy

mak

ers

and

the

publ

ic. P

rodu

ctio

n pa

ckag

es

that

are

dev

elop

ed fr

om tr

aditi

onal

med

icine

s as

-wel

l-as

food

s, va

ccin

es a

nd b

iolo

gica

l pro

duct

s ut

ilizat

ion

by e

nd b

enef

iciar

ies

and

prod

uct p

acka

ges

prod

uced

by

othe

r aca

dem

ic in

stitu

tions

will

al

so b

e va

lidat

ed a

nd e

nsur

e fo

llow

ing

arra

ngem

ents

of M

emor

andu

m o

f Und

erst

andi

ng (M

oU)

that

inclu

de p

aten

t/ut

ility

right

for r

oyal

ty.

Utiliz

ed e

vide

nce

base

d in

form

atio

n, p

rodu

ct

pack

ages

and

pro

duct

s


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

C2: Im

prov

e pu

blic

heal

th e

mer

genc

y re

spon

se a

nd re

habi

litat

ion

C2.S

I1

Stre

ngth

en

Epid

emic

resp

onse

and

re

habi

litat

ion

Resp

onse

will

be

impr

oved

thr

ough

sou

nd e

arly

war

ning

sys

tem

, pre

pare

dnes

s an

d sy

stem

atic

supp

ort

for

the

regi

onal

leve

l and

Wor

edas

to

assu

me

incr

easi

ng le

ader

ship

and

res

pons

ibilit

y.

A Ra

pid

Resp

onse

Tea

m a

nd a

n em

erge

ncy

oper

atio

n ce

nter

will

be

esta

blis

hed

at c

entr

al le

vel

equi

pped

with

sta

te o

f th

e ar

t IT

and

com

mun

icatio

n eq

uipm

ent.

Prob

lem

s do

not

dis

appe

ar

once

the

acut

e em

erge

ncy

is c

ontr

olle

d or

the

dise

ase

is c

onta

ined

. Rec

over

y an

d re

habi

litat

ion

will

rec

eive

spe

cializ

ed a

tten

tion

inclu

ding

in s

uppo

rt f

or a

sses

sing

the

eco

nom

ic co

sts

of a

n em

erge

ncy/

disa

ster

and

mob

ilizin

g re

sour

ces.

Decr

ease

d m

orbi

dity

and

m

orta

lity

reha

bilit

ated

com

mun

ity

C3: In

crea

se a

nd m

aint

ain

qual

ity a

ssur

ed la

bora

torie

s

C3.S

I1

Impl

emen

tatio

n of

Ste

pwis

e La

bora

tory

Qu

ality

Im

prov

emen

t Pr

oces

s to

war

ds

Accr

edita

tion

(SLI

PTA)

The S

tepw

ise L

abor

ator

y Im

prov

emen

t Pro

cess

Tow

ards

Acc

redi

tatio

n (S

LIPT

A) is

a co

mpr

ehen

sive

ap

proa

ch to

str

engt

hen

heal

th la

bora

tory

ser

vice

s in

a s

tepw

ise

man

ner b

y pr

ovid

ing

grad

uate

d le

vels

of

perf

orm

ance

rec

ogni

tion

as t

hey

mov

e to

war

ds t

he f

ulfil

lmen

t of

ISO

151

89/1

7025

st

anda

rds

over

tim

e. S

LIPT

A pr

ovid

es a

pat

hway

that

aim

s at

ach

ievi

ng fu

ll-fle

dged

conf

orm

ity b

y br

eaki

ng d

own

the

proc

ess

into

a s

erie

s of

spe

cific

and

achi

evab

le im

plem

enta

tion

stag

es. S

LIPT

A re

cogn

izes

labo

rato

ries

whe

re t

hey

are

in t

he p

roce

ss o

f qu

ality

impr

ovem

ent;

supp

orts

the

m

thro

ugh

the

prov

isio

n of

regu

lar a

udits

and

tech

nica

l ass

ista

nce

so a

s to

enh

ance

cont

inua

l qua

lity

impr

ovem

ent a

nd e

nsur

e m

aint

enan

ce o

f ach

ieve

men

ts.

As a

nat

iona

l str

ateg

y, SL

IPTA

will

be

impl

emen

ted

at a

ll tie

rs o

f the

nat

iona

l lab

orat

ory

netw

ork

whe

reby

the

Natio

nal a

nd R

egio

nal r

efer

ence

labo

rato

ries,

all H

ospi

tal l

abor

ator

ies

and

thos

e of

He

alth

Cen

ters

with

hig

h te

st v

olum

es a

re g

iven

prio

rity.

Stre

ngth

enin

g la

bora

tory

man

agem

ent

tow

ards

acc

redi

tatio

n (S

LMTA

) will

be

impl

emen

ted

to

serv

e as

a to

ol a

nd e

ntry

poi

nt to

SLI

PTA.

SLM

TA is

a ta

sk-b

ased

trai

ning

and

men

torin

g pr

ogra

m

prov

ided

to la

bora

tory

per

sonn

el in

thre

e ph

ased

wor

ksho

ps w

ith s

ite m

ento

rshi

ps a

nd co

achi

ng

supp

ort i

n be

twee

n th

e ph

ases

ass

ocia

ted

with

impl

emen

tatio

n of

sel

ecte

d qu

ality

impr

ovem

ent

proj

ects

. Lab

orat

orie

s ar

e en

rolle

d in

to th

e pr

ogra

m b

ased

on

natio

nally

est

ablis

hed

crite

ria a

nd

will

gra

duat

e w

ith p

ost S

LMTA

exi

t rig

orou

s ex

tern

al a

sses

smen

t by

an in

depe

nden

t aut

horiz

ed

natio

nal o

r reg

iona

l bod

y/ag

ency

usi

ng S

ILPT

A ch

eckl

ist.

This

ext

erna

l ass

essm

ent w

ill d

eter

min

e th

e la

bs’ a

chie

vem

ents

and

pos

ition

s on

the

SLIP

TA g

radu

ated

Sta

r Lev

els

of 1

-5.

Labo

rato

ries

will

cont

inue

to b

e re

gula

rly m

ento

red

and

coac

hed

as th

ey p

ursu

e co

ntin

ual q

ualit

y im

prov

emen

t and

impl

emen

tatio

n of

SLI

PTA

tow

ards

acc

redi

tatio

n to

ISO

1518

9/17

025

stan

dard

s.

Impl

emen

tatio

n w

ise,

labo

rato

ries

with

bes

t per

form

ance

in S

LMTA

/SLI

PTA

will

be

supp

orte

d an

d en

cour

aged

to a

pply

for I

SO a

ccre

dita

tion.

Sus

tain

ed s

uppo

rt w

ill a

lso

be p

rovi

ded

to a

ll la

bs th

at

have

ach

ieve

d ac

cred

itatio

n in

ord

er to

mai

ntai

n th

is s

tatu

s at

all

times

.

SLM

TA g

radu

ated

la

bora

torie

sSt

ar le

vel r

ecog

nize

d la

bora

torie

s IS

O 15

189/

1702

5

Accr

edite

d la

bora

torie

s


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

C4: E

nhan

ce co

mm

unity

ow

ners

hip

C4.S

I1

Impl

emen

tatio

n of

com

mun

ity

base

d su

rvei

llanc

e

The c

omm

unity

will

be in

volv

ed in

the n

atio

nal s

urve

illanc

e sys

tem

thro

ugh

notif

ying

the o

ccur

renc

e of

dis

ease

s th

at a

re re

quire

d to

be

repo

rted

and

any

oth

er ill

ness

es th

at th

e co

mm

unity

cons

ider

s un

usua

l or o

ccur

ring

in e

xces

s of

wha

t is

expe

cted

and

une

xpla

ined

dea

ths.

Thi

s w

ill e

nhan

ce th

e ea

rly d

etec

tion

of o

utbr

eaks

and

tim

ely

resp

onse

. The

hou

seho

lds

are

expe

cted

to

repo

rt s

uch

dise

ases

or u

nusu

al e

vent

s am

ong

thei

r fam

ily to

the

1 to

5 n

etw

orks

, and

the

netw

orks

repo

rt to

he

alth

dev

elop

men

t tea

m o

r to

heal

th e

xten

sion

wor

kers

. At t

he e

nd o

f the

str

ateg

ic pl

an 8

0% o

f Ke

bele

s of

the

coun

try

will

fully

impl

emen

t com

mun

ity s

urve

illanc

e.

• Co

ntin

uous

wee

kly

notif

icatio

n re

port

s•

Kebe

les

impl

emen

ting

Com

mun

ity s

urve

illanc

e fu

lly

P1: Im

prov

e pu

blic

heal

th s

urve

illanc

e sy

stem

P1.S

I1

Surv

eilla

nce

of

dise

ases

and

thei

r de

term

inan

ts

This

mea

ns s

urve

illanc

e of

com

mun

icabl

e an

d no

n-co

mm

unica

ble

dise

ases

(CDs

and

NCD

s) a

nd

thei

r det

erm

inan

ts to

iden

tify a

nd cl

osel

y mon

itor p

ublic

hea

lth th

reat

s, pr

edict

ing

the

risk

it po

ses

on th

e hea

lth of

the p

ublic

and

to al

low

effe

ctiv

e res

pons

e and

actio

ns. It

also

inclu

des d

emog

raph

ic,

beha

vior

and

soc

ial f

acto

rs. I

n th

e N

CDs

cate

gory

maj

or d

isea

ses

such

as

card

iova

scul

ar, s

trok

e, hy

pert

ensi

on, d

iabe

tes,

men

tal il

lnes

s, ca

ncer

(cer

vica

l, bre

ast,

etc),

chro

nic r

espi

rato

ry a

nd H

IV, T

B be

havi

oral

sur

veilla

nces

and

inve

stig

atin

g th

e ca

use

of d

eath

s us

ing

verb

al a

utop

sy m

etho

d w

ill

be co

nduc

ted.

• Di

seas

es s

urve

illanc

e ou

tput

s in

the

form

of

tech

nica

l rep

orts

.•

Dise

ases

sur

veilla

nce

outp

uts

in th

e fo

rm o

f pe

er re

view

ed jo

urna

ls.

P1.S

I2

Surv

eilla

nce

of d

rugs

and

in

sect

icide

re

sist

ance

This

initi

ativ

e inc

lude

s the

surv

eilla

nce o

f ant

i-micr

obia

l dru

g res

ista

nce a

nd th

e irr

atio

nal u

tiliz

atio

n of

ant

imicr

obia

l dru

gs t

o pr

even

t an

d co

ntro

l em

ergi

ng o

f re

sist

ance

for

the

impr

ovem

ents

of

trea

tmen

t ou

tcom

es, t

o al

levi

ate

drug

add

ictio

n, s

ubst

ance

s of

abu

se a

nd t

heir

socia

l fac

tors

. Th

is in

clude

s an

ti-ba

cter

ial,

anti-

vira

l, an

ti-pa

rasi

tic d

rug

resi

stan

ces

and

phar

amac

ovig

ilanc

e fo

r the

maj

or d

isea

ses

of C

Ds a

nd N

CDs

of p

ublic

hea

lth im

port

ance

. Sur

veilla

nce

on th

e bu

rden

an

d pr

eval

ence

of

illicit

dru

gs (i

llicit

drug

use

) and

sub

stan

ce o

f ab

use

(suc

h as

Kha

t, To

bacc

o,

Alco

hol,

etc.)

and

thei

r det

erm

inan

t fac

tors

will

als

o be

don

e. I

nsec

ticid

e re

sist

ance

sur

veilla

nce

will

be

cond

ucte

d in

sel

ecte

d ar

eas

to id

entif

y th

e co

nven

tiona

l cau

ses

and

gene

tic fa

ctor

chan

ges

of t

he m

ajor

vec

tor/

s ba

sed

dise

ases

tra

nsm

issi

on. T

his

inclu

des,

sent

inel

site

s m

onito

ring

of

susc

eptib

ility

of m

alar

ia v

ecto

rs to

diff

eren

t mos

quito

cidal

chem

icals

, inse

ctici

des

used

for i

ndoo

r re

sidu

al s

pray

and

the

eff

icacy

of

mos

quito

cidal

impr

egna

ted

bed

nets

in k

illing

the

mos

quito

w

ithin

the

reco

mm

ende

d tim

e pe

riod.

• Dr

ugs

and

inse

ctici

de

resi

stan

ce s

urve

illanc

e ou

tput

s in

the

form

of

tech

nica

l rep

orts

.•

Drug

s an

d in

sect

icide

re

sist

ance

sur

veilla

nce

outp

uts

in th

e fo

rm o

f pe

er re

view

jour

nals

.


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P1.S

I3

Surv

eilla

nce

of

food

and

nut

ritio

n is

sues

This

is a

bout

the

sur

veilla

nce

of f

ood

fort

ifica

tion

and

micr

onut

rient

sta

tus.

Act

iviti

es in

clude

co

ntin

ues

asse

ssm

ent o

f foo

d fo

rtifi

catio

n at

food

indu

stry

leve

l and

mag

nitu

de o

f micr

onut

rient

de

ficie

ncie

s de

term

inat

ion

for t

rack

ing

inte

rven

tions

suc

h as

food

fort

ifica

tion

and

salt

iodi

zatio

n fo

r the

impr

ovem

ent o

f the

pub

lic h

ealth

.

• Fo

od a

nd n

utrit

ion

surv

eilla

nce

outp

uts

in

the

form

of t

echn

ical

repo

rts.

• Fo

od a

nd n

utrit

ion

surv

eilla

nce

outp

uts

in

the

form

of p

eer r

evie

w

jour

nals

.

P1.S

I 4Su

rvei

llanc

e of

re

prod

uctiv

e he

alth

issu

es

Repr

oduc

tive

heal

th s

urve

illanc

e an

d th

eir d

eter

min

ants

inclu

de ri

sky

beha

vior

s be

fore

or d

urin

g pr

egna

ncy

(abo

rtio

n, s

till

birt

h, e

tc),

neon

atal

and

chi

ld/i

nfan

t ill

hea

lth a

nd d

eath

, mat

erna

l m

orbi

dity

and

mor

talit

y, pr

egna

ncy

rela

ted

even

ts-S

TI, f

amily

pla

nnin

g, c

ontr

acep

tive

prac

tices

an

d un

inte

nded

pre

gnan

cy, i

nfer

tility

, rep

rodu

ctiv

e or

gan

canc

ers,

mat

erna

l and

chi

ld n

utrit

ion

indi

cato

rs w

ill a

lso

be in

clude

d.

• Re

prod

uctiv

e he

alth

is

sues

sur

veilla

nce

outp

uts

in th

e fo

rm o

f te

chni

cal r

epor

ts.

• Re

prod

uctiv

e he

alth

is

sues

sur

veilla

nce

outp

uts

in th

e fo

rm o

f pe

er re

view

ed jo

urna

ls.


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P1.S

I5

Stre

ngth

en

rout

ine

Su

rvei

llanc

e (ID

S, S

entin

el

Labo

rato

ry b

ased

su

rvei

llanc

e, Nu

triti

on)

Elec

tron

ic Re

port

ing

Syst

em

facil

itate

s da

ta

shar

ing,

al

ertin

g,

notif

icatio

n an

d ep

idem

ic in

form

atio

n ex

chan

ge. T

he s

yste

m w

ill b

e es

tabl

ishe

d fr

om h

ealth

facil

ity to

nat

iona

l lev

el w

ith

all t

he n

eces

sary

tool

s an

d pr

ogra

mm

es. T

he h

ealth

risk

s/th

reat

s id

entif

ied

thro

ugh

the

indi

cato

r an

d ev

ent b

ased

surv

eilla

nce

shou

ld b

e an

alyz

ed a

nd d

isse

min

ated

to th

e pu

blic,

stak

ehol

ders

and

re

leva

nt p

artn

ers.

The

risk

cou

ld b

e di

ssem

inat

ed in

the

form

of p

erio

dic

new

slet

ters

or a

d ho

c bu

lletin

s on

hea

lth a

spec

ts o

f em

erge

ncie

s, fr

eque

nt u

pdat

ing

of w

eb si

tes,

oper

atio

n of

a n

atio

nal

aler

t net

wor

k on

a s

ecur

e w

ebsi

te fo

r em

erge

ncy

aler

ting

and

notif

icatio

n of

hea

lth p

erso

nnel

and

pa

rtne

rs, i

ssua

nce

of te

chni

cal p

ress

rele

ases

and

org

aniz

atio

n of

pre

ss c

onfe

renc

es a

s w

ell a

s th

e re

spon

se to

the

man

y re

ques

ts fo

r spe

cific

info

rmat

ion

from

par

tner

s. T

he e

ffec

tiven

ess

of

the

cent

er in

the

eyes

of t

he p

ublic

and

par

tner

s w

ill b

e de

term

ined

by

the

qual

ity, t

imel

ines

s an

d co

mpr

ehen

sive

ness

of t

he a

naly

sis

mad

e av

aila

ble

by th

e te

am.

The

eHM

IS/P

HEM

is a

n in

form

atio

n sy

stem

that

ena

bles

hea

lth fa

ciliti

es, W

ored

a He

alth

Off

ices

(Wor

HO),

Zona

l Hea

lth D

epar

tmen

ts (

ZHD)

, and

RHB

s to

ele

ctro

nica

lly c

ompi

le P

HEM

wee

kly

and

imm

edia

tely

repo

rtab

le, o

ut-p

atie

nt d

epar

tmen

t (OP

D), i

npat

ient

-dep

artm

ent

(IPD

data

and

el

ectr

onica

lly r

ecei

ve a

nd s

ubm

it th

em t

o th

e ne

xt le

vel.

Repo

rts

are

subm

itted

and

rec

eive

d el

ectr

onica

lly t

hrou

gh s

ecur

e e-

mai

l by

mea

ns o

f an

y av

aila

ble

com

mun

icatio

n in

fras

truc

ture

s in

cludi

ng C

DMA,

GPR

S, P

STN-

Dial

up, b

road

band

and

usi

ng m

obile

(SM

S) te

chno

logi

es fo

r PHE

M.

The

data

can

als

o be

exp

orte

d vi

a re

mov

able

med

ia s

uch

as U

SB fl

ash

driv

es, a

nd C

D/DV

D w

here

in

tern

et/n

etw

ork

conn

ectiv

ity is

not

ava

ilabl

e.

• Ti

mel

y an

d co

mpl

ete

wee

kly

surv

eilla

nce

repo

rt•

Heal

th fa

ciliti

es w

ith

func

tiona

l ePH

EM.

• Co

mm

unica

ted

publ

ic he

alth

risk

s, •

Iden

tifie

d sy

stem

gap

s an

d co

rrec

tive

mea

sure

s

P1.S

I6

Esta

blis

h Em

erge

ncy

Oper

atio

n Ca

nter

s (E

OC s

)

EOC

is a

phy

sica

l loc

atio

n at

whi

ch t

he c

oord

inat

ion

of in

form

atio

n an

d re

sour

ces

to s

uppo

rt

incid

ent m

anag

emen

t (on

-sce

ne o

pera

tions

) act

iviti

es n

orm

ally

take

s pl

ace.

The

maj

or fu

nctio

ns

of a

n EO

C ar

e ac

quiri

ng, a

lloca

ting,

and

tra

ckin

g re

sour

ces;

Man

agin

g an

d sh

arin

g in

form

atio

n;

esta

blis

hing

resp

onse

prio

ritie

s am

ong

incid

ents

; pro

vidi

ng le

gal a

nd fi

nanc

ial s

uppo

rt; a

nd L

iais

on

with

oth

er ju

risdi

ctio

ns a

nd o

ther

leve

ls o

f gov

ernm

ent.

• Es

tabl

ishe

d EO

C,•

Coor

dina

ted

info

rmat

ion

and

reso

urce

s sh

ared


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P2: Im

prov

e re

sear

ch a

nd e

valu

atio

n on

key

hea

lth &

nut

ritio

n is

sues

P2.S

I1

Cond

uct d

isea

ses

and

thei

r de

term

inan

ts

rese

arch

This

is a

bout

a b

road

are

a of

res

earc

h th

at c

onsi

sts

of c

omm

unica

ble

dise

ases

(CDs

), in

cludi

ng

emer

ging

and

re-e

mer

ging

and

non

-com

mun

icabl

e di

seas

es (N

CDs)

and

sur

vey

stud

ies.

Act

iviti

es

such

as;

i) Bi

omed

ical r

esea

rch

on v

iral,

bact

eria

l, fu

ngal

and

par

asiti

c di

seas

es t

hat

invo

lves

th

e in

vest

igat

ion

of b

iolo

gica

l pro

cess

and

the

cau

ses

of d

isea

se a

nd d

eath

thr

ough

car

eful

ex

perim

enta

tion,

obs

erva

tion,

lab

orat

ory

wor

k an

d an

alys

is o

f fin

ding

s fo

r th

e de

velo

pmen

t of

new

and

impr

oved

pre

vent

ion

and

cont

rol m

odal

ities

; ii)

Clin

ical r

esea

rch

that

invo

lves

the

et

iolo

gy, p

reve

ntio

n, d

iagn

osis

or

trea

tmen

t of

hum

an d

isea

se u

sing

hum

an s

ubje

cts,

hum

an

popu

latio

ns a

nd u

tiliz

e tis

sues

or p

atho

gens

if th

ey c

an b

e lin

ked

to a

pat

ient

; iii)

Epid

emio

logi

cal

rese

arch

inclu

des

the

patt

erns

, cau

ses,

and

effe

cts

of h

ealth

and

dis

ease

con

ditio

ns in

def

ined

po

pula

tions

inclu

ding

dis

ease

s et

iolo

gy, t

rans

mis

sion

, out

brea

k in

vest

igat

ion,

dis

ease

sur

veilla

nce

and

scre

enin

g, b

io-m

onito

ring

and

com

paris

ons

of t

reat

men

t ef

fect

s su

ch a

s in

clin

ical t

rials

; iv

) Beh

avio

ral a

nd s

ocia

l res

earc

h, d

eals

with

the

actio

ns o

r rea

ctio

ns o

f per

sons

in re

spon

se to

co

mm

unica

ble

and

non-

com

mun

icabl

e di

seas

es. I

t al

so s

eeks

to

iden

tify

rele

vant

pre

dict

ors

of

hum

an b

ehav

ior o

n kn

owle

dge,

perc

eptio

n, p

ract

ice a

nd a

nthr

opol

ogy/

socio

-cul

ture

det

erm

inan

ts.

• Di

seas

es r

esea

rch

outp

uts

in th

e fo

rm o

f te

chni

cal r

epor

ts

• Ge

nera

ted

rese

arch

ou

tput

s in

the

form

of

peer

revi

ew jo

urna

ls.

P2.S

I2

Perf

orm

tr

aditi

onal

and

m

oder

n m

edici

ne

rese

arch

This

initi

ativ

e inc

lude

s tra

ditio

nal m

edici

ne re

sear

ch an

d su

rvey

on tr

aditi

onal

med

icine

and

mod

ern

med

icine

s, dr

ug a

ddict

ion,

subs

tanc

e of

abu

se a

nd th

eir s

ocia

l fac

tors

. Act

iviti

es e

ncom

pass

es th

e sy

stem

atic

expl

orat

ion

of tr

aditi

onal

med

icine

know

ledg

e an

d pr

actic

es th

roug

h co

mm

unity

bas

ed

surv

eys

and

ethn

o-m

edica

l/eth

no-b

otan

ical s

tudi

es, d

ocum

enta

tion

of th

e in

dige

nous

kno

wle

dge

and

trad

ition

al m

edici

ne p

ract

ices

to e

xplo

re t

heir

pote

ntia

l thr

ough

bio

med

ical s

tudi

es a

s w

ell

as s

tudi

es o

n en

dang

ered

med

icina

l pla

nts

for c

onse

rvat

ion.

It a

lso

invo

lves

the

valid

atio

n of

the

safe

ty, e

ffica

cy, c

hem

ical c

onst

ituen

ts a

nd q

ualit

y of

pla

nt, a

nim

al a

nd m

iner

al b

ased

med

icine

s th

at a

re tr

aditi

onal

ly e

mpl

oyed

for t

reat

ing

vario

us a

ilmen

ts ta

rget

ing

to th

e pr

iorit

y di

seas

es o

f pu

blic

heal

th im

port

ance

for

the

dev

elop

men

t of

sta

ndar

dize

d pr

oduc

ts o

f re

liabl

e qu

ality

and

ra

tiona

lizat

ion

of th

eir u

se.

• Tr

aditi

onal

and

mod

ern

med

icine

res

earc

h ou

tput

s in

the

form

of

tech

nica

l rep

orts

• Tr

aditi

onal

and

mod

ern

med

icine

rese

arch

ou

tput

s in

the

form

of

peer

revi

ew jo

urna

ls.


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P2.S

I3Co

nduc

t foo

d an

d nu

triti

on re

sear

ch

This

initi

ativ

e is

abo

ut re

sear

ch o

n fo

od a

nd n

utrit

ion

rela

ted

issu

es a

nd fo

od a

nd w

ater

safe

ty a

nd

qual

ity. A

ctiv

ities

inclu

de g

ener

atio

n of

evi

denc

e ba

sed

info

rmat

ion

on m

icron

utrie

nt d

efici

ency

an

d de

term

inat

ion

of th

e mag

nitu

de o

f nut

ritio

nal d

isea

ses t

o de

velo

p m

icro

nutr

ient

inte

rven

tions

an

d en

sure

the

heal

th o

f the

pub

lic. I

n ad

ditio

n, s

tudi

es o

n na

tiona

l micr

onut

rient

sur

vey,

lifes

tyle

an

d di

etar

y re

late

d no

n-co

mm

unica

ble

dise

ases

, foo

d an

d w

ater

saf

ety

and

qual

ity, p

ublic

hea

lth

prob

lem

s as

socia

ted

with

ani

mal

foo

ds, d

ocum

enta

tion

of in

dige

nous

foo

d, in

fant

and

you

ng

child

feed

ing

prac

tice,

unde

rutil

ized

food

s fo

r foo

d an

d nu

triti

on s

ecur

ity, s

afet

y, st

abilit

y an

d bi

o-av

aila

bilit

y of f

ortif

icant

, ana

lyzin

g, e

xpan

sion

and

upd

atin

g of

exis

ting

Ethi

opia

n fo

od co

mpo

sitio

n ta

ble,

the

linka

ge o

f nut

ritio

n, h

ealth

, agr

icultu

re a

nd cl

imat

e va

riabi

lity/

chan

ge, f

ood

shel

f life

, the

ef

fect

of m

ultip

le m

icron

utrie

nt p

owde

r on

child

mor

bidi

ty a

nd m

orta

lity,

etc.

will

be

cond

ucte

d to

ge

nera

te e

vide

nces

of e

ffec

tive

linka

ge fo

r bet

ter h

ealth

and

nut

ritio

n.

• Fo

od a

nd n

utrit

ion

re

sear

ch o

utpu

ts in

the

form

of t

echn

ical r

epor

ts

• Fo

od a

nd n

utrit

ion

rese

arch

out

puts

in th

e fo

rm o

f pee

r rev

iew

jo

urna

ls.

P2.S

I4

Carr

yout

po

licy,

stra

tegy

an

d pr

ogra

m

eval

uatio

ns

This

is a

bout

eva

luat

ion

of d

isea

ses

cont

rol,

nutr

ition

and

foo

d pr

ogra

ms.

Act

iviti

es in

clude

a

syst

emat

ic m

etho

d fo

r co

llect

ing,

ana

lyzin

g an

d us

ing

info

rmat

ion

to a

nsw

er q

uest

ions

abo

ut

proj

ects

, pol

icies

, pro

gram

s an

d st

rate

gies

impl

emen

tatio

n pa

rticu

larly

abo

ut th

eir e

ffec

tiven

ess

and

effic

ienc

y re

late

d to

dis

ease

s co

ntro

l, n

utrit

ion

and

food

pro

gram

s. It

focu

ses

on im

port

ant

cons

ider

atio

ns th

at of

ten

inclu

de h

ow m

uch

the p

rogr

am co

sts,

how

the p

rogr

am co

uld b

e im

prov

ed,

whe

ther

the

pro

gram

is w

orth

whi

le o

r th

ere

are

bett

er a

ltern

ativ

es, i

f th

ere

are

unin

tend

ed

outc

omes

, and

whe

ther

the

pro

gram

goa

ls a

re a

ppro

pria

te a

nd u

sefu

l. Po

licie

s, st

rate

gies

and

pr

ogra

ms

eval

uatio

n w

ill b

e co

nduc

ted

for

bett

er im

prov

emen

t, im

plem

enta

tion

and/

or c

hang

e of

act

iviti

es in

the

heal

th s

ecto

r. In

this

initi

ativ

e, pr

ogra

ms

eval

uatio

n of

vac

cine

prev

enta

ble

and

prio

ritiz

ed n

egle

cted

trop

ical d

isea

ses

cont

rol,

erad

icatio

n an

d el

imin

atio

n he

alth

pro

gram

s w

ith

spec

ial e

mph

asis

on

polio

, mea

sles

, gui

nea

wor

m, m

alar

ia, e

tc., n

atio

nal n

utrit

ion

prog

ram

(NNP

) an

d co

mm

unity

bas

ed n

utrit

ion

(CBN

), acu

te m

alnu

triti

on m

anag

emen

t (CM

AM), m

alar

ia in

dica

tor,

WAS

H su

rvey

and

als

o HI

V an

d TB

pro

gram

s ev

alua

tion

will

be

inclu

ded.

• Po

licy,

stra

tegy

and

pr

ogra

m e

valu

atio

ns

outp

uts

in th

e fo

rm o

f te

chni

cal r

epor

ts

• Po

licy,

stra

tegy

and

pr

ogra

m e

valu

atio

ns

outp

uts

in th

e fo

rm o

f pe

er re

view

jour

nals


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P2.S

I5Co

nduc

t hea

lth

syst

em re

sear

ch

This

initi

ativ

e in

clude

s re

sear

ch o

n se

rvice

del

iver

y an

d or

gani

zatio

n, h

ealth

car

e re

sour

ce a

nd

heal

th s

yste

m g

over

nanc

e an

d kn

owle

dge

man

agem

ent.

Activ

ities

invo

lves

a m

ultid

iscip

linar

y sc

ient

ific

field

tha

t ex

amin

es h

ow s

ocia

l fac

tors

, fin

ancin

g sy

stem

s, or

gani

zatio

nal s

truc

ture

s an

d pr

oces

ses,

med

ical t

echn

olog

y an

d pe

rson

al b

ehav

iors

aff

ect

avai

labi

lity,

acce

ss (p

hysi

cal

and

serv

ices)

and

util

izat

ion

of h

ealth

car

e an

d m

edica

l pro

duct

s, te

chno

logi

es, c

halle

nges

and

op

port

uniti

es w

ill a

lso

be a

sses

sed.

• He

alth

sys

tem

rese

arch

ou

tput

s in

the

form

of

tech

nica

l rep

orts

• He

alth

sys

tem

rese

arch

ou

tput

s in

the

form

of

peer

revi

ew jo

urna

ls

P2.S

I6

Cond

uct

envi

ronm

enta

l, oc

cupa

tiona

l he

alth

and

thei

r de

term

inat

es

rese

arch

This

initi

ativ

e in

clude

s re

sear

ch o

n en

viro

nmen

tal, o

ccup

atio

nal h

ealth

and

saf

ety

rela

ted

issu

es.

Activ

ities

inclu

de s

tudi

es o

n as

sess

men

t and

dis

trib

utio

n of

Per

sist

ent O

rgan

ic Po

lluta

nts

(POP

s),

inte

grat

ed r

isk

asse

ssm

ent

of p

ollu

tion

in t

he v

icini

ty o

f ind

ustr

ial a

reas

, ind

oor a

ir qu

ality

and

he

alth

of

at r

isk

popu

latio

n,

micr

obia

l air

qual

ity o

f op

erat

ion

thea

ters

, del

iver

y ro

oms,

and

inte

nsiv

e ca

re u

nits

, eva

luat

ion

of co

ntrib

utin

g fa

ctor

s for

road

acc

iden

t (In

fras

truc

tura

l, beh

avio

ral

and

dem

ogra

phic

fact

ors)

, car

com

bust

ion

and

hum

an h

ealth

(res

pira

tory

and

oth

er d

isea

ses

), tr

ends

of r

oad

traf

fic a

ccid

ent

mor

bidi

ty a

nd m

orta

lity,

wat

er q

ualit

y an

d sa

nita

tion

insp

ectio

n of

com

mun

ity w

ater

sup

ply,

asse

ssm

ent

of h

ouse

hold

w

ater

han

dlin

g an

d hy

gien

ic pr

actic

es,

asse

ssm

ent o

f w

ater

was

hed

and

born

dis

ease

s w

ith s

anita

tion

and

hygi

enic

prac

tices

, clim

ate

chan

ge a

nd h

ygie

ne a

nd s

anita

tion,

dev

elop

men

t of w

ater

trea

tmen

t tec

hnol

ogie

s, as

sess

men

t of

indi

geno

us k

now

ledg

e an

d pr

actic

e in

hou

seho

ld t

reat

men

t, he

alth

car

e w

aste

man

agem

ent

prac

tices

, haz

ard,

exp

osur

e an

d ris

k as

sess

men

t in

occu

patio

nal s

ettin

gs (m

inin

g, m

anuf

actu

ring,

co

nstr

uctio

n an

d ag

ricul

tura

l ind

ustr

y) w

ill a

lso

be in

clude

d.

• En

viro

nmen

tal a

nd

occu

patio

nal r

esea

rch

ou

tput

s in

the

form

of

tech

nica

l rep

orts

• En

viro

nmen

tal a

nd

occu

patio

nal

rese

arch

ou

tput

s in

the

form

of

peer

revi

ew jo

urna

ls

P2.S

I7Co

nduc

t Re

prod

uctiv

e he

alth

rese

arch

Repr

oduc

tive

heal

th re

sear

ch e

ncom

pass

es co

nduc

ting

biom

edica

l, clin

ical, o

pera

tiona

l and

soc

io-

beha

vior

al re

sear

ch o

n va

rious

asp

ects

of r

epro

duct

ive

heal

th; i

nclu

ding

mat

erna

l and

new

born

he

alth

, chi

ld h

ealth

, and

ado

lesc

ent

and

youn

g pe

ople

sex

ual a

nd r

epro

duct

ive

heal

th.

Here

, ac

tiviti

es s

uch

as e

valu

atio

n of

mat

erna

l and

chi

ld h

ealth

pro

gram

s, ut

ilizat

ion

and

acce

sses

to

adol

esce

nt a

nd y

oung

peo

ple

sexu

al a

nd re

prod

uctiv

e he

alth

ser

vice

s, et

c. w

ill b

e co

nduc

ted.

• Re

prod

uctiv

e he

alth

re

sear

ch o

utpu

ts in

the

form

of t

echn

ical r

epor

ts

• Re

prod

uctiv

e he

alth

re

sear

ch o

utpu

ts in

the

form

of p

eer r

evie

w

jour

nals

.


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P3: Im

prov

e te

chno

logy

eva

luat

ion

and

tran

sfer

P3.S

I1

Deve

lop

heal

th

tech

nolo

gy

prod

uctio

n pa

ckag

es fr

om

abro

ad a

nd

indi

geno

us

prac

tices

This

mea

ns a

ppro

pria

te h

ealth

tech

nolo

gies

will

be

asse

ssed

, int

rodu

ced,

tran

sfer

red,

eva

luat

ed

and

adop

ted

for

prod

ucin

g pr

oduc

tion

pack

ages

and

pro

duct

s. I

n th

is in

itiat

ives

app

ropr

iate

te

chno

logy

for

foo

d pr

oces

sing

, pro

duct

ion

of M

enin

goco

ccal

men

ingi

tis &

rab

ies

vacc

ines

and

An

ti-se

ra w

ill b

e tr

ansf

erre

d fr

om o

utsi

de a

nd a

dopt

ed. D

evel

op h

ealth

tec

hnol

ogy

prod

uctio

n pa

ckag

es m

eans

pro

duct

ion

of p

artia

lly p

roce

ssed

pro

duct

s fo

r br

ingi

ng a

fin

al p

rodu

ct f

or

bene

ficia

ries.

Her

e, he

alth

tech

nolo

gy p

rodu

ctio

n pa

ckag

es w

ill b

e de

velo

ped

and

valid

ated

for t

he

prod

uctio

n of

com

plem

enta

ry a

nd s

uppl

emen

tary

food

pac

kage

s, un

deru

tiliz

ed in

dige

nous

food

s fo

r co

nsum

ptio

n an

d nu

triti

on s

ecur

ity, d

iagn

ostic

med

ia a

nd k

it fo

r th

e di

agno

sis

of b

acte

rial

infe

ctio

n (W

idal

dia

gnos

tic k

it) u

sing

Eth

iopi

an s

trai

n/s

and

trad

ition

al m

edici

nes.

The

pro

duct

ion

pack

ages

, whi

ch w

ill b

e ge

nera

ted

from

the

proc

ess,

will

be

diss

emin

ated

and

use

d by

indu

strie

s m

ass

prod

uctio

n to

brin

g fin

al p

rodu

cts

for c

omm

ercia

lizat

ion.

• Id

entif

ied,

tran

sfer

red

and

adap

ted

know

ledg

e on

Hea

lth a

nd N

utrit

ion

tech

nolo

gy.

• De

velo

ped

prod

uctio

n pa

ckag

es

P3.S

I2Pr

oduc

tion

of

heal

th te

chno

logy

pr

oduc

ts

This

is a

bout

pro

duct

ion

of t

radi

tiona

l vac

cines

, Ant

i-Ser

a pr

oduc

ts a

nd p

rodu

ctio

n of

pan

els.

Ac

tiviti

es in

clude

pro

duct

ion

of a

nti-c

omm

unica

ble

dise

ases

vac

cines

and

Ant

i-ser

a pr

oduc

ts fo

r en

d be

nefic

iarie

s. In

this

initi

ativ

e th

e tr

ansf

er a

nd a

dopt

ion

of te

chno

logy

/bio

tech

nolo

gy fo

r the

pr

oduc

tion

of va

ccin

es su

ch a

s, ce

ll cul

ture

bas

ed a

nti-r

abie

s for

hum

an, M

enin

goco

ccal

men

ingi

tis.

Addi

tiona

lly, a

nti-r

abie

s m

onoc

lona

l ant

ibod

y, hu

man

ant

i-rab

ies

imm

unog

lobu

lin a

nd p

olyv

alen

t an

ti-ve

nom

pro

duct

ion

will

be

prod

uced

to im

prov

e an

d pr

omot

e th

e pu

blic

heal

th.

• He

alth

and

nut

ritio

n te

chno

logy

pro

duct

s

P3.S

I3

Eval

uatio

n of

dia

gnos

tic

and

dise

ase

prev

entiv

e te

chno

logi

es

Eval

uatio

n of

dia

gnos

tic te

chno

logi

es a

nd d

isea

se p

reve

ntiv

e su

pplie

s suc

h as

bed

net

s, di

agno

stic

tool

s/ki

ts, e

tc. w

ill b

e pr

oduc

ed fo

r sta

keho

lder

s in

cludi

ng p

olic

y m

aker

s, FM

oH, W

HO, U

NICE

F, et

c. an

d th

e pu

blic

at la

rge.

• Re

com

men

ded

diag

nost

ic an

d di

seas

e pr

even

tive

tech

nolo

gies

fo

r use


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P4: Im

prov

e pu

blic

heal

th e

mer

genc

y pr

epar

edne

ss

P4.S

I1

Vuln

erab

ility

Asse

ssm

ent a

nd

Risk

map

ping

(V

RAM

) and

av

ail e

mer

genc

y su

pplie

s

Risk

Man

agem

ent i

s fo

unde

d in

the

capa

city

for a

ll le

vels

of g

over

nmen

t to

iden

tify

and

mea

sure

ris

k pr

ior t

o an

eve

nt, b

ased

on

thre

ats/

haza

rds,

vuln

erab

ilitie

s, an

d co

nseq

uenc

es, a

nd to

man

age

the e

xpos

ure t

o tha

t ris

k thr

ough

the p

riorit

izat

ion

and

impl

emen

tatio

n of

risk

-red

uctio

n st

rate

gies

. Th

e m

ajor

act

iviti

es in

pre

parin

g he

alth

pro

file

are

asse

ssin

g ha

zard

s and

Vul

nera

bilit

y; es

tabl

ish

a da

ta b

ase

that

focu

ses u

pon

the

likel

y eff

ects

of p

oten

tial h

azar

ds, m

appi

ng th

e he

alth

risk

s in

the

coun

try a

nd a

ntici

patin

g re

lief n

eeds

and

ava

ilabl

e re

sour

ces

to a

vert

the

risk

or m

anag

e th

e cr

isis

.

• Pu

blic

Heal

th ri

sk p

rofil

e da

ta b

ase

deve

lope

d an

d m

appe

d•

Stoc

k pi

led

and

mob

ilized

reso

urce

P5: E

nhan

ce la

bora

tory

qua

lity

man

agem

ent s

yste

m im

plem

enta

tion

P5.S

I1Im

plem

entin

g Ex

tern

al Q

ualit

y As

sess

men

t (EQ

A)

EQA

is a

sys

tem

for

obj

ectiv

ely

chec

king

the

labo

rato

ry’s

perf

orm

ance

by

an e

xter

nal a

genc

y em

ploy

ing

one

or a

ll of

the

ava

ilabl

e m

etho

ds n

amel

y, pr

ofici

ency

tes

ting

(PT)

, Rec

heck

ing/

rete

stin

g an

d on

-site

eva

luat

ion

inclu

ding

all

suita

ble

inte

r-la

bora

tory

com

paris

on m

etho

ds s

uch

as s

plit

sam

ple

test

ing,

etc

. Par

ticip

atio

n in

EQA

is im

port

ant t

o ev

alua

te re

liabi

lity

of m

etho

ds,

mat

eria

ls, e

quip

men

t, m

onito

ring

of c

ompe

tenc

y an

d tr

aini

ng im

pact

, and

bui

ld c

usto

mer

s’ an

d he

alth

reg

ulat

ory

auth

oriti

es’ c

onfid

ence

in la

bora

tory

res

ults

. Par

ticip

atio

n in

EQA

cre

ates

a

suita

ble

mec

hani

sm f

or c

omm

unica

tions

, and

can

be

a pr

oven

too

l for

enh

ancin

g th

e na

tiona

l la

bora

tory

net

wor

k. Ju

stifi

ably

, EQA

par

ticip

atio

n is

one

of t

he m

ajor

crit

eria

for a

ccre

dita

tion.

It

is m

anda

tory

for

all c

linica

l and

pub

lic h

ealth

labo

rato

ries

of a

ll tie

rs in

the

nat

iona

l lab

orat

ory

syst

em to

par

ticip

ate

in a

t lea

st o

ne o

f the

thre

e EQ

A m

etho

ds, n

amel

y, Pr

ofici

ency

Pan

el Te

stin

g,

Rand

om B

linde

d Re

chec

king

and

ons

ite s

uper

visi

on f

or a

ll te

sts

they

per

form

.

• Na

tiona

l EQA

labo

rato

ry•

PT p

anel

s fo

r NEQ

AS

alw

ays

avai

labl

e•

All l

abs

part

icipa

ting

in

EQA

prog

ram

s


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P5.S

I2Do

cum

ents

and

in

form

atio

n m

anag

emen

t

Docu

men

ts a

re n

eede

d in

the

labo

rato

ry t

o in

form

how

to

perf

orm

tes

ts a

nd a

re c

ritica

l too

ls

to s

tand

ardi

ze la

bora

tory

pro

cess

es a

nd a

ctiv

ities

. The

pro

duct

of t

he la

bora

tory

is in

form

atio

n,

prim

arily

in

the

form

of

test

res

ults

. In

form

atio

n (d

ata)

nee

ds t

o be

car

eful

ly c

aptu

red

and

man

aged

to e

nsur

e pr

ivac

y an

d co

nfid

entia

lity

patie

nts

and

othe

r sou

rces

, as

wel

l as

acce

ssib

ility

to th

e la

bora

tory

sta

ff a

nd h

ealth

car

e pr

ovid

ers.

Pro

perly

ana

lyze

d an

d in

terp

rete

d in

form

atio

n is

cru

cial f

or e

vide

nce

base

d de

cisio

n m

akin

g an

d po

licy

form

ulat

ions

. Lab

orat

ory

info

rmat

ion

may

be

colle

cted

, man

aged

and

con

veye

d us

ing

eith

er p

aper

or

elec

tron

ic sy

stem

s. A

s pa

rt o

f th

e im

plem

enta

tion

of t

his

initi

ativ

e, ne

w g

uide

lines

, man

uals

, tra

inin

g an

d ot

her

mat

eria

ls

will

be

deve

lope

d or

exis

ting

ones

rev

ised

in v

iew

of

curr

ently

pre

vailin

g ne

eds

with

a g

oal t

o en

sure

the

uni

form

ity a

nd s

moo

th im

plem

enta

tion

of L

abor

ator

y Qu

ality

Man

agem

ent

Syst

em

natio

nwid

e. A

ppro

pria

te s

yste

ms

and

tool

s fo

r el

ectr

onic

capt

urin

g, s

torin

g, r

etrie

ving

, ana

lysi

s an

d in

terp

reta

tion

of la

bora

tory

info

rmat

ion

will

be

deve

lope

d an

d im

plem

ente

d at

all

tiers

of t

he

natio

nal l

abor

ator

y ne

twor

k.

• De

velo

ped

and

/or

revi

sed

Guid

elin

es/

Man

uals

, etc

•

Stan

dard

ized

ele

ctro

nic

or p

aper

-bas

ed

info

rmat

ion/

data

ca

ptur

ing

syst

em in

pl

ace

• St

anda

rdiz

ed

trai

ning

mat

eria

ls

P5.S

I3Eq

uipm

ent

and

supp

lies

man

agem

ent

Prop

er m

anag

emen

t of e

quip

men

t and

sup

plie

s re

quire

d fo

r the

opt

imal

ope

ratio

n of

a la

bora

tory

ar

e fu

ndam

enta

l pre

requ

isite

s to

ens

ure

the

prov

isio

n of

acc

urat

e, re

liabl

e an

d tim

ely

test

ing

serv

ices.

Pro

per e

quip

men

t and

sup

ply

man

agem

ent p

rogr

ams

are

key

to m

aint

ain

a hi

gh le

vel o

f la

bora

tory

per

form

ance

, red

uce

varia

tion

in te

st re

sults

, impr

ove

the

tech

nolo

gist

’s co

nfid

ence

in

the

accu

racy

of t

estin

g re

sults

, low

er re

pair

cost

s, le

ngth

en in

stru

men

t life

, red

uce

inte

rrup

tion

of

serv

ices,

incr

ease

saf

ety

for w

orke

rs a

nd th

e en

viro

nmen

t as

wel

l as

to p

rodu

ce g

reat

er cu

stom

er

satis

fact

ion.

To

ach

ieve

the

afor

emen

tione

d go

al, r

equi

rem

ents

for p

rope

r spe

cifica

tion,

sel

ectio

n, in

stal

latio

n,

perf

orm

ance

verif

icatio

n an

d va

lidat

ion,

oper

ator

/use

r and

mai

nten

ance

trai

ning

s will

be d

evel

oped

an

d im

plem

ente

d. N

atio

nal e

quip

men

t pla

tfor

ms

will

be

esta

blis

hed,

cap

aciti

es fo

r the

pro

visi

on

of p

reve

ntiv

e an

d cu

rativ

e m

aint

enan

ce s

ervi

ces

will

be

stre

ngth

ened

bot

h at

nat

iona

l an

d re

gion

al le

vels

. Oth

er v

iabl

e st

rate

gies

that

will

cont

ribut

e to

str

engt

heni

ng la

bora

tory

equ

ipm

ent

mai

nten

ance

ser

vice

s lik

e co

ntra

ct a

gree

men

ts w

ith v

endo

rs a

nd fr

ee o

f cha

rge

swap

out

s ol

d in

stru

men

ts w

ill b

e de

sign

ed a

nd im

plem

ente

d. S

yste

m fo

r pos

t-m

arke

t sur

veilla

nce

rela

ted

to

the

prop

er fu

nctio

nalit

y of

labo

rato

ry e

quip

men

t and

dev

ices

will

als

o be

est

ablis

hed.

• Es

tabl

ishe

d Na

tiona

l an

d Re

gion

al la

bora

tory

eq

uipm

ent w

orks

hops

• Tr

aine

d m

aint

enan

ce

pers

onne

l•

Vend

or co

ntra

cts

• Es

tabl

ishe

d sy

stem

for

equi

pmen

t sw

ap o

uts

• Es

tabl

ishe

d sy

stem

for p

ost-

mar

ket

surv

eilla

nce

of e

quip

men

t fu

nctio

nalit

y


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P5.S

I4Pr

oces

s co

ntro

l an

d pr

oces

s im

prov

emen

t

Proc

ess

cont

rol c

ompr

ises

sev

eral

act

iviti

es t

hat

are

fund

amen

tal t

o en

surin

g th

e qu

ality

of

labo

rato

ry t

estin

g pr

oces

ses.

The

se a

ctiv

ities

inc

lude

, but

not

lim

ited

to, q

ualit

y co

ntro

l fo

r te

stin

g, a

ppro

pria

te m

anag

emen

t of

pat

ient

spe

cimen

s an

d en

viro

nmen

tal s

ampl

es, i

nclu

ding

co

llect

ion

and

hand

ling,

and

met

hod

verif

icatio

n an

d va

lidat

ion

exer

cises

. Pro

cess

impr

ovem

ent

is a

sys

tem

atic

and

perio

dic a

ppro

ach

to im

prov

ing

labo

rato

ry q

ualit

y an

d th

e in

puts

and

out

puts

th

at g

lue

thes

e pr

oces

ses

toge

ther

. Thu

s, pr

oces

s im

prov

emen

t is

the

core

con

cept

and

prim

ary

goal

in a

qua

lity

man

agem

ent s

yste

m. V

ario

us Q

ualit

y As

sura

nce

mea

sure

s w

ill b

e im

plem

ente

d at

all l

abs n

atio

nwid

e to

ens

ure

relia

bilit

y of a

ll lab

orat

ory t

estin

g pr

oces

ses a

nd o

pera

tions

for t

he

prov

isio

n of

acc

urat

e an

d tim

ely

resu

lts.

• Co

ntin

ued

qual

ity

Impr

ovem

ent a

ctiv

ities

• Fu

nctio

nal s

yste

ms

for

IQC,

met

hod

verif

icatio

n an

d va

lidat

ion

as

wel

l as

spec

imen

m

anag

emen

t

P5.S

I5Fa

cility

and

saf

ety

Facil

ity a

nd s

afet

y is

one

of

the

key

esse

ntia

ls o

f qu

ality

. Th

e la

bora

tory

wor

k sp

ace

and

the

gene

ral f

acilit

y m

ust

be o

rgan

ized

in s

uch

a w

ay t

hat

the

wor

kloa

d ca

n be

per

form

ed w

ithou

t co

mpr

omis

ing

the

qual

ity o

f te

stin

g an

d th

e sa

fety

of

the

labo

rato

ry s

taff,

oth

er h

ealth

car

e pe

rson

nel,

patie

nts

and

the

com

mun

ity. A

s pa

rt o

f th

is in

itiat

ive,

a na

tiona

l lab

orat

ory

safe

ty

and

bio-

secu

rity

prog

ram

will

be

impl

emen

ted

to e

nsur

e sa

fe la

bora

tory

ope

ratio

ns a

t all

times

. Pr

iorit

y ar

eas

inclu

de, b

ut n

ot li

mite

d to

, the

pro

tect

ion

of e

mpl

oyee

s, pa

tient

s, th

e en

viro

nmen

t an

d th

e co

mm

unity

from

haz

ardo

us ch

emica

ls a

nd A

nti-S

era

path

ogen

s as

wel

l as

the

prot

ectio

n of

lab

equi

pmen

t and

the

facil

ity fr

om u

nexp

ecte

d di

re e

vent

s.Hi

gh le

vel b

io-s

afet

y con

tain

men

ts su

ch a

s BSL

3 an

d BS

L4 ar

e crit

ically

requ

ired

whe

n de

alin

g with

kn

own

dead

ly a

nd lif

e th

reat

enin

g ex

otic

path

ogen

s or

age

nts

with

unk

now

n ris

k of

tran

smis

sion

. Th

us, a

ctiv

ities

will

be

unde

rtak

en to

inst

all t

hese

sys

tem

s at

the

Natio

nal R

efer

ence

Lab

orat

orie

s of

the

EPHI

and

sel

ecte

d Re

gion

al R

efer

ence

Lab

orat

orie

s.

• S

afe

labo

rato

ries

and

w

orki

ng e

nviro

nmen

t•

BSL3

and

4 la

bora

tory

fa

ciliti

es in

pla

ce•

Miti

gate

d ri

sk o

f in

fect

ions

and

oth

er

accid

ents

in th

e la

b •

Miti

gate

d ris

k of

env

ironm

enta

l co

ntam

inat

ion


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P6: S

tren

gthe

ning

Lab

orat

ory

Capa

city

for R

efer

ral a

nd B

acku

p Te

stin

g Se

rvice

s

P6.S

I1

Stre

ngth

enin

g la

bora

tory

ne

twor

k an

d re

ferr

al te

stin

g se

rvice

s

The

natio

nal r

efer

ence

labo

rato

ry m

ust h

ave

the

high

est p

ossi

ble

tech

nica

l cap

acity

to p

erfo

rm

all t

ests

tha

t ar

e ro

utin

ely

done

by

all o

ther

tie

rs in

cludi

ng e

sote

ric s

pecia

lized

tes

ts w

hich

are

no

t ava

ilabl

e el

sew

here

in th

e co

untr

y. L

ikew

ise

regi

onal

refe

renc

e la

bora

torie

s ne

ed to

hav

e th

e ca

pacit

y to p

rovi

de re

ferr

al te

stin

g ser

vice

s for

heal

th fa

ciliti

es in

thei

r res

pect

ive r

egio

ns. In

addi

tion

to th

is ve

rtica

l ref

erra

l sys

tem

, inte

r-tie

r hor

izon

tal r

efer

ral s

ervi

ces a

re to

be

prov

ided

in th

e ev

ent

of in

stru

men

t bre

akdo

wn,

sup

ply

shor

tage

s or

sam

ple

back

logs

. A fu

nctio

nal l

abor

ator

y ne

twor

k an

d ro

bust

spe

cimen

tran

spor

tatio

n an

d ef

ficie

nt re

sult

deliv

ery

syst

em is

key

for t

he s

ucce

ss o

f re

ferr

al te

stin

g se

rvice

s. A

s su

ch, m

any

activ

ities

will

be

unde

rtak

en in

ord

er to

str

engt

hen

the

linka

ges

betw

een

and

with

in la

b tie

rs in

add

ition

to e

stab

lishi

ng a

relia

ble

spec

imen

and

resu

lt co

urie

r sy

stem

. Sui

tabl

e IT

tec

hnol

ogie

s w

ill a

lso

be d

eplo

yed

to e

nhan

ce c

omm

unica

tions

and

in

form

atio

n flo

w w

ithin

the

netw

ork.

• N

etw

orke

d la

bora

torie

s•

Robu

st s

yste

m fo

r sp

ecim

en re

ferr

al,

test

ing

and

resu

lt de

liver

y•

Unin

terr

upte

d la

b te

stin

g s

ervi

ces

at a

ll tim

es

P6.S

I2

Stre

ngth

enin

g di

agno

stic

capa

city

of

Labo

rato

ries

It is

ess

entia

l to

prov

ide

supp

ort t

o re

gion

al, f

eder

al a

nd p

erip

hera

l lab

orat

orie

s in

ord

er to

ena

ble

them

to

acco

mpl

ish

thei

r re

spon

sibi

litie

s. L

abor

ator

y su

ppor

t in

clude

s in

fras

truc

ture

upg

rade

s, tr

aini

ng p

rogr

ams,

qual

ity a

ssur

ance

pro

gram

s, la

bora

tory

equ

ipm

ent

mai

nten

ance

and

oth

er

stra

tegi

es th

at w

ill a

ssis

t the

labo

rato

ries

to e

nhan

ce th

eir a

bilit

y to

pro

vide

labo

rato

ry s

ervi

ces

for i

nteg

rate

d di

seas

es. H

owev

er, m

ultit

ude

gaps

exis

t bet

wee

n th

eir c

urre

nt s

tate

s an

d re

quire

d st

anda

rds;

fulfi

lling

thes

e ga

ps is

the

key

obj

ectiv

e of

thi

s in

itiat

ive

and

achi

evin

g it

in t

his

plan

per

iod

is c

onsi

dere

d as

an

impo

rtan

t m

ilest

one

in t

he n

atio

nal e

ffor

ts t

owar

ds im

prov

ing

the

qual

ity a

nd a

cces

sibi

lity

of c

linica

l and

pub

lic h

ealth

labo

rato

ry s

ervi

ces.

Act

iviti

es in

clude

, am

ong

othe

r thi

ngs,

intr

oduc

tion

and

scal

ing

up o

f adv

ance

d te

st m

etho

ds a

nd te

chno

logi

es, a

nd

unde

rtak

ing

exte

nsiv

e ca

pacit

y bu

ildin

g pr

ogra

ms

rela

ted

to in

stru

men

tatio

ns, h

uman

reso

urce

, in

fras

truc

ture

, etc

.

• Ca

pacit

y es

tabl

ishe

d bo

th a

t nat

iona

l lev

els

for a

dvan

ced

test

ing

serv

ices

• N

ew m

etho

ds a

nd/o

r te

chno

logi

es i

ntro

duce

d


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

P7: Im

prov

e Pr

ogra

ms/

Proj

ects

and

Inst

itutio

nal P

olici

es D

evel

opm

ent a

nd M

anag

emen

t

P7.S

I1

Stre

ngth

enin

g pr

ogra

m/p

roje

ct

mon

itorin

g

and

Eval

uatio

n sy

stem

Stre

ngth

enin

g pr

ogra

m/p

roje

ct

mon

itorin

g is

to

m

ake

cont

inuo

us

trac

king

of

ef

fect

ive

impl

emen

tatio

n of

pla

nned

act

iviti

es,

it in

clude

s d

evel

opm

ent o

f lon

g te

rm p

lans

( ne

xt 5

yea

r, vi

sion

201

5), P

repa

ratio

n of

ann

ual o

pera

tiona

l pla

n, q

uart

erly

mon

itorin

g of

pro

gram

/ pr

ojec

ts

,cond

uctin

g s

uppo

rtiv

e su

perv

isio

n, m

akin

g an

nual

revi

ew m

eetin

g an

d fo

llow

up

of s

cient

ific a

nd

ethi

cal c

ompl

ianc

e of

rese

arch

pro

ject

s. E

valu

atio

n is

cond

uctin

g th

e 5y

rs S

PM tw

ice a

nd p

roje

cts/

prog

ram

s m

idte

rm &

end

term

eva

luat

ions

.

• M

onito

red

and

eval

uate

d P

rogr

ams/

proj

ects

and

str

ateg

y

P7.S

I2

Stre

ngth

en

adm

inis

trat

ive

and

tech

nica

l po

licie

s an

d gu

idel

ines

This

ini

tiativ

e is

to

in p

lace

and

cus

tom

izes

all

oper

atio

nal

in

tern

al p

olici

es/g

uide

lines

for

ad

min

istr

ativ

e ac

tiviti

es a

nd c

ompl

ianc

e, st

reng

then

tec

hnica

l gu

idel

ines

for

pro

gram

mat

ic ac

tiviti

es, e

nsur

e leg

al co

mpl

ianc

e of a

ll act

iviti

es, a

nd en

sure

goo

d go

vern

ance

and

mai

nstr

eam

ing

of H

IV p

reve

ntio

n, w

omen

and

you

th a

ffai

rs.

• De

velo

ped

Inst

itutio

nal

Polic

ies,

guid

elin

es,

man

uals

F1: Im

prov

e ef

ficie

nt m

obiliz

atio

n an

d ut

ilizat

ion

of fi

nanc

ial r

esou

rce

F1.S

I1

Esta

blis

h ef

ficie

nt

finan

cial r

esou

rce

mob

ilizat

ion

and

ut

ilizat

ion

syst

em

Thi

s in

itiat

ive

is a

imed

at r

aisi

ng s

uffic

ient

fund

for t

hose

act

iviti

es h

avin

g ga

p in

the

stra

tegi

c pl

an a

nd h

avin

g ef

ficie

nt u

tiliz

atio

n sy

stem

. Th

eref

ore

reso

urce

map

ping

, gap

ide

ntifi

catio

n,

stra

tegy

dev

elop

men

t, pr

opos

al d

evel

opm

ent a

nd m

obiliz

atio

n on

one

han

d an

d d

evel

opin

g ac

tion

plan

, tim

ely

trac

king

, eff

ectiv

e fo

llow

up,

pro

per d

ocum

enta

tion,

insp

ectio

ns a

nd e

nsur

ing

prop

er

utiliz

atio

n.

For

this

per

iodi

c fu

nd li

quid

atio

n, s

uppo

rtiv

e su

perv

isio

ns a

nd c

ontin

uous

feed

back

ac

tiviti

es a

re k

ey a

ctio

ns re

quire

d.

Fina

ncia

l and

per

form

ance

aud

iting

and

insp

ectio

n is

use

d to

ens

ure

prop

er u

tiliz

atio

n of

the

re

sour

ces.

• Ad

equa

te fi

nanc

ial

reso

urce

mob

ilized

• Ef

ficie

nt fi

nanc

ial

reso

urce

util

izat

ion


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

F1.S

I2

Stre

ngth

enin

g lo

gist

ics

man

agem

ent

syst

em

Sinc

e si

gnifi

cant

am

ount

of t

he In

stitu

te b

udge

t is

inve

sted

on

the

proc

urem

ent o

f goo

ds, s

ervi

ces,

cons

truc

tion

and c

onsu

ltanc

y, ta

king

it as

an in

itiat

ive i

s of a

para

mou

nt im

port

ance

. Thu

s, in

plac

ing

syst

ems

and

proc

edur

es w

hich

ena

bles

ens

urin

g ef

ficie

ncy,

tran

spar

ency

and

acc

ount

abilit

y is

the

maj

or fo

cus

of th

is in

itiat

ive.

Thi

s in

clude

s de

velo

ping

gen

eral

equ

ipm

ent a

nd s

uppl

ies

dire

ctor

y fo

r all l

abor

ator

ies,

annu

al p

rocu

rem

ent p

lan

prep

arat

ion

and

exec

utio

n, in

pla

cing

stoc

k da

taba

se,

havi

ng p

rope

rty

disp

osal

sys

tem

.Th

is i

s to

hav

e w

ell

plan

ned

tran

spor

t se

rvice

pro

visi

on f

or t

he e

ffici

ent

prog

ram

/ pr

ojec

t im

plem

enta

tion

and

effe

ctiv

e re

sour

ce u

tiliz

atio

n th

roug

h ha

ving

veh

icles

at

all t

imes

, tim

ely

vehi

cle m

aint

enan

ce a

nd p

uttin

g in

pla

ce lo

g sh

eet a

nd tr

ansp

ort s

ervi

ce m

anag

emen

t with

GPI

S.

• Un

inte

rrup

ted

inpu

t su

pply

• Ef

ficie

nt tr

ansp

ort a

nd

vehi

cle m

anag

emen

t sy

stem

CB1:

Impr

ove

Hum

an R

esou

rce

Deve

lopm

ent a

nd M

anag

emen

t

CB1.

SI1

Stre

ngth

en H

DA

of th

e In

stitu

te

Alth

ough

HDA

str

engt

heni

ng is

par

t of e

mpl

oyee

cap

acity

dev

elop

men

t, it

is s

epar

atel

y ta

ken

as

an in

itiat

ive

to s

tren

gthe

n in

divi

dual

s an

d te

am p

erfo

rman

ce th

roug

h co

ntin

uous

per

form

ance

ap

prai

sals

, giv

ing

feed

back

, rec

ogni

tion

of b

ette

r per

form

ers

and

prov

idin

g tr

aini

ng b

y id

entif

ying

th

e ga

p ai

min

g to

brin

g al

l em

ploy

ees

to th

e hi

ghes

t sta

ndar

d le

vel o

f eff

icien

cy (A

).

• Fu

ll sc

ale

impl

emen

tatio

n of

HDA

• Be

st p

erfo

rmin

g st

affs

/te

ams/

foru

ms

and

Inst

itute


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

CB1.

SI2

Stre

ngth

en

Hum

an R

esou

rce

De

velo

pmen

t th

roug

h tr

aini

ng

This

is to

dev

elop

em

ploy

ee c

apac

ity o

f the

Inst

itute

by

prov

idin

g lo

ng a

nd s

hort

term

Tra

inin

gs

with

pro

per g

ap a

naly

sis

and

desi

gnin

g st

rate

gy. P

rovi

ding

sho

rt te

rm tr

aini

ngs

rele

vant

to th

e ta

rget

ed m

issi

ons

and

obje

ctiv

es a

nd p

rovi

ding

long

term

trai

ning

s of

BA,

MSC

, MPH

/MA

and

PhD

prog

ram

s fo

r the

Inst

itute

sta

ff a

re th

e in

tern

al H

R de

velo

pmen

t.Th

e ot

her H

R de

velo

pmen

t is

focu

sing

on

the

over

all s

kill

and

know

ledg

e de

velo

pmen

t of h

ealth

w

orke

rs in

the

sect

or p

ertin

ent t

o th

e In

stitu

tion

mis

sion

and

obj

ectiv

es. E

stab

lishi

ng p

ublic

hea

lth

trai

ning

ope

ratio

nal s

yste

m is

focu

sing

to o

pera

tiona

lize

the

natio

nal p

ublic

hea

lth tr

aini

ng ce

nter

(N

PHTC

) in

its fu

ll sca

le. T

his

inclu

des

Fina

lizat

ion

of th

e TC

phy

sica

l wor

k, se

ttin

g its

man

agem

ent

syst

em, d

evel

opin

g tr

aini

ng m

anua

ls a

nd m

odul

es, d

esig

ning

cou

rses

on

sele

cted

dis

ciplin

es,

host

ing

loca

l re

gion

al a

nd in

tern

atio

nal p

ublic

hea

lth co

nfer

ence

s.Kn

owle

dge d

evel

opm

ent a

nd im

prov

emen

t of h

ealth

prof

essi

onal

s in

sele

cted

nat

iona

l and

regi

onal

pu

blic

heal

th re

sear

ch In

stitu

tes,

Univ

ersi

ties

and

othe

rs e

ngag

ed in

pub

lic h

ealth

rese

arch

will

be

capa

citat

ed in

term

s of

trai

ning

s on

rese

arch

met

hodo

logi

es/t

echn

ique

s, et

hics

, dat

a an

alys

is a

nd

man

agem

ent.

Desi

gnin

g of

trai

ning

s, de

velo

pmen

t of t

rain

ing

man

uals

and

mod

ules

on

rese

arch

, et

hics

dat

a an

alys

is, m

anag

emen

t and

rela

ted

disc

iplin

es a

nd h

ostin

g of

regi

onal

and

inte

rnat

iona

l pu

blic

heal

th re

sear

ch w

orks

hops

/con

fere

nces

in c

olla

bora

tion

with

par

tner

s w

ill b

e am

ong

the

plan

ned

activ

ities

.

• Tr

aine

d Em

ploy

ees

CB1.

SI3

Recr

uit a

nd re

tain

th

e sk

illed

hum

an

reso

urce

This

initi

ativ

e is

fillin

g va

canc

ies

thro

ugh

deve

lopi

ng c

lear

HR

stra

tegy

and

recr

uitin

g e

mpl

oyee

s as

pla

nned

.Re

tent

ion

initi

ativ

e is

pla

nned

to re

view

the

care

er s

truc

ture

, dev

elop

ing

and

in p

lacin

g in

cent

ive

guid

elin

e, ex

pand

ing

the

tr

ansp

ort

serv

ices

cove

rage

fo

r em

ploy

ees,

Impr

ovin

g t

he c

antin

g se

rvice

by c

ontin

uous

exis

ting

qual

ity im

prov

emen

t an

d Es

tabl

ishi

ng s

port

and

oth

er re

crea

tiona

l ac

tiviti

es. T

his

is to

bui

ld s

tand

ard

grou

nd te

nnis

fiel

d an

d ba

sket

bal

l fie

ld.

• Re

crui

ted

and

reta

ined

sk

illed

HR


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

CB1.

SI4

Enha

nce

good

go

vern

ance

This

str

ateg

ic in

itiat

ive

is a

bout

enh

ancin

g go

od g

over

nanc

e of

pub

lic h

ealth

. It

requ

ires

impl

emen

tatio

n of

the

prin

ciple

s of

goo

d go

vern

ance

, i.e.

rule

of l

aw, t

rans

pare

ncy,

inclu

sive

ness

an

d eq

uity

, re

spon

sive

ness

, ef

ficie

ncy

and

effe

ctiv

enes

s, an

d pa

rtici

pato

ry e

ngag

emen

t of

cit

izen

s. F

or g

ood

gove

rnan

ce to

pre

vail

ther

e is

a n

eed

for s

tron

g le

ader

ship

and

com

mitm

ent,

staf

fs c

omm

itmen

t, ro

bust

par

ticip

atio

n of

pub

lic w

ing,

and

invo

lvem

ent o

f the

priv

ate

sect

or in

up

hold

ing

the

prin

ciple

s of

goo

d go

vern

ance

. Goo

d go

vern

ance

is p

aram

ount

to p

rom

ote

effe

ctiv

e de

liver

y of

pub

lic h

ealth

ser

vice

s. C

ritica

l ar

e ap

prop

riate

sta

ndar

ds, i

ncen

tives

, inf

orm

atio

n,

and

acco

unta

bilit

ies,

whi

ch i

nduc

e hi

gh p

erfo

rman

ce f

rom

pub

lic p

rovi

ders

. Im

prov

ed p

ublic

pe

rfor

man

ce is

one

mea

ns t

o en

hanc

e re

turn

s to

pub

lic h

ealth

inve

stm

ents

. It

can

also

redu

ce

heal

th s

ervi

ce q

ualit

y di

spar

ities

. Mor

eove

r, go

od g

over

nanc

e di

scou

rage

s co

rrup

tion

and

rent

-se

ekin

g pr

actic

es, w

hich

dire

ctly

aff

ects

the

per

form

ance

of t

he p

ublic

hea

lth in

terv

entio

ns. T

o im

prov

e go

vern

ance

and

sub

sequ

ently

the

perf

orm

ance

of h

ealth

sys

tem

s it

is cr

itica

l to

iden

tify

the

wea

k po

ints

that

cont

ribut

e to

poo

r per

form

ance

and

corr

uptio

n.

Good

gov

erna

nce

allo

ws

citiz

ens

to e

xpre

ss t

heir

pref

eren

ces

and

be in

volv

ed in

the

dec

isio

n-m

akin

g pr

oces

ses

and

assu

res

that

the

vie

ws

of a

ll se

gmen

ts o

f th

e po

pula

tion,

par

ticul

arly

th

e vo

ices

of t

he m

ost

vuln

erab

le s

egm

ents

of s

ocie

ty a

re h

eard

in d

ecis

ion-

mak

ing.

It is

als

o re

spon

sive

to th

e pr

esen

t and

futu

re n

eeds

of t

he s

ocie

ty. T

o re

aliz

e go

od g

over

nanc

e it

shou

ld b

e ow

ned

by e

ach

staf

f of t

he in

stitu

te a

nd s

take

hold

ers.

• Go

od g

over

nanc

e at

all

leve

ls

CB1.

SI5

Mai

nstr

eam

ing

of g

ende

r, HI

V co

ntro

l and

en

viro

nmen

tal

issu

es

This

initi

ativ

e is

abo

ut m

ains

trea

min

g th

e cr

itica

l and

cros

scut

ting

issu

es o

f the

socie

ty, v

iz: g

ende

r, HI

V co

ntro

l and

env

ironm

enta

l iss

ues.

It in

clude

s cr

eatin

g sa

fe, c

lean

and

att

ract

ive

envi

ronm

ent

for

staf

fs a

nd c

usto

mer

s to

be

serv

ed, e

nhan

cing

HIV

cont

rol,

and

facil

itatin

g ge

nder

equ

ity in

le

ader

ship

and

gend

er m

ains

trea

min

g in

all a

spec

ts. A

ll act

iviti

es o

f the

inst

itute

tow

ards

ach

ievi

ng

its m

issi

on a

nd v

isio

n w

ill b

e im

plem

ente

d by

invo

lvin

g th

e pe

rspe

ctiv

es o

f gen

der, H

IV co

ntro

l and

en

viro

nmen

tal i

ssue

s m

ains

trea

min

g.

• M

ains

trea

med

gen

der,

HIV

cont

rol a

nd

envi

ronm

enta

l iss

ues


SI. N

oSt

rate

gic

Initi

ativ

es(S

I) Sc

ope

of th

e SI

SI D

eliv

erab

le

CB2:

Enh

ance

Infr

astr

uctu

re a

nd S

yste

m d

evel

opm

ent

CB2.

SI1

Build

and

st

reng

then

ad

min

istr

ativ

e

and

tech

nica

l in

fras

truc

ture

s

The

adm

inis

trat

ive

infr

astr

uctu

re i

s to

bui

ld

the

Ins

titut

e’s m

ain

Com

plex

and

sta

ndar

d w

areh

ouse

, whi

ch h

as a

ll fa

ciliti

es in

one

com

poun

d to

ena

ble

the

Inst

itute

to p

rovi

de a

ll se

rvice

s in

one

pre

mis

e. T

he te

chni

cal in

fras

truc

ture

is to

bui

ld h

igh

leve

l labo

rato

ries,

emer

genc

y ope

ratio

n ce

nter

and

bas

ic ut

ility

facil

ities

for t

he re

sear

ch a

nd s

ervi

ce p

rovi

sion

.

• Bu

ilt In

fras

truc

ture

s

CB2.

SI2

Deve

lopi

ng

data

base

s an

d au

tom

ate

all

oper

atio

ns

This

initi

ativ

e is

to m

ake

the

Inst

itute

fully

aut

omat

ed a

nd h

avin

g al

l the

dat

a ba

ses

in o

rder

to

impr

ove

effic

ienc

y an

d ef

fect

iven

ess

in t

he o

vera

ll pr

ogra

m im

plem

enta

tion.

All

adm

inis

trat

ive

and

tech

nica

l ope

ratio

n w

ill b

e fu

lly a

utom

ated

and

com

pute

rized

usi

ng re

leva

nt s

oft w

ares

• Au

tom

ated

Ope

ratio

ns

CB3:

Enh

ance

Com

mun

icatio

n, C

oord

inat

ion

and

Part

ners

hip

CB3.

SI1

Esta

blis

h

info

rmat

ion

and

com

mun

icatio

n sy

stem

for t

he

publ

ic

This

initi

ativ

e is

to

have

eff

ectiv

e in

form

atio

n an

d co

mm

unica

tion

to t

he g

ener

al p

ublic

and

re

leva

nt s

take

hold

ers.

Thi

s in

volv

es d

evel

opm

ent

of

info

rmat

ion

and

com

mun

icatio

n st

rate

gy,

orga

nizin

g

info

rmat

ion

diss

emin

atio

n fo

r mas

s m

edia

, or

gani

zing

natio

nal E

vent

s ,d

evel

opin

g an

d di

ssem

inat

e au

dio-

visu

al m

essa

ges

and

Orga

nizin

g co

nfer

ence

s an

d w

orks

hops

• Co

mm

unica

tion

syst

em D

evel

oped

and

op

erat

iona

lized

CB3.

SI2

Stre

ngth

enin

g co

llabo

ratio

n an

d pa

rtne

rshi

p at

all

leve

l

This

initi

ativ

e is

aim

ed a

t to

wor

k in

col

labo

ratio

n w

ith p

artn

ers

and

stak

ehol

ders

to

mee

t th

e In

stitu

te’s

mis

sion

and

obj

ectiv

e. T

his

inclu

des

iden

tifyi

ng k

ey p

artn

ers/

stak

ehol

ders

, pre

parin

g di

rect

ory

for p

artn

ersh

ip, d

evel

opin

g pa

rtne

rshi

p st

rate

gy b

ased

on

the

mis

sion

and

obj

ectiv

es o

f th

e Ins

titut

e and

fina

lly es

tabl

ishi

ng an

d m

aint

aini

ng p

artn

ersh

ip b

ased

on

the d

evel

oped

stra

tegy

. Th

is in

itiat

ive

inclu

des

enha

nce

com

mun

icatio

n, c

oord

inat

ion

and

part

ners

hip

of n

atio

nal p

ublic

he

alth

rese

arch

as

per t

he n

atio

nal p

riorit

y re

sear

ch a

gend

a by

dev

elop

ing

and

impl

emen

ting

one

heal

th re

sear

ch fr

amew

ork

appr

oach

that

evo

lve

pote

ntia

l par

tner

s fr

om lo

cal a

nd in

tern

atio

nal

rese

arch

Inst

itute

s, Un

iver

sitie

s, an

d ot

hers

eng

aged

in p

ublic

hea

lth re

sear

ch. I

t is

aim

ed to

wor

k in

clos

e co

llabo

ratio

n w

ith p

artn

ers

and

stak

ehol

ders

to m

eet t

he in

stitu

tes’

rese

arch

mis

sion

and

ob

ject

ives

. Ide

ntify

ing

of k

ey p

artn

ers/

stak

ehol

ders

, est

ablis

h an

d m

aint

ain

part

ners

hip

base

d on

th

e st

rate

gy d

evel

oped

and

nat

iona

l hea

lth re

sear

ch a

gend

a w

ill b

e am

ong

the

maj

or a

ctiv

ities

.

• Co

mm

unica

tion

esta

blis

hed

• Co

llabo

ratio

n an

d pa

rtne

rshi

ps

esta

blis

hed

• Co

mm

unica

tion,

co

llabo

ratio

n an

d pa

rtne

rshi

ps m

aint

aine

d


Anne

x -2

: Maj

or A

ctiv

ities

and

spe

cific

act

iviti

es u

nder

eac

h in

itiat

ive

and

thei

r ta

rget

s

S. N

o.In

itiat

ive

Maj

or A

ctiv

ities

Spe

cific

Act

ivity

Uni

t of

Mea

sure

Impl

emen

tatio

n Y

ear

2015

/ 16

2016

/ 17

2017

/ 18

2018

/ 19

20

19/

20

C1:

Impr

ove

tran

slat

ion

and

utiliz

atio

n of

evi

denc

e- b

ased

info

rmat

ion,

pro

duct

ion

pack

ages

and

pro

duct

s

C1.

SI1

Dis

sem

inat

e ev

iden

ce b

ased

in

form

atio

n,

prod

uctio

n pa

ckag

es a

nd

prod

ucts

Dis

sem

inat

ion

of e

vide

nce

base

d in

form

atio

n (o

n C

Ds,

N

CD

s, N

utrit

ion,

Tra

ditio

nal

and

Mod

ern

Med

icin

e, H

ealth

sy

stem

, Rep

rodu

ctiv

e he

alth

, en

viro

nmen

tal a

nd o

ccup

atio

nal

heal

th, P

olic

y, p

rogr

am a

nd

stra

tegy

eva

luat

ion

issu

es.)

Dis

sem

inat

e sy

nthe

size

d ev

iden

ce b

ased

in

form

atio

n (o

n m

alar

ia, z

oono

sis,

HIV

, HIV

/STI

, H

IV/T

B, T

B, N

utrit

ion,

Tra

ditio

nal a

nd m

oder

n m

edic

ine,

Hea

lth s

yste

m. r

epro

duct

ive

heal

th )

Num

ber

105

106

Con

duct

pol

icy

dial

ogN

umbe

r5

65

511

Dis

sem

inat

ion

of o

utpu

ts b

y pr

epar

ing

prog

ram

s th

roug

h m

edia

.N

umbe

r5

64

48

Dis

sem

inat

ion

of o

utpu

ts th

roug

h co

nfer

ence

N

umbe

r1

11

11

Dis

sem

inat

ion

of o

utpu

ts th

roug

h w

orks

hops

Num

ber

7 10

69

13

Dis

sem

inat

ion

of o

utpu

ts th

roug

h EP

HI J

ourn

al

Num

ber

11

11

1

Dis

sem

inat

ion

of o

utpu

ts th

roug

h sc

ient

ific

new

slet

ter

Num

ber

22

22

2

Dis

sem

inat

e di

etar

y m

enus

(for

chr

onic

dis

ease

s,

for p

eopl

e liv

ing

in c

amp

like

univ

ersi

ty s

tude

nts,

sp

ort a

cade

my

& a

rmy)

.N

umbe

r1

12

1

Dev

elop

men

t & d

isse

min

atio

n of

Eth

iopi

an fo

od

guid

e py

ram

id.

Num

ber

1

Dis

sem

inat

ion

of p

rodu

ctio

n pa

ckag

es o

n Tr

aditi

onal

m

edic

ine

and

nutr

ition

Dis

sem

inat

e Te

chno

logy

brie

f on

Trad

ition

al

med

icin

e an

d N

utrit

ion

(loca

l)N

umbe

r1

45

49

Dis

trib

utio

n of

pro

duct

type

sD

istr

ibut

ion

of v

acci

nes

and

anti-

sera

pro

duct

ty

pes

Num

ber

1*1*

3**

4**

5**


NB

:*

The

sam

e pr

oduc

t (Fe

rmi r

abie

s va

ccin

e) w

ill be

dis

trib

uted

onl

y fo

r 2

year

s an

d st

oppe

d af

ter

2 ye

ars.

**N

ewly

dev

elop

ed p

rodu

cts

will

be d

istr

ibut

ed c

ontin

ually

, in

cum

ulat

ive

way

from

yea

r to

yea

r.

C1.

SI2

Ensu

re

tran

slat

ion

and

utiliz

atio

n of

ev

iden

ce b

ased

in

form

atio

n,

prod

uctio

n pa

ckag

es a

nd

prod

ucts

Con

duct

Con

trib

utio

n m

appi

ng

(eva

luat

ion)

of u

tiliz

ed e

vide

nce

base

d in

form

atio

n an

d pr

oduc

tion

pack

ages

Con

duct

con

trib

utio

n m

appi

ng (e

valu

atio

n) o

f ut

ilized

evi

denc

e ba

sed

info

rmat

ion.

Num

ber

11

11

1

Con

duct

con

trib

utio

n m

appi

ng (e

valu

atio

n) o

f ut

ilized

pro

duct

ion

pack

ages

Num

ber

11

11

C2:

Impr

ove

prom

pt h

ealth

em

erge

ncy

resp

onse

and

reha

bilit

atio

n

C2.

SI1

Stre

ngth

en

Epid

emic

R

espo

nse

and

Reh

abilit

atio

n

Out

brea

k In

vest

igat

ion

Con

duct

fiel

d in

vest

igat

ion

%75

8090

9595

Out

brea

k co

nfirm

atio

n w

ith la

bora

tory

%75

8590

9095

Take

pre

vent

ive

and

cont

rol m

easu

res

%85

9095

100

100

Con

duct

pos

t Epi

dem

ic A

sses

smen

t for

maj

or

publ

ic h

ealth

em

erge

ncie

s%

5060

7080

85

Con

duct

reha

bilit

atio

n an

d re

cove

ry

Con

duct

rapi

d da

mag

e as

sess

men

t dur

ing

emer

genc

y tim

e%

100

100

100

100

100

Mai

ntai

n ba

sic

heal

th s

ervi

ces

%10

010

010

010

010

0

Con

duct

psy

chos

ocia

l ser

vice

s%

100

100

100

100

100


C3:

Incr

ease

and

mai

ntai

n qu

ality

ass

ured

labo

rato

ries

C3.

SI1

Enha

nce

the

impl

emen

tatio

n of

Ste

pwis

e La

bora

tory

Q

ualit

y Im

prov

emen

t P

roce

ss T

owar

ds

Acc

redi

tatio

n (S

LIP

TA)

Enro

ll la

bora

torie

s fo

r st

reng

then

ing

labo

rato

ry

man

agem

ent t

owar

ds

accr

edita

tion

(SLM

TA)

SLM

TA tr

aini

ng a

nd m

ento

ring

of l

abor

ator

ies

Num

ber

7080

100

120

150

Con

duct

SLI

PTA

fina

l ass

essm

ent a

nd s

tar l

evel

re

cogn

ition

Per

cent

100

100

100

100

100

Ena

ble

labo

rato

ries

to

achi

eve

ISO

151

89/1

7025

A

ccre

dita

tion

Enab

le la

bora

torie

s to

ISO

151

89/1

7025

With

Li

mite

d sc

ope

Acc

redi

tatio

n by

at l

east

one

di

scip

line

Num

ber

45

70

100

120

150

Enab

le la

bora

torie

s to

incr

ease

thei

r Lim

ited

scop

e IS

O 1

5189

/170

25 A

ccre

dita

tion

by a

t lea

st o

ne

disc

iplin

eN

umbe

r

2

4

570

100

120

Enab

le la

bora

torie

s to

ISO

151

89/1

7025

ac

cred

itatio

n w

ith fu

ll sc

ope

accr

edita

tion

Num

ber

66

1829

38

Mai

ntai

n la

bora

torie

s w

ith th

eir I

SO

151

89/1

7025

A

ccre

dita

tion

Per

cent

100

100

100

100

100

C4:

Enh

ance

com

mun

ity o

wne

rshi

p

C4.

SI1

Impl

emen

tatio

n of

com

mun

ity

base

d su

rvei

llanc

e

Dev

elop

sys

tem

for c

omm

unity

ba

sed

surv

eilla

nce

Esta

blis

h to

ols

and

pro

cedu

res

%10

0

Mak

e co

mm

unity

bas

ed

surv

eilla

nce

oper

atio

nal

Impl

emen

t com

mun

ity s

urve

illanc

e %

1040

6080

P1:

Impr

ove

publ

ic h

ealth

sur

veilla

nce

syst

em

P1.

SI1

Sur

veilla

nce

of d

isea

ses

and

thei

r de

term

inan

ts

Sur

veilla

nce

on C

omm

unic

able

D

isea

ses.

Sur

veilla

nce

of R

abie

s.N

umbe

r1

11

11

Sur

veilla

nce

on H

IV a

nd re

late

d di

seas

es.

Num

ber

77

77

7

Sur

veilla

nce

on H

IV a

nd T

B C

o-in

fect

ion.

Num

ber

11

11

1

Sur

veilla

nce

on v

iral s

exua

lly-t

rans

mitt

ed in

fect

ion.

Num

ber

11

11

1


P1.

SI1

Sur

veilla

nce

of d

isea

ses

and

thei

r de

term

inan

ts

Sur

veilla

nce

on C

omm

unic

able

D

isea

ses.

Nat

iona

l HIV

est

imat

ion

and

proj

ectio

n.N

umbe

r1

22

22

Con

duct

labo

rato

ry b

ased

sur

veilla

nce

on v

acci

ne

prev

enta

ble

vira

l dis

ease

s (P

olio

, Mea

sles

/Rub

ella

, R

ota,

Influ

enza

, Hep

atiti

s, e

tc)

Num

ber

56

66

6

Sur

veilla

nce

on T

B.

Num

ber

1

Sen

tinel

site

sur

veilla

nce

on v

acci

ne p

reve

ntab

le

bact

eria

l dis

ease

s (m

enin

gitis

, pur

tesi

s, e

tc)

Num

ber

22

22

2

Sen

tent

ial s

ite s

urve

illanc

e on

ent

eric

bac

teria

l di

seas

es.

Num

ber

11

11

Sen

tent

ial s

ite s

urve

illanc

e on

bac

teria

l sex

ually

-tr

ansm

itted

dis

ease

s.N

umbe

r1

11

1

Sen

tent

ial s

ite s

urve

illanc

e on

mal

aria

(cas

e,

clim

ate,

and

Vec

tor)

para

site

. N

umbe

r1

11

Clim

ate

info

rmat

ion

anal

ysis

for m

alar

ia e

limin

atio

n.N

umbe

r1

1

Sen

tent

ial s

ite s

urve

illanc

e of

NTD

s (o

ncho

cerc

iasi

s, ly

mph

atic

fila

riasi

s, s

oil-

tran

smitt

ed h

elm

enth

iasi

s, le

ishm

ania

sis

, sc

hist

osom

iasi

s an

d tr

acho

ma

)

Num

ber

33

33

Beh

avio

ral a

nd d

emog

raph

ic s

urve

illanc

e on

HIV

.N

umbe

r1

1

Beh

avio

ral a

nd d

emog

raph

ic s

urve

illanc

e on

TB

. N

umbe

r1

1

Pub

licat

ion

in p

eer-

revi

ew J

ourn

als

Num

ber

57

97

18

Tech

nica

l Rep

orts

N

umbe

r17

2927

2825


P1.

SI1

Sur

veilla

nce

of d

isea

ses

and

thei

r de

term

inan

ts

Sur

veilla

nce

on N

on

Com

mun

icab

le D

isea

ses

(NC

Ds

and

Beh

avio

ral,

dem

ogra

phic

and

soc

ial

dete

rmin

ants

)

Beh

avio

ral &

dem

ogra

phic

sur

veilla

nce

on

CVD

, hyp

erte

nsio

n, d

iabe

tes,

can

cers

, chr

onic

re

spira

tory

illn

ess,

men

tal i

llnes

s th

roug

h he

alth

&

dem

ogra

phic

site

s of

Uni

vers

ities

.

Num

ber

1

Sur

veilla

nce

on m

orbi

dity

and

m

orta

lity.

Inve

stig

atin

g th

e ca

use

of d

eath

s us

ing

verb

al

Aut

opsy

met

hod.

Num

ber

1

P1.

SI2

.

Sur

veilla

nce

of d

rugs

and

in

sect

icid

e re

sist

ance

.

Con

duct

ant

i-mic

robi

al d

rug

resi

stan

ce s

urve

illanc

e (a

nti-

vira

l, ba

cter

ial,

para

sitic

)

Sur

veilla

nce

of a

nti-m

alar

ial d

rug

effic

acy

Num

ber

11

Sur

veilla

nce

of C

omm

on a

ntib

acte

rial d

rug

resi

stan

ce

Num

ber

11

11

1

Ant

imic

robi

al re

sist

ance

(AM

R) i

n an

imal

pa

thog

ens

of p

ublic

hea

lth s

igni

fican

ceN

umbe

r1

11

Sur

veilla

nce

of N

TDs

drug

effi

cacy

stu

dy.

(Lei

shm

ania

sis,

Onc

hoce

rcia

sis,

Lf,

STH

&

Sch

isto

som

iasi

s)

Num

ber

11

HIV

dru

g re

sist

ance

Num

ber

4

4

4

4

4

TB-d

rug

resi

stan

ceN

umbe

r2

12

22

Dru

g, s

ubst

ance

s ab

use

and

thei

r det

erm

inan

ts a

nd h

ealth

ef

fect

s

Ass

essi

ng th

e tre

nds

and

burd

en o

f Sub

stan

ce o

f ab

use

(Kha

t, ci

gare

ttes,

alc

ohol

, etc

.) an

d na

rcot

ic

and

psyc

hotro

pic

drug

s/m

edic

ines

addi

ctio

n pa

ttern

add

ictio

n an

d th

eir d

eter

min

ant

and

heal

th e

ffect

s

1

Pha

ram

covi

gila

nce

stud

y

Pha

ram

covi

gila

nce

stud

y of

Ant

i-mal

aria

l dru

gsN

umbe

r1

11

Pha

ram

covi

gila

nce

stud

y of

Pre

vent

ive

Che

mo

ther

apy

(PC

), N

TDs.

Num

ber

11

1

phar

mac

ovig

illanc

e su

rvei

llanc

e on

ke

y th

erap

eutic

age

nts.

Num

ber

11

1


P1.

SI2

.

Sur

veilla

nce

of d

rugs

and

in

sect

icid

e re

sist

ance

.

Inse

ctic

ide

susc

eptib

ility

m

onito

ring

stud

y

Eval

uatio

n of

inse

ctic

ides

use

d fo

r ind

oor r

esid

ual

spra

y.N

umbe

r1

11

11

Inse

ctic

ides

use

d fo

r im

preg

natio

n of

long

-last

ing

mos

quito

net

sN

umbe

r1

11

11

Pub

licat

ion

in p

eer-

revi

ew jo

urna

ls

Num

ber

22

33

5

Tech

nica

l Rep

orts

N

umbe

r3

12

13

1512

P1.

SI3

Sur

veilla

nce

of

food

and

nut

ritio

n is

sues

.

Food

fort

ifica

tion

surv

eilla

nce

Con

tinue

s as

sess

men

t of f

ood

fort

ifica

tion

at fo

od

indu

stry

leve

l.N

umbe

r1

1

Esta

blis

hmen

t of f

ood

fort

ifica

tion

and

mic

ronu

trie

nt s

tatu

s su

rvei

llanc

e si

te.

Num

ber

1

Sal

t for

tifica

tion

surv

eilla

nce.

Num

ber

11

11

1

Mic

ronu

trie

nt s

tatu

s su

rvei

llanc

e

Ass

essm

ent o

f ane

mia

and

oth

er m

icro

nutr

ient

st

atus

from

sel

ecte

d fa

cilit

ies.

Num

ber

11

Pub

licat

ion

in p

eer-

revi

ew J

ourn

als

Num

ber

12

23

Tech

nica

l Rep

orts

Num

ber

12

23

2

P1.

SI4

Stre

ngth

en

rout

ine

S

urve

illanc

e (ID

S

surv

eilla

nce,

N

utrit

ion)

Con

duct

indi

cato

r bas

ed

surv

eilla

nce

Sur

veilla

nce

data

in w

eekl

y ba

ses

colle

cted

from

he

alth

faci

litie

s%

8588

8890

95

Pre

pare

and

sha

re w

eekl

y Fe

edba

ck%

8090

9090

95

Sen

ding

Epi

dem

iolo

gica

l bul

letin

to re

gion

s%

8090

9090

95

Com

mun

icat

e id

entifi

ed ri

sk s

to R

Hbs

and

pa

rtne

rs%

8090

9090

95

Esta

blis

h e

-PH

EMD

evel

op a

nd u

pdat

e e

-PH

EM s

oftw

are

Num

ber

11

11

1

Incr

ease

pro

port

ion

of h

ealth

faci

litie

s re

port

ing

us

ing

e-P

HEM

%25

3045

6080


P1.

SI5

Esta

blis

h Em

erge

ncy

Ope

ratio

n C

ente

rs (E

OC

s)

Stre

ngth

en E

OC

sys

tem

Dev

elop

and

ado

pt g

uide

lines

and

SO

Ps

For E

OC

O

pera

tions

Num

ber

12

Link

the

e-P

HEM

with

the

EOC

Num

ber

1

Tech

nica

l ass

ista

nt to

regi

ons

to e

stab

lish

EOC

Num

ber

11

12

Stre

ngth

en e

vent

bas

ed

surv

eilla

nce

Iden

tify

and

use

the

sour

ce a

nd m

eans

of E

vent

B

ased

sur

veilla

nce

Num

ber

11

11

1

Link

the

Even

t ba

sed

surv

eilla

nce

with

EO

C

Num

ber

1

P2:

Impr

ove

rese

arch

and

eva

luat

ion

on k

ey h

ealth

& n

utrit

ion

issu

es

P2.

SI1

Con

duct

di

seas

es

and

thei

r de

term

inan

ts

rese

arch

.

Con

duct

Com

mun

icab

le

Dis

ease

s (v

iral,

bact

eria

l, pa

rasi

tic a

nd, v

ecto

rs)

re

sear

ch a

nd th

eir b

ehav

iora

l /

soci

al fa

ctor

s

HIV

- Im

mun

o-pa

thog

enes

is (i

mm

une-

mod

ulat

ors)

N

umbe

r7

78

1010

HIV

Mol

ecul

ar e

pide

mio

logy

Num

ber

46

56

5

TB-H

IV c

o-in

fect

ion

path

ogen

esis

& m

olec

ular

in

tera

ctio

nsN

umbe

r3

34

44

HIV

& re

late

d di

seas

es (c

ance

r, di

abet

es, O

Is.)

Num

ber

32

22

2

Iden

tifica

tion

of b

iom

arke

rs fo

r HIV

Num

ber

22

33

3

TB-Im

mun

e-pa

thog

enes

is (i

mm

une-

mod

ulat

ors)

Num

ber

23

33

3

TB M

olec

ular

epi

dem

iolo

gy

Num

ber

11

TB a

nd re

late

d di

seas

es (c

ance

r, di

abet

es)

Num

ber

22

3

NTN

dis

ease

pre

vale

nce

and

thei

r ris

k fa

ctor

sN

umbe

r1

1

Iden

tifica

tion

, qua

lifica

tion,

and

val

idat

ion

of

biom

arke

rs fo

r TB

Num

ber

33

33

4

Pilo

t stu

dy fo

r rab

ies

Elim

inat

ion

Num

ber

1

Nos

ocom

ial c

ausi

ng b

acte

rial i

nfec

tion

surv

eyN

umbe

r1

Met

hici

llin-r

esis

tant

Sta

phyl

ococ

cus

aure

us

carr

iage

sur

vey

Num

ber

1


P2.

SI1

Con

duct

di

seas

es

and

thei

r de

term

inan

ts

rese

arch

.

Con

duct

Com

mun

icab

le

Dis

ease

s (v

iral,

bact

eria

l, pa

rasi

tic a

nd, v

ecto

rs)

re

sear

ch a

nd th

eir b

ehav

iora

l /

soci

al fa

ctor

s

Pre

vale

nce

of S

trept

ococ

cus

agal

actie

a in

pr

egna

nt w

omen

Num

ber

1

Ass

essm

ent o

n co

mm

unity

aw

aren

ess

&

heal

th s

ervi

ce d

eliv

ery

syst

em fr

om Z

oono

ses

pers

pect

ive

Num

ber

1

Stu

dy o

n pr

iorit

y zo

onot

ic d

isea

ses

at h

uman

an

imal

eco

syst

em in

terfa

ce.

Num

ber

32

3

Com

mun

ity c

ompl

ianc

e to

MD

A o

f O

ncho

cerc

iasi

s, L

F, S

chis

to/S

TH a

nd T

rach

oma

(Qua

litat

ive)

Num

ber

1

Ecol

ogic

al &

epi

dem

iolo

gica

l stu

dy o

f em

ergi

ng

and

re-e

mer

ging

dis

ease

s in

clud

ing

Yello

w F

ever

&

Den

gue

Feve

r.N

umbe

r1

Epid

emio

logy

of

Leis

hman

iasi

s in

Eth

iopi

aN

umbe

r1

Mol

ecul

ar e

pide

mio

logy

of m

alar

ia p

aras

ites.

Num

ber

1

Stu

dy o

f Myc

olog

ical

dis

ease

s/ m

edic

ally

im

port

ant y

east

s.N

umbe

r1

Gen

etic

stu

dy a

nd v

acci

ne d

evel

opm

ent f

rom

lo

cally

isol

ated

rabi

es v

irus

Num

ber

1

Cap

sula

r sw

itch

stud

y of

men

igoc

occa

l men

ingi

tisN

umbe

r1

The

effe

ct o

f Pha

ram

coge

netic

var

iabi

lity

stud

y on

the

effic

acy

of a

nti-m

alar

ial d

rugs

in E

thio

pian

po

pula

tions

.N

umbe

r1

Epid

emio

logy

of p

ublic

hea

lth im

port

ant v

iral

dise

ases

(pap

illom

a, re

spira

tory

, dia

rrhe

a, e

tc.)

Num

ber

11

1

Opp

ortu

nist

ic b

acte

rial a

nd fu

ngal

infe

ctio

ns

amon

g H

IV s

ero-

posi

tives

.N

umbe

r1

Epid

emio

logy

of e

mer

ging

& re

-em

ergi

ng p

riorit

y di

seas

es (b

acte

rial,

vira

l, pa

rasi

tic).

Num

ber

11

1

HIV

rela

ted

epid

emio

logi

cal s

urve

y N

umbe

r6

88

810

TB r

elat

ed e

pide

mio

logi

cal s

urve

yN

umbe

r4

68

810


P2.

SI1

Con

duct

di

seas

es

and

thei

r de

term

inan

ts

rese

arch

.

Con

duct

Com

mun

icab

le

Dis

ease

s (v

iral,

bact

eria

l, pa

rasi

tic a

nd, v

ecto

rs)

re

sear

ch a

nd th

eir b

ehav

iora

l /

soci

al fa

ctor

s

HIV

rela

ted

beha

vior

al s

urve

yN

umbe

r1

11

TB re

late

d be

havi

oral

sur

vey

Num

ber

11

1

Pub

licat

ion

in p

eer-

revi

ew J

ourn

als

Num

ber

1215

2025

30

Tech

nica

l Rep

orts

Num

ber

3747

5756

64

Con

duct

non

com

mun

icab

le

dise

ases

rese

arch

Con

duct

ing

rese

arch

on

non-

com

mun

icab

le

dise

ases

Num

ber

11

Pub

licat

ion

in p

eer-

revi

ew J

ourn

als

Num

ber

22

1

Tech

nica

l Rep

orts

Num

ber

11

Pre

clin

ical

stu

dy o

f sta

ndar

dize

d tr

aditi

onal

m

edic

ines

on

fung

al s

kin

infe

ctio

ns, h

elm

inth

es,

hype

rten

sion

and

dia

betic

sN

umbe

r 3

Hea

lth o

utco

me

asse

ssm

ent o

n co

mm

only

util

ized

m

edic

inal

pla

nts

Num

ber

1

Ass

essi

ng th

e H

ealth

see

king

beh

avio

r (K

AP

) of

the

com

mun

ity to

war

ds h

ealth

car

e se

rvic

e de

liver

y, p

rofe

ssio

nal p

ract

ices

, tra

ditio

nal

med

icin

e, tr

aditi

onal

hea

lers

& th

eir p

ract

ices

Num

ber

1

Pre

clin

ical

tria

l on

poly

vale

nt a

nti-v

enom

Num

ber

1

Pre

clin

ical

tria

l on

hum

an c

ell c

ultu

re a

nti-r

abie

s va

ccin

e1

Pre

clin

ical

tria

l on

hum

an a

nti-r

abie

s im

mun

oglo

bulin

N

umbe

r1

Pre

clin

ical

tria

l of T

rival

ent M

enin

goco

ccal

m

enin

gitis

vac

cine

Num

ber

1

Effe

ct o

f HIV

Car

e an

d tre

atm

ent

Num

ber

46

810

14

HIV

, Can

cer a

nd o

rgan

dys

func

tion

rese

arch

N

umbe

r2

510

12

HIV

and

tran

sitio

nal s

tudy

Num

ber

12

22

2

Effe

ct o

f TB

car

e an

d Tr

eatm

ent

Num

ber

43

35

4


P2.

SI1

Con

duct

di

seas

es

and

thei

r de

term

inan

ts

rese

arch

.

Car

e &

trea

tmen

t

stud

y on

CD

and

NC

D

dise

ases

.

Ass

ocia

tion

of T

B a

nd c

o-m

orbi

ditie

s (n

utrit

ion,

di

abet

es e

tc.)

Num

ber

33

56

3

Hea

lth s

ervi

ce a

ctiv

ities

rela

ted

to T

B

Num

ber

45

67

7

Sta

ble

isot

opes

tech

niqu

e re

sear

ch to

det

erm

ine

nutr

ient

bio

ava

ilabi

lity

& s

tore

Num

ber

11

Pub

licat

ion

in p

eer-

revi

ew

Num

ber

810

1212

14

Tech

nica

l Rep

ort

Num

ber

1625

3241

46

P2.

SI2

Con

duct

tr

aditi

onal

and

m

oder

n m

edic

ine

rese

arch

.

Eva

luat

e sa

fety

, effi

cacy

and

qu

ality

of t

radi

tiona

l med

icin

e

Eval

uate

the

Effic

acy,

saf

ety

and

qual

ity

of c

omm

only

util

ized

med

icin

al p

lant

s by

th

e co

mm

unity

and

trad

ition

al h

eale

rs fo

r th

e tre

atm

ent o

f C

Ds

and

NC

Ds

(mal

aria

, le

shem

ania

sis,

tryp

anos

omiy

asis

, hel

met

hics

, ba

cter

ial a

nd fu

ngal

infe

ctio

ns, H

IV/A

IDS

, di

abet

ics,

ast

hma,

hyp

erte

nsio

n, c

ance

r, ra

bies

, re

prod

uctiv

e an

d Fa

mily

hea

lth)

roun

ds1

1 1

Pub

licat

ion

in p

eer-

revi

ew jo

urna

lsN

umbe

r1

11

Tech

nica

l rep

orts

N

umbe

r1

11

Sur

vey

on tr

aditi

onal

med

icin

e

Ass

essi

ng th

e ca

tego

ries,

util

izat

ion

and

the

cont

ribut

ion

of tr

aditi

onal

med

icin

e to

the

heal

th

care

sys

tem

in E

thio

pia

Num

ber

1

Con

duct

ing

an in

vent

ory

surv

ey o

f tra

ditio

nal

med

icin

es s

old

by v

ende

rs in

the

mar

kets

of

diffe

rent

citi

es in

Eth

iopi

a.N

umbe

r1

Ass

essm

ent o

f end

ange

red

med

icin

al p

lant

s an

d es

tabl

ish

thei

r con

serv

atio

n.N

umbe

r1

Ethn

omed

icin

al, b

iolo

gica

l and

clin

ical

sup

port

for

med

icin

al p

lant

s us

e in

sel

ecte

d re

gion

s of

Eth

iopi

aN

umbe

r1

Pub

licat

ion

in p

eer-

revi

ew jo

urna

lsN

umbe

r1

1

Tech

nica

l rep

orts

N

umbe

r1

12


P2.

SI2

Con

duct

tr

aditi

onal

and

m

oder

n m

edic

ine

rese

arch

.

Con

duct

rese

arch

on

Mod

ern

Med

icin

e

Nat

iona

l ass

essm

ent o

f ant

ibio

tic, a

nti-d

iabe

tic

and

anti-

hype

rten

sive

med

icat

ion

and

patie

nt

adhe

renc

e, p

resc

riptio

n pr

actic

es in

the

publ

ic a

nd

priv

ate

heal

th fa

cilit

ies

Num

ber

1

Ass

essm

ent o

f pre

vale

nce

and

type

of d

rug,

su

bsta

nces

of a

buse

and

det

erm

inan

t fac

tors

and

th

eir i

nflue

nce

on h

ealth

and

soc

ial f

acto

rsN

umbe

r1

Met

abol

ism

of t

oxic

ity o

f dru

gs a

nd S

ubst

ance

s,

dete

rmin

e m

etab

olis

m o

f Tox

icity

of d

rugs

an

d S

ubst

ance

s, A

sses

s dy

nam

ic p

hase

of

met

abol

ism

toxi

city

Num

ber

11

11

Pub

licat

ion

in p

eer-

revi

ew jo

urna

lsN

umbe

r1

1

P2.

SI3

Stre

ngth

en fo

od

and

nutr

ition

re

sear

ch

Con

duct

rese

arch

on

nutr

ition

an

d re

late

d is

sues

Mic

ronu

trie

nt (a

nem

ia ,

iron

defi

cien

cy, v

itam

in A

,

Iodi

ne d

efici

ency

, Zi

nc d

efici

ency

, Vi

tam

in B

12

and

folia

te,

hous

ehol

ds w

ith a

dequ

atel

y io

dize

d sa

lt)

Num

ber

1

Inte

grat

ing

stra

tegi

es fo

r the

pre

vent

ion

of

pree

clam

psia

and

ane

mia

into

com

mun

ity b

ased

pr

ogra

mN

umbe

r1

Stu

dy o

n di

et re

late

d N

CD

s su

ch a

s ob

esity

, di

abet

es m

ellit

us, c

ardi

ovas

cula

r dis

ease

, hy

pert

ensi

on a

nd s

troke

rela

tion:

Coh

ort s

tudy

.N

umbe

r1

1

Mea

sure

IYC

F pr

actic

e &

thei

r nut

ritio

nal s

tatu

s be

twee

n em

ploy

ed &

non

em

ploy

ed m

othe

rs.

Num

ber

1

Pilo

t stu

dy fo

r est

ablis

hing

nat

iona

l hum

an b

reas

t m

ilk b

ank

in E

thio

pia

Num

ber

1

Iden

tify

cultu

ral a

nd s

ocia

l bar

riers

of c

hild

feed

ing

prac

tice

in e

mer

ging

regi

on /

past

oral

com

mun

ity

of E

thio

pia.

Num

ber

11

Tran

slat

ing

adop

tion

of im

prov

ing

varie

ties

(qua

lity

prot

ein

mai

ze) i

nto

nutr

ition

al im

pact

in ru

ral

Ethi

opia

N

umbe

r1

The

effe

ct o

f mai

ze w

ith Z

inc,

fert

ilizat

ion

on

nutr

ition

al s

tatu

s of

you

ng c

hild

ren

and

wom

en o

f re

prod

uctiv

e ag

e in

rura

l, Et

hiop

ia

Num

ber

1


P2.

SI3

Stre

ngth

en fo

od

and

nutr

ition

re

sear

ch

Con

duct

rese

arch

on

nutr

ition

an

d re

late

d is

sues

The

effe

ct o

f clim

ate

varia

bilit

y on

food

sec

urity

an

d nu

triti

onal

sta

tus

amon

g w

omen

& c

hild

ren

in

Ethi

opia

Num

ber

11

Fore

st d

istr

ibut

ion

in re

latio

n w

ith n

utrit

ion

and

heal

th.

Num

ber

1

Expl

orin

g th

e ag

ro e

colo

gica

l pot

entia

l for

en

hanc

ed c

hild

nut

ritio

n.N

umbe

r1

The

effe

ct o

f mul

tiple

mic

ronu

trie

nt p

owde

r on

child

mor

bidi

ty a

nd m

orta

lity:

Effe

ctiv

enes

s tr

ial

Num

ber

1

Det

erm

inat

ion

of b

ioav

aila

bilit

y of

zin

c an

d vi

tam

in

A s

tore

usi

ng s

tabl

e is

otop

e te

chni

que

Num

ber

11

Res

earc

h on

food

and

rela

ted

issu

es.

Doc

umen

tatio

n of

indi

geno

us fo

od a

nd te

chni

ques

us

ed b

y et

hnic

gro

ups

for

ferm

ente

d, n

on-

ferm

ente

d a

nd o

ther

s in

dige

nous

food

sN

umbe

r1

Stu

dy o

n un

deru

tiliz

ed fo

ods

for f

ood

and

nutr

ition

se

curit

y

Num

ber

1

Expa

nsio

n an

d up

datin

g ex

istin

g Et

hiop

ian

food

co

mpo

sitio

n ta

ble

Num

ber

1

Res

earc

h on

food

and

wat

er

safe

ty &

qua

lity

Ass

essm

ent o

f myc

otox

ins

in s

tapl

e fo

ods

and

iden

tifica

tion

of th

e re

spon

sibl

e fu

ngus

for i

ts

prod

uctio

ns.

Num

ber

11

11

Mol

ecul

ar e

pide

mio

logy

of S

alm

onel

la e

nter

tides

an

d ot

her e

nter

ic p

atho

gens

in E

thio

pia.

Num

ber

1

Stu

dy o

n m

icro

bio

tech

nolo

gica

l asp

ects

of

ferm

ente

d fo

ods

and

drin

ks o

f Eth

iopi

a.N

umbe

r1

Saf

ety

of s

treet

food

in E

thio

pia.

N

umbe

r1

Ass

essm

ent o

f foo

d ad

ulte

ratio

n in

Eth

iopi

a (c

offe

e, re

d pe

pper

and

but

ter)

Num

ber

1

Sta

tus

of fo

od s

afet

y pl

an a

nd q

ualit

y in

Eth

iopi

a.N

umbe

r1

1

Stu

dy o

n sa

fety

of e

dibl

e oi

lN

umbe

r1

1


P2.

SI3

Stre

ngth

en fo

od

and

nutr

ition

re

sear

ch

Res

earc

h on

food

and

wat

er

safe

ty &

qua

lity

Stu

dy o

n pu

blic

hea

lth p

robl

ems

asso

ciat

ed w

ith

food

s fro

m a

nim

al o

rigin

N

umbe

r1

11

Food

she

lf lif

e of

indu

stria

lly p

roce

ssin

g fo

od in

Et

hiop

ia.

Num

ber

11

11

Food

she

lf lif

e of

loca

lly p

roce

ssin

g fo

od in

Eth

iopi

aN

umbe

r1

11

11

Dev

elop

die

tary

men

u fo

r pat

ient

with

chr

onic

di

seas

es v

ulne

rabl

e gr

oups

, spo

rt a

cade

my

&

arm

y.N

umbe

r1

11

1

Dev

elop

men

t & d

isse

min

atio

n of

Eth

iopi

an fo

od

guid

e py

ram

id.

Num

ber

1

Pub

licat

ion

in p

eer-

revi

ew jo

urna

lsN

umbe

r5

22

1011

Tech

nica

l Rep

orts

Num

ber

711

910

8

Stu

dy o

n sa

fety

, sta

bilit

y &

bio-

avai

labi

lity

of

fort

ifica

nt.

Num

ber

1

Ass

essm

ent o

f myc

otox

ins

in s

tapl

e fo

ods

and

iden

tifica

tion

of th

e re

spon

sibl

e fu

ngus

for i

ts

prod

uctio

ns.

Num

ber

11

11

P2.

SI4

Pol

icy,

pro

gram

an

d st

rate

gy

eval

uatio

n

Eval

uatio

n of

dis

ease

con

trol

prog

ram

s

Eval

uatio

n of

prio

ritiz

ed n

egle

cted

trop

ical

dis

ease

s co

ntro

l, el

imin

atio

n an

d er

adic

atio

n pr

ogra

ms

Num

ber

1

NTD

s ep

idem

iolo

gica

l and

pro

gram

impa

ct s

tudi

es

(onc

hoce

rcia

sis,

lym

phat

ic fi

laria

sis

and

STH

/S

chis

toso

mia

sis,

trac

hom

a.)

Num

ber

1

Mal

aria

indi

cato

r sur

vey

Num

ber

11

WA

SH

sur

vey

Num

ber

12

1

HIV

rela

ted

prog

ram

eva

luat

ion

Num

ber

23

45

6

TB re

late

d pr

ogra

m e

valu

atio

nN

umbe

r1

12

11

Eval

uatio

n of

nut

ritio

n an

d fo

od

prog

ram

s

Nat

iona

l nut

ritio

n pr

ogra

m e

valu

atio

n N

umbe

r1

Pul

se c

omm

unity

bas

ed n

utrit

ion

form

ativ

e st

udy

to in

dent

ify th

e ga

p in

hea

lth a

gric

ultu

re &

ed

ucat

ion

sect

ors

at th

e co

mm

unity

leve

l.N

umbe

r1


P2.

SI4

Pol

icy,

pro

gram

an

d st

rate

gy

eval

uatio

n

Eval

uatio

n of

nut

ritio

n an

d fo

od

prog

ram

s

Eval

uatio

n of

inte

rven

tion

stra

tegy

of c

omm

unity

ba

sed

nutr

ition

pro

gram

to g

ener

ate

info

rmat

ion

on d

ieta

ry d

iver

sity

, com

plem

enta

ry fe

edin

g,

anth

ropo

met

ric a

nd h

emog

lobi

n le

vel o

n st

udy

part

icip

ants

.

Num

ber

11

Stu

dy o

n C

MA

M P

rogr

am e

valu

atio

nC

omm

enta

ry &

bud

get n

eede

dN

umbe

r1

Dev

elop

pol

icy

and

te

chno

logy

brie

fs

Dev

elop

Pol

icy

brie

fsN

umbe

r5

75

611

Dev

elop

tech

nolo

gy b

rief o

n pr

oduc

tion

pack

ages

fro

m in

tern

atio

nal s

ourc

e N

umbe

r1

11

11

Pub

licat

ion

in p

eer-

revi

ew J

ourn

als

Num

ber

15

42

8

Tech

nica

l rep

ort

Num

ber

1919

1722

28

P2.

SI5

Stre

ngth

en

heal

th s

yste

m

rese

arch

Con

duct

hea

lth s

ervi

ce d

eliv

ery

and

orga

niza

tion

rese

arch

Ser

vice

ava

ilabi

lity

and

Rea

dine

ss A

sses

smen

t (S

AR

A) i

nclu

ding

UH

C a

t PH

CU

.N

umbe

r1

11

1

Ser

vice

Pro

visi

on A

sses

smen

t Plu

s (S

PA+)

Num

ber

1

Opp

ortu

nitie

s an

d ch

alle

nges

in la

bora

tory

test

su

ppor

t to

fede

ral h

ospi

tals

incl

udin

g re

ferr

al

serv

ice

deliv

ery

by E

PH

I. N

umbe

r1

Res

earc

h on

hea

lth e

quity

, Hea

lth s

ervi

ces

utiliz

atio

n an

d ac

cess

to h

ealth

car

e.N

umbe

r1

Ava

ilabi

lity

& re

adin

ess

of s

ervi

ces

for P

HEM

(p

ublic

hea

lth e

mer

genc

y) re

port

able

cas

es in

he

alth

faci

litie

s.N

umbe

r1

Eval

uatio

n of

hea

lth s

ervi

ces

refe

rral

link

age

and

effic

ienc

y of

the

syst

em a

cros

s di

ffere

nt le

vels

of

faci

litie

s.N

umbe

r1

Con

duct

hea

lth s

yste

m

Gov

erna

nce

and

know

ledg

e m

anag

emen

t Res

earc

h

Eval

uatio

n of

med

ical

equ

ipm

ent a

nd

phar

mac

eutic

al s

uppl

y ch

ain

man

agem

ent

Num

ber

11

Eco

nom

ic e

valu

atio

n of

sel

ecte

d h

ealth

pro

gram

s in

Eth

iopi

a N

umbe

r1

Cha

lleng

es a

nd o

ppor

tuni

ties

for m

anag

ing

Hum

an R

esou

rces

for h

ealth

(HR

H) i

n Et

hiop

ia.

Num

ber

1


P2.

SI5

Stre

ngth

en

heal

th s

yste

m

rese

arch

Con

duct

hea

lth C

are

reso

urce

re

sear

ch

Kno

wle

dge,

mot

ivat

ion,

per

cept

ion

& a

ttitu

des

of c

omm

unity

hea

lth w

orke

rs in

clud

ing

Hea

lth

Dev

elop

men

t Arm

y’s

(HD

A) o

n pr

imar

y he

alth

car

e.N

umbe

r1

Eval

uatio

n of

Eth

iopi

a he

alth

car

e fin

anci

ng

stra

tegi

es in

clud

ing

the

impl

emen

tatio

n of

the

natio

nal h

ealth

insu

ranc

e N

umbe

r1

1

Con

duct

hea

lth s

yste

m

Gov

erna

nce

and

know

ledg

e m

anag

emen

t Res

earc

h

Verifi

catio

n of

rout

ine

heal

th fa

cilit

y da

ta (D

QA

). N

umbe

r1

11

Impl

emen

tatio

n st

atus

and

util

izat

ion

of h

ealth

m

anag

emen

t inf

orm

atio

n sy

stem

for s

trat

egic

de

cisi

on a

t all

leve

ls in

Eth

iopi

a

Num

ber

1

Eval

uatio

n of

cha

lleng

es a

nd o

ppor

tuni

ties

in

natio

nal b

lood

ban

k sy

stem

.N

umbe

r1

Pub

licat

ion

in p

eer-

revi

ew jo

urna

lsN

umbe

r3

45

56

Tech

nica

l rep

ort

Num

ber

46

44

4

P2.

SI6

.

Car

ryou

t en

viro

nmen

tal

and

occu

patio

nal

heal

th re

sear

ch

Con

duct

rese

arch

on

envi

ronm

enta

l hea

lth a

nd

rela

ted

issu

es

Indo

or a

ir qu

ality

and

hum

an h

ealth

bur

den

Num

ber

11

1

Mic

robi

al A

ir Q

ualit

y of

Ope

ratio

n Th

eate

rs,

Del

iver

y R

oom

s, a

nd In

tens

ive

Car

e U

nits

in M

ajor

R

efer

ral H

ospi

tals

in E

thio

pia

Num

ber

11

1

Ass

essm

ent o

f the

dis

trib

utio

n of

per

sist

ent

orga

nic

pollu

tant

s (P

OP

s)N

umbe

r1

11

Hea

lth c

are

was

te m

anag

emen

t pra

ctic

es a

nd

optio

ns.

Num

ber

11

1

Roa

d tr

ansp

ort,

hum

an h

ealth

and

con

trib

utin

g fa

ctor

sN

umbe

r1

21

Wat

er s

uppl

y, s

anita

tion,

hyg

iene

and

hea

lth

Num

ber

11

Inte

grat

ed e

nviro

nmen

tal r

isk

asse

ssm

ent i

n th

e vi

cini

ty o

f ind

ustr

ial

and

mun

icip

al a

reas

N

umbe

r1

11

2

Con

duct

rese

arch

on

occu

patio

nal h

ealth

and

rela

ted

issu

es

Haz

ard,

exp

osur

e an

d ris

k/in

jury

ass

essm

ent i

n oc

cupa

tiona

l set

tings

Num

ber

12

2

Pub

licat

ion

in p

eer-

revi

ew jo

urna

lsN

umbe

r2

25

Tech

nica

l rep

ort

Num

ber

27

910


P2.

SI7

Con

duct

re

prod

uctiv

e he

alth

rese

arch

Mat

erna

l and

new

bor

n re

sear

ch a

nd re

late

d is

sues

Eval

uatio

n of

mat

erna

l and

new

born

hea

lth

prog

ram

sN

umbe

r1

11

Ass

essm

ent o

f util

izat

ion

and

acce

ss to

mat

erna

l an

d ne

wbo

rn h

ealth

ser

vice

s N

umbe

r1

Chi

ld h

ealth

rese

arch

Expa

nded

pro

gram

of i

mm

uniz

atio

n(EP

I) co

vera

ge

incl

udin

g se

ro s

urve

yN

umbe

r1

Eval

uatio

n of

chi

ld h

ealth

pro

gram

s N

umbe

r1

1

Ado

lesc

ent a

nd y

oung

peo

ple

sexu

al a

nd re

prod

uctiv

e he

alth

re

sear

ch

Ass

essm

ent o

f ris

ky s

exua

l beh

avio

rs a

mon

g ad

oles

cent

s an

d yo

uth

Util

izat

ion

and

acce

ss to

ado

lesc

ent a

nd y

oung

pe

ople

sex

ual a

nd re

prod

uctiv

e he

alth

ser

vice

s

Pub

licat

ion

in p

eer-

revi

ew jo

urna

ls

Tech

nica

l rep

ort

P3:

Impr

ove

tech

nolo

gy e

valu

atio

n an

d tr

ansf

er

P3.

SI1

Dev

elop

hea

lth

and

nutr

ition

te

chno

logy

pr

oduc

tion

pack

ages

.

Car

ryou

t tec

hnol

ogy

deve

lopm

ent

Food

pro

cess

ing

tech

nolo

gy id

entifi

catio

n,

eval

uatio

n fo

r ada

ptat

ion

and

diss

emin

atio

n.

Num

ber

11

Tech

nolo

gy a

sses

smen

t for

ada

ptio

n fo

od

proc

essi

ng te

chno

logy

Num

ber

11

Reg

ion

base

d co

mpl

emen

tary

food

dev

elop

men

tN

umbe

r1

11

1

Sup

plem

enta

ry fo

od d

evel

opm

ent

Num

ber

1

Trad

ition

al m

edic

ine

prod

uctio

n pa

ckag

e fo

r hu

man

ski

n di

seas

esN

umbe

r1

Trad

ition

al m

edic

ine

prod

uctio

n pa

ckag

e fo

r m

osqu

ito re

pelle

nt

Num

ber

1

Trad

ition

al m

edic

ine

prod

uctio

n pa

ckag

e fo

r wat

er

clar

ifyin

g ag

ent

Num

ber

1

Trad

ition

al m

edic

ine

prod

uctio

n pa

ckag

e fo

r an

imal

ant

i-Ect

opar

asite

sN

umbe

r1

1

Pub

licat

ion

in p

eer-

revi

ew jo

urna

ls

Num

ber

23

Tech

nica

l rep

ort

Num

ber

13

33

4


P3.

SI1

Dev

elop

hea

lth

and

nutr

ition

te

chno

logy

pr

oduc

tion

pack

ages

.

Per

form

vac

cine

tech

nolo

gy

tran

sfer

Tech

nolo

gy tr

ansf

er fo

r the

pro

duct

ion

of T

ypho

id

vacc

ine

Num

ber

1

Tech

nolo

gy tr

ansf

er fo

r the

pro

duct

ion

of c

hole

ra

vacc

ine

Num

ber

1

Tech

nolo

gy tr

ansf

er fo

r the

pro

duct

ion

of y

ello

w

feve

r vac

cine

Num

ber

1

Tech

nolo

gy tr

ansf

er o

n ce

ll cu

lture

bas

ed a

nti-

rabi

es v

acci

neN

umbe

r1

Dev

elop

ant

i-rab

ies

vacc

ine

prod

uctio

n pa

ckag

e fro

m lo

cal r

abie

s vi

rus

stra

ins

Num

ber

1

Tech

nica

l rep

ort

Num

ber

12

2

Car

ryou

t tec

hnol

ogy

eval

uatio

n

Wid

al R

DT

kit

eval

uatio

nN

umbe

r1

Blo

od c

ultu

re m

edia

tech

nolo

gy e

valu

atio

n N

umbe

r1

Mal

aria

dia

gnos

tic to

ols

eval

uatio

nN

umbe

r1

11

11

Inse

ctic

ide

kits

eva

luat

ion

(IR

S a

nd L

LIN

s)N

umbe

r1

11

11

HIV

dia

gnos

tics

eval

uatio

nN

umbe

r3

44

44

HIV

co-

infe

ctio

ns d

iagn

ostic

eva

luat

ion

Num

ber

23

33

3

TB d

iagn

ostic

s ev

alua

tion

(Act

ive

TB, L

TBI,

child

ho

od T

B,

EPTB

, TB

/HIV

)N

umbe

r3

33

33

Eval

uatio

n an

d sc

ale

up o

f rab

ies

diag

nost

ic

tech

niqu

e to

regi

ons

Num

ber

23

22

Dia

gnos

tic te

chno

logy

eva

luat

ion

for F

ood

and

Nut

ritio

nN

umbe

r1

Pub

licat

ion

in p

eer-

revi

ew jo

urna

ls

Num

ber

56

79

9

Tech

nica

l rep

orts

Num

ber

1013

1212

14


P3.

SI2

Pro

duct

ion

of

heal

th te

chno

logy

pr

oduc

ts

Pro

duct

ion

of V

acci

nes

and

Ser

um

Ferm

i typ

e an

t-ra

bies

vac

cine

pro

duct

ion

for

hum

ans

Dos

e32

,000

32,0

00

Cel

l-cul

ture

ant

i-rab

ies

vacc

ine

prod

uctio

n fo

r hu

man

Dos

e50

,000

50,0

0050

,000

Rab

ies

Imm

unog

lobu

lin (R

IG) p

rodu

ctio

n fo

r th

erap

eutic

use

Dos

e1,

000

1,00

01,

000

Ant

i-rab

ies

mon

oclo

nal a

ntib

ody

Vial

1,00

01,

000

1,00

0

Triv

alen

t Men

goco

cal m

enin

gitis

vac

cine

pr

oduc

tion

Dos

e18

0,00

0

Pol

yval

ent a

nti-v

enom

pro

duct

ion

Dos

e5,

000

Tech

nica

l rep

orts

Num

ber

11

33

5

Pub

licat

ion

in p

eer-

revi

ewed

jou

rnal

sN

umbe

r3

1

Pro

duct

ion

of p

anel

s (P

aras

itic,

Bac

teria

l and

TB

/H

IV)

Num

ber

38

88

Tech

nica

l rep

orts

Num

ber

38

88

P4:

Impr

ove

publ

ic h

ealth

em

erge

ncy

prep

ared

ness

P4.

SI1

Vuln

erab

ility

Ass

essm

ent a

nd

Ris

k m

appi

ng

(VR

AM

) and

av

ail e

mer

genc

y su

pplie

s

Pre

pare

risk

pro

file

for p

ublic

he

alth

risk

s an

d m

ap

Con

duct

vul

nera

bilit

y an

d ris

k as

sess

men

tN

umbe

r1

Pre

pare

risk

map

Num

ber

1

Esta

blis

h ca

paci

ty fo

r pr

even

tion

and

cont

rol o

f pub

lic

heal

th ri

sks

Pre

parin

g E

PR

P

Sto

ckpi

le e

mer

genc

y dr

ugs

and

supp

lies


Trav

eler

s H

ealth

and

In

tern

atio

nal V

acci

natio

n

Dev

elop

ing

and

adop

ting

Gui

delin

es a

nd S

OP

sN

umbe

r1

1

Iden

tify

and

map

trav

eler

s ri

sk a

reas

(Glo

bal a

nd

Loca

l)1

Dev

elop

trav

eler

s he

alth

mes

sage

1

Initi

ate

vario

us V

acci

natio

ns fo

r tra

vels

to a

ny ri

sk

area

s%

100

100

100

100

100

Pro

vide

adv

ice

for t

rave

lers

to h

ealth

risk

are

as%

100

100

100

100

100

Esta

blis

h Q

uara

ntin

e si

tes

at p

oint

s of

ent

ry%

5075

100

P5:

Enh

ance

labo

rato

ry q

ualit

y m

anag

emen

t sys

tem

impl

emen

tatio

n

P5.

SI1

Stre

ngth

en

Exte

rnal

Qua

lity

Ass

essm

ent

Cap

acity

bui

ldin

g fo

r nat

iona

l EQ

A p

rogr

ams

Esta

blis

h N

atio

nal E

QA

labo

rato

ry b

y IS

O 1

7043

S

tand

ard

Num

ber

1

Pre

para

tion

of d

iffer

ent t

ypes

of P

T fo

r NEQ

AS

Num

ber

35

55

5

Stre

ngth

en R

egio

nal E

QA

pr

ogra

ms

Sup

port

Reg

iona

l Lab

orat

orie

s fo

r EQ

A a

ctiv

ities

Num

ber

1313

1313

13

Enro

ll la

bora

torie

s in

diff

eren

t EQ

A p

rogr

ams

Per

cent

8085

9095

100

Stre

ngth

en s

yste

m fo

r PT

dist

ribut

ion,

resu

lt co

llect

ion

and

feed

back

pro

visi

onP

erce

nt

100

100

100

100

100

P5.

SI2

Equi

pmen

t an

d su

pplie

s m

anag

emen

t

Stre

ngth

en e

quip

men

t m

aint

enan

ce

Esta

blis

h an

d st

reng

then

Cen

tral

and

Reg

iona

l M

aint

enan

ce w

orks

hops

N

umbe

r 9

1313

1313

Pro

vide

pre

vent

ive

labo

rato

ry e

quip

men

t m

aint

enan

ce s

ervi

ces

Per

cent

100

100

100

100

100

Pro

vide

cur

ativ

e la

bora

tory

equ

ipm

ent

mai

nten

ance

ser

vice

s P

erce

nt10

010

010

010

010

0

Esta

blis

h ag

reem

ent f

or v

ende

r inv

olve

men

t in

mai

nten

ance

act

iviti

esN

umbe

r 3

55

55

Ensu

re th

e av

aila

bilit

y of

nec

essa

ry s

pare

-par

tspe

rcen

t10

010

010

010

010

0


P5.

SI2

Equi

pmen

t an

d su

pplie

s m

anag

emen

t

Eval

uatio

n/va

lidat

ion

of

Equi

pmen

t and

sup

plie

s

Und

erta

ke v

alid

atio

n an

d ce

rtifi

catio

n of

Bio

saf

ety

Cab

inet

s an

d N

egat

ive

Pre

ssur

es

%10

010

010

010

010

0

Pro

vide

Val

idat

ion/

Verifi

catio

n se

rvic

es fo

r la

bora

tory

equ

ipm

ent,

reag

ents

and

dev

ices

Num

ber

55

55

5

Und

erta

ke P

ost m

arke

t sur

veilla

nce

of la

bora

tory

eq

uipm

ent,

reag

ents

and

dev

ices

Num

ber

77

710

10

P5.

SI3

Pro

cess

con

trol

and

impr

ovem

ent

Qua

lity

assu

ranc

e im

plem

enta

tion

Impl

emen

t Qua

lity

Ass

uran

ce m

easu

res

at a

ll la

bora

tory

faci

litie

s%

100

100

100

100

100

Esta

blis

h tie

r bas

ed m

inim

um q

ualit

y st

anda

rd

Num

ber

22

P5.

SI4

Stre

ngth

en fa

cilit

y an

d sa

fety

Labo

rato

ry in

frast

ruct

ure/

syst

em d

evel

opm

ent

Esta

blis

h en

hanc

ed B

SL-

3 La

bora

tory

sys

tem

at

natio

nal l

evel

Num

ber

1

Esta

blis

h B

SL-

3 La

bora

tory

sys

tem

at n

atio

nal a

nd

regi

onal

leve

lN

umbe

r1

22

Bio

-saf

ety

and

Bio

-sec

urity

sy

stem

Ensu

re a

ppro

pria

te v

acci

natio

n fo

r lab

orat

ory

wor

kers

%

100

100

100

100

100

Intro

duce

sys

tem

for

Bio

-sec

urity

%75

8595

100

Impr

ove

was

te d

ispo

sal a

nd s

ewer

age

syst

em%

7585

9095

100

P6:

Stre

ngth

enin

g La

bora

tory

Cap

acity

for R

efer

ral a

nd B

acku

p Te

stin

g S

ervi

ces

P6.

SI1

Stre

ngth

enin

g la

bora

tory

ne

twor

k an

d re

ferr

al te

stin

g se

rvic

es

Stre

ngth

en n

atio

nal s

yste

ms

for

refe

rral

spe

cim

en tr

ansp

orta

tion

and

resu

lt de

liver

y

Stre

ngth

enin

g sp

ecim

en re

ferr

al a

nd tr

ansp

orta

tion

syst

em%

100

100

100

100

100

IT te

chno

logi

es d

eplo

ymen

t for

resu

lt de

liver

y%

6575

8595

100

Pro

vide

ref

erra

l tes

ting

serv

ices

Pro

vide

ref

erra

l tes

ting

serv

ices

for p

ublic

prio

rity

serv

ices

%75

8090

9510

0

Pro

vide

bac

kup

test

ing

serv

ices

Pro

vide

bac

kup

test

ing

serv

ices

%10

010

010

010

010

0

Cap

acity

for m

icro

biol

ogic

al te

st fo

r sel

ecte

d ho

spita

ls%

3545

7585

100

Incr

ease

faci

litie

s te

st m

enu

per e

stab

lishe

d st

anda

rd

%40

5065

7580

Stre

ngth

enin

g na

tiona

l and

regi

onal

cap

aciti

es fo

r de

tect

ion

and

char

acte

rizat

ion

of e

pide

mic

pro

ne

and

othe

r dis

ease

of

Pub

lic H

ealth

impo

rtan

ce

Num

ber

1015

2025

35


P7:

Impr

ove

prog

ram

s/pr

ojec

ts a

nd In

stitu

tiona

l pol

icie

s D

evel

opm

ent a

nd M

anag

emen

t

P7.

SI1

Stre

ngth

enin

g pr

ogra

m/p

roje

ct

plan

, mon

itorin

g

and

Eval

uatio

n sy

stem

Dev

elop

lon

g te

rm a

nd a

nnua

l op

erat

iona

l pla

n

Dev

elop

5 y

ears

and

vis

ioni

ng p

lans

Num

ber

11

Dev

elop

ann

ual o

pera

tiona

l pla

nN

umbe

r4

44

44

Dev

elop

pub

lic h

ealth

rese

arch

age

nda

Num

ber

11

Con

duct

Mon

itorin

g of

pr

ogra

ms/

proj

ects

Con

duct

qua

rter

ly m

onito

ring

of p

rogr

ams/

proj

ects

an

d su

bmit

prog

ress

repo

rts

Rou

nds

44

44

4

Con

duct

inte

grat

ed s

uppo

rtiv

e su

perv

isio

nN

umbe

r1

22

22

Con

duct

ann

ual r

evie

w m

eetin

g

Num

ber

11

11

1

Rev

iew

res

earc

h pr

opos

al d

ocum

ents

qua

rter

lyN

umbe

r3

44

44

Con

duct

mon

itorin

g of

rese

arch

pro

ject

s on

thei

r ad

here

nce

to a

ppro

val

%50

7590

100

100

Con

duct

str

ateg

y an

d pr

ogra

ms/

Pro

ject

s e

valu

atio

ns

Con

duct

mid

term

and

end

-ter

m s

trat

egy

plan

m

anag

emen

t (S

PM

) N

umbe

r1

1

Con

duct

pro

gram

s an

d M

ega-

proj

ects

ev

alua

tions

Num

ber

11

21

P7.

SI2

Stre

ngth

en

adm

inis

trat

ive

and

tech

nica

l po

licie

s an

d gu

idel

ines

de

velo

pmen

t and

us

e

Dev

elop

int

erna

l pol

icie

s/gu

idel

ines

for

adm

inis

trat

ive

and

com

plia

nce

activ

ities

Cus

tom

izat

ion

of

inte

rnal

pol

icie

s/gu

idel

ines

for

adm

inis

trat

ive

activ

ities

N

umbe

r2

23

Dev

elop

int

erna

l pol

icie

s/gu

idel

ines

to

ensu

re

com

plia

nce

Num

ber

11

1

Dev

elop

pol

icie

s/gu

idel

ines

for

la

bora

tory

, res

earc

h an

d P

HEM

op

erat

ions

/act

iviti

es

Dev

elop

pol

icie

s/gu

idel

ines

for

qua

lity

labo

rato

ry

syst

emN

umbe

r5

66

66

Dev

elop

pol

icie

s/gu

idel

ines

for

rese

arch

op

erat

ions

/act

iviti

esN

umbe

r1

Dev

elop

pol

icie

s/gu

idel

ines

for

PH

EM (

PH

EM

guid

elin

e, Y

ello

w fe

ver,

Den

gue

feve

r, A

nthr

ax,

Rab

ies,

MER

S-C

ov, E

bola

, , M

ater

nal d

eath

su

rvei

llanc

e, E

OC

SO

P, a

nd e

-PH

EM S

OP

)

Num

ber

33

4


F1: I

mpr

ove

finan

cial

reso

urce

mob

ilizat

ion

and

utiliz

atio

n ef

ficie

ncy

F1.S

I1

Esta

blis

h ef

ficie

nt

finan

cial

reso

urce

m

obiliz

atio

n sy

stem

Fund

Mob

ilizat

ion

base

d on

the

stra

tegy

Iden

tify

gaps

and

map

fina

ncia

l res

ourc

es%

100

100

100

100

100

Dev

elop

fina

ncia

l res

ourc

e m

obiliz

atio

n st

rate

gyN

umbe

r1

Dev

elop

meg

a pr

ojec

ts a

nd m

obiliz

e re

sour

ces

Num

ber

25

35

2

F1.S

I2En

sure

effi

cien

t fin

anci

al re

sour

ce

utiliz

atio

n sy

stem

Trac

k pr

oper

and

effi

cien

t fin

anci

al u

tiliz

atio

n C

ondu

ct in

tern

al m

onth

ly fi

nanc

ial u

tiliz

atio

n au

ditin

g R

ound

s12

1212

1212

Ensu

re a

nd in

spec

t pr

oper

ut

ilizat

ion

of fi

nanc

ial r

esou

rce

Con

duct

mon

thly

fina

ncia

l util

izat

ion

insp

ectio

nR

ound

s12

1212

1212

F1.S

I3

Enha

nce

logi

stic

s m

anag

emen

t sy

stem

Esta

blis

h Ef

ficie

nt

Pro

cure

men

t sys

tem

Dev

elop

gen

eral

equ

ipm

ent a

nd s

uppl

ies

dire

ctor

y N

umbe

r1

Impl

emen

t on

line

auto

mat

ed p

rocu

rem

ent a

nd

prop

erty

adm

inis

trat

ion

%10

010

010

010

010

0

Pre

pare

ann

ual p

rocu

rem

ent p

lan

Num

ber

11

11

1

Ava

il go

ods

and

supp

lies

as p

er th

e ne

ed a

nd le

ad

time

%10

010

010

010

010

0

Con

duct

on

time

prop

erty

inve

ntor

y an

d m

anag

emen

t to

redu

ce w

asta

ge

Rou

nds

22

22

2

Dec

reas

e tim

e ta

ken

for c

usto

m c

lear

ance

D

ays

109

88

6

Esta

blis

h ef

ficie

nt E

mer

genc

y D

rugs

and

sup

plie

s m

anag

emen

t and

fast

trac

k sy

stem

Con

duct

reg

ular

Em

erge

ncy

drug

s an

d su

pplie

s

inve

ntor

y N

umbe

r12

1212

1212

Esta

blis

h Em

erge

ncy

Dru

gs fa

st tr

ack

syst

em%

5060

8090

95

Esta

blis

h ef

ficie

nt tr

ansp

ort

serv

ice

& v

ehic

le m

aint

enan

ce

syst

em

Pur

chas

e an

d av

ail v

ehic

les

for t

rans

port

ser

vice

s N

umbe

r

Con

duct

on

time

vehi

cle

mai

nten

ance

%

100

100

100

100

100

Pro

vide

on

time

and

effic

ient

tran

spor

t ser

vice

s%

9595

100

100

100

Impl

emen

t aut

omat

ed lo

g sh

eet a

nd G

PIS

for

tran

spor

t man

agem

ent

%10

010

010

010

010

0


CB

1: Im

prov

e H

uman

Res

ourc

e D

evel

opm

ent,

Man

agem

ent

and

Gov

erna

nce

CB

1.S

I1S

treng

then

HD

A

of th

e In

stitu

te

Con

duct

con

tinuo

us H

DA

pe

rform

ance

eva

luat

ion

and

supp

ort

Con

duct

HD

A m

onito

ring,

eva

luat

ion

and

feed

back

Rou

nds

44

44

4

Pre

pare

indi

vidu

als

casc

aded

pla

n us

ing

BS

C a

nd

perfo

rman

ce e

valu

atio

n R

ound

s2

22

22

Rec

ogni

ze b

ette

r per

form

ers

annu

ally

Rou

nds

11

11

1

Con

duct

HD

A tr

aini

ngpr

ovid

e H

DA

sch

eme

trai

ning

bas

ed o

n id

entifi

ed

gaps

%

100

100

100

100

100

Stre

ngth

enin

g ot

her r

efor

m

tool

s im

plem

enta

tions

Pilo

ting

and

impl

emen

ting

Kai

zen

tool

on

labo

rato

ry, p

rope

rty

and

proc

urem

ent

adm

inis

trat

ion

%50

100

100

100

Rev

isin

g an

d up

datin

g EP

HI B

PR

doc

umen

t%

100

100

100

100

CB

1.S

I2

Stre

ngth

en

Hum

an R

esou

rce

Dev

elop

men

t th

roug

h tr

aini

ng

Pro

vide

sho

rt te

rm tr

aini

ng

for i

nter

nal a

nd e

xter

nal

prof

essi

onal

s

Pro

vide

sho

rt te

rm tr

aini

ng fo

r int

erna

l and

ext

erna

l pe

rson

nel i

n di

ffere

nt la

bora

tory

dis

cipl

ines

Num

ber

1500

1500

1500

1500

1500

Trai

n P

HEM

offi

cers

/pro

fess

iona

ls in

diff

eren

t P

HEM

ope

ratio

nsN

umbe

r75

185

275

165

`70

Pro

vide

sho

rt te

rm tr

aini

ng o

n re

sear

ch p

ropo

sal

writ

ing

and

ethi

cs

Num

ber

2570

8090

100

Pro

vide

sho

rt te

rm tr

aini

ng o

n di

ffere

nt d

isci

plin

es

(lead

ersh

ip -

gove

rnan

ce)

Num

ber

110

120

130

140

150

Pro

vide

lon

g te

rm tr

aini

ng fo

r in

tern

al a

nd e

xter

nal h

ealth

w

orke

rs

Trai

n w

orke

rs w

ith M

SC

/MP

H/M

A le

vel

Num

ber

1015

1015

15

Trai

n w

orke

rs w

ith P

hD le

vel

Num

ber

510

1012

12

Fiel

d Ep

idem

iolo

gy a

nd la

bora

tory

Tra

inin

g pr

ogra

m (L

ab a

nd E

pi tr

acks

)N

umbe

r12

612

612

612

612

6

Hig

hly

Spe

cial

ized

sub

ject

mat

ter T

rain

ing

(MP

H,

MS

c., P

hD)

Num

ber

12

13

3

Esta

blis

hing

pub

lic h

ealth

trai

ning

ope

ratio

nal

syst

emN

umbe

r1

CB

1.S

I3A

vail

and

reta

in

the

skille

d hu

man

re

sour

ce

App

ly a

ttrac

tive

sch

emes

to

reta

in s

kille

d w

orkf

orce

Con

duct

ass

essm

ent t

o kn

ow w

orke

rs

satis

fact

ions

Num

ber

11

11

1

Esta

blis

h co

mpr

ehen

sive

ret

entio

n sc

hem

es%

100

100

100

100

100


CB

1.S

I4E

nhan

ce g

ood

gove

rnan

ce

Impl

emen

t goo

d go

vern

ance

Impl

emen

t citi

zen

char

ter a

nd tr

ack

prog

ress

Rou

nd4

44

44

Ensu

re th

e 8

prin

cipl

es o

f goo

d go

vern

ance

and

tr

ack

prog

ress

roun

d4

44

44

Ensu

re a

nd m

aint

aini

ng a

ccou

ntab

ility,

and

trac

k pr

ogre

ssro

und

44

44

4

CB

1.S

I5

Mai

nstr

eam

ing

wom

en &

yo

uths

, HIV

co

ntro

l and

en

viro

nmen

tal

issu

es

Mai

nstre

amin

g w

omen

&

yout

hs a

ffairs

Wom

en &

you

ths

affa

irs m

ains

tream

ing,

faci

litat

e ge

nder

equ

ity in

lea

ders

hip,

and

trac

k pr

ogre

ssro

und

44

44

4

Mai

nstre

amin

g H

IV c

ontro

l H

IV c

ontro

l mai

nstre

amin

g an

d tr

ack

prog

ress

Rou

nd4

44

44

Mai

nstre

amin

g en

viro

nmen

tal

prot

ectio

n is

sues

Cre

ate

wor

king

saf

ety

and

envi

ronm

ent

prot

ectio

n m

ains

tream

ing,

and

trac

k pr

ogre

ssR

ound

44

44

4

CB

2.S

I1B

uild

and

st

reng

then

in

frast

ruct

ures

Bui

ld t

he I

nstit

ute’

s m

ain

pr

emis

es in

clud

ing

war

ehou

se

and

sec

urity

Bui

ld

the

Inst

itute

’s m

ain

Com

plex

N

umbe

r1

Con

stru

ct s

tand

ard

war

ehou

seN

umbe

r1

Con

stru

ct c

ompo

und

secu

rity

faci

lity

Num

ber

1

CB

2: E

nhan

ce In

frast

ruct

ure

and

Sys

tem

dev

elop

men

t

CB

2.S

I1B

uild

and

st

reng

then

in

frast

ruct

ures

Bui

ld t

he I

nstit

ute’

s m

ain

pr

emis

es in

clud

ing

war

ehou

se

and

sec

urity

Bui

ld th

e In

stitu

te’s

mai

n C

ompl

ex

Num

ber

1

Con

stru

ct s

tand

ard

war

ehou

seN

umbe

r1

Con

stru

ct c

ompo

und

secu

rity

faci

lity

Num

ber

1

Bui

ld h

igh

leve

l te

chni

cal

faci

litie

s

Bui

ld e

nhan

ced

BS

L3 L

abor

ator

y at

nat

iona

l lev

elN

umbe

r1

Est

ablis

h B

SL3

Lab

orat

ory

at n

atio

nal a

nd re

gion

al

leve

lN

umbe

r1

22

Ren

ovat

e se

lect

ed h

ospi

tal l

abor

ator

ies

Num

ber

86

54

3

Con

stru

ct e

mer

genc

y op

erat

ion

cent

ers

(EO

Cs)

Num

ber

14

Con

stru

ct s

tand

ard

rece

ptio

n ce

nter

Num

ber

1

Con

stru

ct b

asic

util

ity fa

cilit

ies

Num

ber

2


CB

2.S

I2

Str

engt

hen

info

rmat

ion

com

mun

icat

ion

tech

nolo

gy(IC

T) o

f th

e in

stitu

te

Dev

elop

nat

iona

l dig

ital p

ublic

he

alth

dat

a re

posi

tory

Est

ablis

h st

anda

rd d

ata

war

e-ho

use

Num

ber

1

Dev

elop

dat

a st

ruct

ure

dire

ctor

yN

umbe

r1

Con

duct

dat

a co

llect

ion

and

orga

niza

tion

%10

0

Aut

omat

e al

l maj

or o

pera

tions

of

the

inst

itute

Aut

omat

e 17

EP

HI m

ajor

ope

ratio

ns fu

lly

Num

ber

85

4

Exp

and

Ele

ctro

nic

Labo

rato

ry in

form

atio

n sy

stem

Num

ber

4060

8010

015

0

CB

3: E

nhan

ce C

omm

unic

atio

n, C

oord

inat

ion

and

Par

tner

ship

CB

3.S

I1

Est

ablis

h in

form

atio

n an

d co

mm

unic

atio

n sy

stem

Str

engt

hen

com

mun

icat

ion

tool

s ca

paci

ty

Dev

elop

info

rmat

ion

and

com

mun

icat

ion

stra

tegy

N

umbe

r1

Dev

elop

and

dis

sem

inat

e au

dio-

visu

al

prog

ram

mat

ic m

essa

ges

(On

rese

arch

, PH

EM,

qual

ity la

bora

tory

sys

tem

, SER

O, M

&E

)N

umbe

r7

1010

1010

Est

ablis

h in

form

atio

n an

d co

mm

unic

atio

n di

rect

ory

Num

ber

1

Pro

vide

tim

ely

info

rmat

ion

and

effic

ient

co

mm

unic

atio

n w

ithin

10

days

%10

010

010

010

010

0

CB

3.S

I2S

tren

gthe

ning

co

ordi

natio

n a

nd

part

ners

hip

Est

ablis

h na

tiona

l/ re

gion

al/

inte

rnat

iona

l co

llabo

ratio

ns a

nd

part

ners

hips

Dev

elop

par

tner

ship

str

ateg

y ba

sed

on m

issi

on

and

obje

ctiv

esN

umbe

rN

umbe

r1

Est

ablis

h co

llabo

ratio

ns b

ased

on

the

stra

tegy

de

velo

ped

Num

ber

1010

55

2

Est

ablis

h pa

rtne

rshi

p ba

sed

on th

e st

rate

gy

deve

lope

dN

umbe

r4

44

43

Mai

ntai

n EP

HI’s

nat

iona

l/ re

gion

al/

inte

rnat

iona

l co

llabo

ratio

ns a

nd

part

ners

hips

mai

ntai

ned(

RT

T)

Mai

ntai

n pa

rtne

rshi

p ba

sed

on th

e st

rate

gy

deve

lope

d

Enh

ance

pub

lic h

ealth

co

ordi

natio

n

Con

duct

join

t par

tner

ship

coo

rdin

atio

n fo

rum

s of

th

e in

stitu

teN

umbe

r2

22

22

Con

duct

coo

rdin

atio

n fo

rum

s of

PH

EMN

umbe

r4

44

44

Con

duct

coo

rdin

atio

n fo

rum

s of

rese

arch

and

te

chno

logy

tran

sfer

Num

ber

22

22

2

Con

duct

coo

rdin

atio

n fo

rum

s of

qua

lity

labo

rato

ry

syst

emN

umbe

r4

44

44


Annex-3: Participants of the strategic planning processA. Participants of the strategic planning process

A.Name and address of participants of stakeholders on review meeting , which discussed on the

prepared five years (2015-2020) strategic plan held in Kuriftu Hotel , Adama , Ethiopia, June 18-20,

2015 (Sene 11-13/2007 E.C ).

No. Participants name Organization

1 Berhanu Amare CDC Ethiopia

2 Yenew Kebede, Dr. CDC Ethiopia

3 Kiyoon Yoon UNICEF

4 Ashenafi Hailu, Dr. CDC

5 Eshetu Yimer, Dr. Tufts University

6 Redeat Belanehe NAHDIC

7 Hagos Hadish FMHACA

8 Daniel Beshah TASH

9 Feradeselassie Mikru WHO

10 Elias Gossa, Dr. AFRTH

11 Getnet Tsigemealk ENAO

12 Tewodros Adere, Dr. Amanuel Hospital

13 Retalign Geletu EMLA

14 Yohannes H/Michael Jimma University

15 Alemayehu Bayray Mekele University

16 Mesfin Tesfay TRHB

17 G/Selassie Tekle TRHB

18 Tibebu Asfaw FHAPCO

19 Gelila Asamenew ELAR

20 Yalew Birke ORHB

21 Wondimu Gebayehu Bansangul RL

22 Kefni Kelbecha Afar RL

23 Yonas Taffese A & T

24 Bahari Belete CHAl


25 Alemayehu Bekele EPHA

26 Yohannes G/Hawaria TRHB

27 Yemane G/Silassie GRPHL

28 Ayichew Seyoum Harmaya University

29 Nena Okello Gambella RHB

30 Helen Engisa AAHB

31 Teferi Mekonnen ASLM

32 Hailay Berhe Dessie Reg. Lab

33 Nena Okello Gambella RHB

34 Helen Engisa AAHB

35 Teferi Mekonnen ASLM

36 Hailay Berhe Dessie Reg. Lab

37 Mequanent Eyayu EBI

38 Ashebir Gurmessa F.Prison

39 Tibebu Bekele EPHI

40 Yonas Sebsibe St.Petros

41 Mekonnen G/Selassie MOFED

42 Adane Mihret, Dr. AHRI

43 Markos Abebe, Dr. AHRI

44 Gudeta Tibesso, Dr. HEAL TB

45 Wessen Nega ICAP

46 Belete W/Maria SNNPR RHB

47 Dawit Abebe, Dr. EPHLA

48 Mohamed Ismael Harrare Regional lab



49 Ibrahim Adem Afar

50 Tessema Debaca Oromiya

51 Endashaw Shibru SNNP RHB

52 Ahmed Bedru TB/USAID

53 Endale Mengesha EPHI/KNCU

54Teklehaymanot Gebrehiwot

Amhara Regional H.B

55 Girmay Ayana EPHI

56 Amanuel Dibaba EPHI

57 Abraham Haile EPHI

58 Nigussie Gezahegn EPHI

59 Almaz Gonfa, Dr. EPHI

60 Abel Yeshaneh EPHI

61 Abraham Haile EPHI

62 Nigussie Gezahegn EPHI

63 Almaz Gonfa, Dr. EPHI

64 Abel Yeshaneh EPHI

65 Seid Kassaw EPHI

66 Abraham Tesfaye AACAHB

67 Lemma Bogalae Harar RHB

68 Mesele Mulugeta A.A.H.B

69 Amha Kebede, Dr. EPHI

70 Yibeltal Assefa, Dr. EPHI

71 Daddi Jima, Dr. EPHI

72 Habtamu Merha F.Police

73 Assefa Habete EPHI

74 Arega Zeru EPHI

75 Alemayehu Regassa EPHI

76 Firdu Egi EPHI


77 Biruktawit Girma EPHI

78 Amete Mihret EPHI

79 Abebe Mengesha EPHI

80 Adisu Kebede EPHI

81 Mekonnen Tadesse EPHI

82 Tibebu Mogesse EPHI

83 Asefa Deressa, Dr. EPHI

84 Masresha Tessema EPHI

85 Zelalem Yaregal EPHI

86 Hussien Faris EPHI

87 Abdi Ahmed EPHI

88 Ashenafi Assefa EPHI

89 Almaz Abebe, Dr. EPHI

90 Melke Tadesse EPHI

91 Mamuye Hadise, Dr. EPHI

92 Adugna Woyessa, Adamu Belay

EPHI

93 Temesgen Aweke EPHI

94 Samson Yelma EPHI

95 Asmamawe Tigre EPHI

96 Negero Gemeda EPHI

97 Tsegerda Assefa EPHI

98 Mesfin Yohannes EPHI

99 Tadesse Abebe EPHI

100 Ashenefe Tadesse EPHI

101 Achamayeleh Mulugeta EPHI

102 Kissi Mudi EPHI

103 Nuria Yesufe EPHI

104 Tesfaye Hailu EPHI



105 Abyot Bekele EPHI

106 Kelbessa urga EPHI

107 Mekonnen Tadesse EPHI

108 Tibebu Mogesse EPHI

109 Aweke Kebede, Dr. EPHI

110 Wondwossen Kassa EPHI

111 Getachew Addis, Dr. EPHI

112 Asfaw Debella, Dr. EPHI

113 Teshome Abdeta EPHI

114 Molla Deribie EPHI

115 Abiy Nigussie EPHI

116 Adimasu Shibru, Dr. Education S. Center


B. Senior Management that have overseen the SPM process

1. Dr. Amha Kebede-Director General

2. Dr. Yibeltal Assefa-D/Director General

3. Dr. Daddi Jimma-D/Director General

C. SPM Development Core Team Members

1. Dr. Almaz Abebe-Chairperson (Research and Technology Transfer)

2. Ato Arega Zeru-Secretary (Planning, Monitoring and Evaluation Directorate)

3. Dr. Asfaw Debela-Co-Chair (Research and Technology Transfer)

4. Ato Adisu Kebede-Member (Laboratory Capacity Building Directorate)

5. Ato Achamyeleh Mulugeta- Member (Laboratory Capacity Building Directorate)

6. Ato Haftom Teame-Member (Public Health Emergency Management)

7. Ato Abdi Ahmed- Member (Public Health Emergency Management)

8. Ato Hussien Faris-Member (Procurement and Finance Directorate)

9. Ato Tadesse Nigatu-Member (Human Resource Management Directorate)

10. Ato Molla Deribie-Member (Planning, Monitoring and Evaluation Directorate)


Diseases on Eradication program in Ethiopia

1. Poliomyelitis (Polio)2. Dracunculiasis (Guinea worm)

Diseases on Elimination program in Ethiopia

1. Onchocerciasis2. Lymphatic filariasis (Elephantiasis)


Participants of the 2nd EPHI’s SPM preparation stakeholders’ review workshop

Regional Coordinatorscross check

IFSS packed fileCentral Server at EPHI IT dept.

Data collectors

INTERNET FILE STREAMING SYSTEM OF EPHI

Data collectors senddata to RC and receive

feedbackSh

are

data

Data collectors send data to central server

Feed back from data quality control team


EPHI’s New Training Center

Director General’s Office . . . . . . . . . . . . . . . . . . . . . . .0112754647

Planning, Evaluation & Monitoring Directorate . . . . . .0112753330

Public Relations Office . . . . . . . . . . . . . . . . . . . . . . . . .0112133499

Fax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0112754647

P.o.Box . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .01242/5654

E-mail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [email protected]

Website . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .www.ephi.gov.et

Where to find us.

Contact

EPHIArbegnoch Street Gulele Sub CityAddis Ababa, Ethiopia

EPHI’s New Training Center

ContactDirector General’s Office . . . . . . . . . . . . . . . . . . . . . . . . . 0112754647Planning, Monitoring & Evaluation Directorate . . . . . 0112753330Public Relations Office . . . . . . . . . . . . . . . . . . . . . . . . . . 0112133499Fax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0112754647P.o.Box . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..1242/5654

E-mail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [email protected] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .www.ephi.gov.et

Where to find us.Arbegnoch Street Gulele Sub City Addis Ababa, Ethiopia

The 2nd BSC Based EPHI’s Strategic Management Plan (2015/16 … · 2018-01-17 · The 2nd BSC...

Documents

Transcript of The 2nd BSC Based EPHI’s Strategic Management Plan (2015/16 … · 2018-01-17 · The 2nd BSC...